<doc>
  <docmeta id="113hr307rs">
    <bill congress="113" type="hr" number="307" version="rs"/>
    <revision size="278404" annotations="0" status="complete" id="15" commit-time="2014-03-26T19:18:39Z" committer="mbohmer" doc="113hr307rs/15.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Reported-in-Senate" bill-type="olc" dms-id="HB7AB2D8E97A9418684C712A33FB65B9F" public-private="public" stage-count="1">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 307 RS: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-23</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<calendar>Calendar No. 14</calendar>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 307</legis-num>
		<current-chamber display="yes">IN THE SENATE OF THE UNITED
		  STATES</current-chamber>
		<action>
			<action-date date="20130123" legis-day="20130103">January 23
			 (legislative day, January 3), 2013</action-date>
			<action-desc>Received; read twice and referred to the
			 <committee-name added-display-style="italic" committee-id="SSHR00" deleted-display-style="strikethrough">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<action stage="Reported-in-Senate">
			<action-date>February 14, 2013</action-date>
			<action-desc>Reported by <sponsor name-id="S172">Mr. Harkin</sponsor>,
			 with an amendment</action-desc>
			<action-instruction>Strike out all after the enacting clause and insert
			 the part printed in italic</action-instruction>
		</action>
		<legis-type>AN ACT</legis-type>
		<official-title display="yes">To reauthorize certain programs under the
		  Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with
		  respect to public health security and all-hazards preparedness and response,
		  and for other purposes.</official-title>
	</form>
	<legis-body id="HFCF3D53D94CD4B26BD5BB79CA21EE529" style="OLC">
		<section changed="deleted" committee-id="SSHR00" id="HCCEE00D5C16146D6A80911AD0E17C2BA" reported-display-style="strikethrough" section-type="section-one">
      <enum>1.</enum>
      <header>Short title; table of
			 contents</header>
			<subsection id="HC5EC0DA583394DC4876141E1DA4D76E5">
        <enum>(a)</enum>
        <header>Short
			 title</header>
        <text>This Act may be cited as the <quote>
            <short-title>Pandemic and All-Hazards Preparedness Reauthorization Act
			 of 2013</short-title>
          </quote>.</text>
			</subsection>
      <subsection id="H778B262165BE4A49BE77ABF940D13842">
        <enum>(b)</enum>
        <header>Table of
			 contents</header>
        <text>The table of contents of this Act is as follows:</text>
				<toc changed="deleted" committee-id="SSHR00" container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration" reported-display-style="strikethrough">
					<toc-entry idref="HCCEE00D5C16146D6A80911AD0E17C2BA" level="section">Sec. 1. Short title; table of
				contents.</toc-entry>
					<toc-entry idref="H59FD4838330446079FDC34FC2212514E" level="title">Title I—Strengthening national
				preparedness and response for public health emergencies</toc-entry>
					<toc-entry idref="H5ACE905990694789A34D96741F241153" level="section">Sec. 101. National Health Security
				Strategy.</toc-entry>
					<toc-entry idref="H080FF024053947CDBF9B76F71DA4340D" level="section">Sec. 102. Assistant Secretary for
				Preparedness and Response.</toc-entry>
					<toc-entry idref="HA6F39285D54F4C3AB9635FA5FC74E82C" level="section">Sec. 103. National Advisory Committee on
				Children and Disasters.</toc-entry>
					<toc-entry idref="HFDBA0EEDB6134A1E80884A45EE3B5D63" level="section">Sec. 104. Modernization of the National
				Disaster Medical System.</toc-entry>
					<toc-entry idref="HA9DC3FAF242F4381BC7AE2DF046BF804" level="section">Sec. 105. Continuing the role of the
				Department of Veterans Affairs.</toc-entry>
					<toc-entry idref="H21F113B4823343B3B80A1C7F4E6E8D53" level="title">Title II—Optimizing State and local
				all-hazards preparedness and response</toc-entry>
					<toc-entry idref="H984CE0335A204E84A6E9CC47BA2AB678" level="section">Sec. 201. Temporary redeployment of
				federally funded personnel during a public health emergency.</toc-entry>
					<toc-entry idref="H92A6E08877024EBAB6226EE1A00ED9B8" level="section">Sec. 202. Improving State and local
				public health security.</toc-entry>
					<toc-entry idref="H331F70D3384F4994BAD3667214F7B4A2" level="section">Sec. 203. Hospital preparedness and
				medical surge capacity.</toc-entry>
					<toc-entry idref="H00289191EB104CD5B3B88678C6DADF93" level="section">Sec. 204. Enhancing situational
				awareness and biosurveillance.</toc-entry>
					<toc-entry idref="HA2F02A10FAA7454990BBCBA5F231D8F1" level="section">Sec. 205. Eliminating duplicative
				Project Bioshield reports.</toc-entry>
					<toc-entry idref="H1363D5FC34FB4F998D7C3EE07200011C" level="title">Title III—Enhancing Medical
				Countermeasure Review</toc-entry>
					<toc-entry idref="HC8A5882A0CFD48818F1E125C33B398FE" level="section">Sec. 301. Special protocol
				assessment.</toc-entry>
					<toc-entry idref="HA2709FB2D3784E098AD5D201DD3568CD" level="section">Sec. 302. Authorization for medical
				products for use in emergencies.</toc-entry>
					<toc-entry idref="HEC0BD8048404458DA08A365CA2C15110" level="section">Sec. 303. Definitions.</toc-entry>
					<toc-entry idref="HFBBB97B5F2094C6B80116CBA431DAD3F" level="section">Sec. 304. Enhancing medical
				countermeasure activities.</toc-entry>
					<toc-entry idref="H2E57CC3BD3CE43CA833392F58FD99ED3" level="section">Sec. 305. Regulatory management
				plans.</toc-entry>
					<toc-entry idref="HDCB0E8E3FE1F4AA5A76C15B4817D1B97" level="section">Sec. 306. Report.</toc-entry>
					<toc-entry idref="HCD660DD3C3A34E93B045250C888AF95E" level="section">Sec. 307. Pediatric medical
				countermeasures.</toc-entry>
					<toc-entry idref="H4A482682FF8C4C76B83DD4F271686E77" level="title">Title IV—Accelerating medical
				countermeasure advanced research and development</toc-entry>
					<toc-entry idref="H0544928AD668436CBDFFD58997C4EB5A" level="section">Sec. 401. BioShield.</toc-entry>
					<toc-entry idref="H2133264C75B543CF97043CADF6F4E2BD" level="section">Sec. 402. Biomedical Advanced Research
				and Development Authority.</toc-entry>
					<toc-entry idref="H8C32E3DC40334E2BA73AAE7843482973" level="section">Sec. 403. Strategic National
				Stockpile.</toc-entry>
					<toc-entry idref="HB37DEC86CD024C59B0FDE9FDB8F0CDA7" level="section">Sec. 404. National Biodefense Science
				Board.</toc-entry>
				</toc>
			</subsection>
    </section>
    <title changed="deleted" commented="no" committee-id="SSHR00" id="H59FD4838330446079FDC34FC2212514E" level-type="subsequent" reported-display-style="strikethrough">
      <enum>I</enum>
      <header display-inline="yes-display-inline">Strengthening national preparedness and
			 response for public health emergencies</header>
			<section commented="no" display-inline="no-display-inline" id="H5ACE905990694789A34D96741F241153" section-type="subsequent-section">
        <enum>101.</enum>
        <header display-inline="yes-display-inline">National Health Security Strategy</header>
				<subsection commented="no" display-inline="no-display-inline" id="HB77E6B0B2EC24809A093B7FE085EB8F6">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">Section 2802 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-1">42 U.S.C. 300hh–1</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H7C5C497048FD4093B73AEA6F9339980A">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (a)(1), by striking
			 <quote>2009</quote> and inserting <quote>2014</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H4B5BEE114A9C415F961AC631CA0BD7F5">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subsection (b)—</text>
						<subparagraph id="H79937996B01F4255A6DB02FFDF2A6EB0">
              <enum>(A)</enum>
              <text>in paragraph
			 (1)(A), by inserting <quote>, including drills and exercises to ensure medical
			 surge capacity for events without notice</quote> after
			 <quote>exercises</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HC7D854FBF35346F6AE105C71BC6AA57B">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (3)—</text>
							<clause commented="no" display-inline="no-display-inline" id="HA9436E4297E649FCB27262C50F6CBDCD">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in the matter preceding subparagraph
			 (A)—</text>
								<subclause commented="no" display-inline="no-display-inline" id="H9831A45233CC4C4C8AAAAA32AE30403F">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>facilities), and trauma
			 care</quote> and inserting <quote>and ambulatory care facilities and which may
			 include dental health facilities), and trauma care, critical care,</quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="H916559F2E58E4F4AB06BE59AC1599451">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by inserting <quote>(including related
			 availability, accessibility, and coordination)</quote> after <quote>public
			 health emergencies</quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="H4834ECAB8EE94E71AF4FD15F7E9AD753">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in subparagraph (A), by inserting
			 <quote>and trauma</quote> after <quote>medical</quote>;</text>
							</clause>
              <clause id="H20DDC8A353C8431F90F2587B10B84332">
                <enum>(iii)</enum>
                <text>in subparagraph
			 (B), by striking <quote>Medical evacuation and fatality management</quote> and
			 inserting <quote>Fatality management</quote>;</text>
							</clause>
              <clause id="HAC90D83C979549FDA382EDCE1B36C4EE">
                <enum>(iv)</enum>
                <text>by redesignating
			 subparagraphs (C), (D), and (E) as subparagraphs (D), (E), and (F),
			 respectively;</text>
							</clause>
              <clause id="HDC54B3BC38F04FE29F33FC0E87C0DBF9">
                <enum>(v)</enum>
                <text>by inserting after
			 subparagraph (B), the following the new subparagraph:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC2591AD8DD7349C089B0AE3CB1E75461" reported-display-style="strikethrough" style="OLC">
									<subparagraph id="HB6C05CFF630244BC96AF401D77BE080A">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">Coordinated medical triage and evacuation
				to appropriate medical institutions based on patient medical need, taking into
				account regionalized systems of
				care.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HACCC590B7D5B4FBDBCEF1490CB5EA310">
                <enum>(vi)</enum>
                <text display-inline="yes-display-inline">in subparagraph (E), as redesignated by
			 clause (iv), by inserting <quote>(which may include such dental health
			 assets)</quote> after <quote>medical assets</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HEB8C11FC83FC4C25BCE1560B028CD1E2">
                <enum>(vii)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H542FB71BA4D74D12B7FF320313E04424" reported-display-style="strikethrough" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="H8D568029494A44E884856DBFB486A9E1">
                    <enum>(G)</enum>
                    <text display-inline="yes-display-inline">Optimizing a coordinated and flexible
				approach to the medical surge capacity of hospitals, other health care
				facilities, critical care, and trauma care (which may include trauma centers)
				and emergency medical
				systems.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HCA1C1839F89F4BB0984B0C836019399D">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in paragraph (4)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H62728AED1FD848808B0F92CD6E8D2D34">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in subparagraph (A), by inserting <quote>,
			 including the unique needs and considerations of individuals with
			 disabilities,</quote> after <quote>medical needs of at-risk
			 individuals</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H22F1822678DF49F48C194A0F890C6AA0">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in subparagraph (B), by inserting
			 <quote>the</quote> before <quote>purpose of this section</quote>; and</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HCF5C55C6C22343E1A3E870E31F33CDA0">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H85DDA8C89469462C8FEA508DBD12C6E0" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H67101D3E6F1D4544843585118DBFD7D1">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Countermeasures</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="HFD746299BB0E493A8914537CF2D4901E">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">Promoting strategic initiatives to advance
				countermeasures to diagnose, mitigate, prevent, or treat harm from any
				biological agent or toxin, chemical, radiological, or nuclear agent or agents,
				whether naturally occurring, unintentional, or deliberate.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HA9EC33439E6A41C6900591D307C0F93B">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">For purposes of this paragraph, the term
				<term>countermeasures</term> has the same meaning as the terms <term>qualified
				countermeasures</term> under section 319F–1, <quote>qualified pandemic and
				epidemic products</quote> under section 319F–3, and <quote>security
				countermeasures</quote> under section 319F–2.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H7450B80689DE4B9B9B192935C1E483C5">
                  <enum>(8)</enum>
                  <header display-inline="yes-display-inline">Medical and public health community
				resiliency</header>
                  <text display-inline="yes-display-inline">Strengthening the
				ability of States, local communities, and tribal communities to prepare for,
				respond to, and be resilient in the event of public health emergencies, whether
				naturally occurring, unintentional, or deliberate by—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H508BDB2403E34D3A943F1D1A05AEABE4">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">optimizing alignment and integration of
				medical and public health preparedness and response planning and capabilities
				with and into routine daily activities; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H75855CDE68E64D719BA39BD9AA51C650">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">promoting familiarity with local medical
				and public health
				systems.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HB4720CE325CC4948BE940B4041333150">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">At-Risk individuals</header>
          <text display-inline="yes-display-inline">Section 2814 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-16">42 U.S.C. 300hh–16</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="HFA6618DBCA7E45DFAEE077244144496A">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">by striking paragraphs (5), (7), and
			 (8);</text>
					</paragraph>
          <paragraph commented="no" id="H67B01E1EF9F64704834176F9DC85D2DA">
            <enum>(2)</enum>
            <text>in paragraph (4),
			 by striking <quote>2811(b)(3)(B)</quote> and inserting
			 <quote>2802(b)(4)(B)</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H39A44BBC52F14DB9A2771898684C8EE0">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by redesignating paragraphs (1) through (4)
			 as paragraphs (2) through (5), respectively;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H119ACF68633E49DCA4DA2EE255C9D1B4">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">by inserting before paragraph (2) (as so
			 redesignated), the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H9C46390EEBAE484BA673536B6AA33F99" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="H2CB8CAB4A5BF496DA05F3052DCBEDD01">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">monitor emerging issues and concerns as
				they relate to medical and public health preparedness and response for at-risk
				individuals in the event of a public health emergency declared by the Secretary
				under section
				319;</text>
							</paragraph>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HBDA1E940910E48789686E24104F62E06">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">by amending paragraph (2) (as so
			 redesignated) to read as follows:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H8109FB9C5A784E52983A325A055D6936" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" id="HD212C3FAFF4A41288B099FDEEBB85B86">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">oversee the implementation of the
				preparedness goals described in section 2802(b) with respect to the public
				health and medical needs of at-risk individuals in the event of a public health
				emergency, as described in section
				2802(b)(4);</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HB903D2D8A11542F5B1109F154D0DDB8E">
            <enum>(6)</enum>
            <text display-inline="yes-display-inline">by inserting after paragraph (6), the
			 following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H0C7BB405E0194431A2A2AA99EDD50B8B" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="HF62F891B460644AEBCA17B4859364D43">
                <enum>(7)</enum>
                <text display-inline="yes-display-inline">disseminate and, as appropriate, update
				novel and best practices of outreach to and care of at-risk individuals before,
				during, and following public health emergencies in as timely a manner as is
				practicable, including from the time a public health threat is identified;
				and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H526B71C123BF4F618C82AF3DDA3DB883">
                <enum>(8)</enum>
                <text display-inline="yes-display-inline">ensure that public health and medical
				information distributed by the Department of Health and Human Services during a
				public health emergency is delivered in a manner that takes into account the
				range of communication needs of the intended recipients, including at-risk
				individuals.</text>
							</paragraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H080FF024053947CDBF9B76F71DA4340D" section-type="subsequent-section">
        <enum>102.</enum>
        <header display-inline="yes-display-inline">Assistant Secretary for Preparedness and
			 Response</header>
				<subsection commented="no" display-inline="no-display-inline" id="H6B6CA3A2894C4C2F8152F1C724FB6C36">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">Section 2811 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-10">42 U.S.C. 300hh–10</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="HFEA65D4DAE25410E9C466504B74B294A">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (b)—</text>
						<subparagraph id="H32766263737E44F7958E2BB3FDB2AA91">
              <enum>(A)</enum>
              <text>in paragraph (3),
			 by inserting <quote>, security countermeasures (as defined in section
			 319F–2),</quote> after <quote>qualified countermeasures (as defined in section
			 319F–1)</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H3279C7184FF24EEB824F393D45825BF8">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (4), by adding at the end the
			 following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HF7FE06318BCE45F6A1751F666D87C3AB" reported-display-style="strikethrough" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="H13C5A95E748E47BAB7D4F9418E245C83">
                  <enum>(D)</enum>
                  <header display-inline="yes-display-inline">Policy coordination and strategic
				direction</header>
                  <text display-inline="yes-display-inline">Provide integrated
				policy coordination and strategic direction with respect to all matters related
				to Federal public health and medical preparedness and execution and deployment
				of the Federal response for public health emergencies and incidents covered by
				the National Response Plan developed pursuant to section 504(6) of the Homeland
				Security Act of 2002, or any successor plan, before, during, and following
				public health emergencies.</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H16733368DD3E478E888CDB0E0E2C9416">
                  <enum>(E)</enum>
                  <header>Identification
				of inefficiencies</header>
                  <text>Identify and minimize gaps, duplication, and
				other inefficiencies in medical and public health preparedness and response
				activities and the actions necessary to overcome these obstacles.</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H4FC758C5008E4639B347F1D388068559">
                  <enum>(F)</enum>
                  <header>Coordination of
				grants and agreements</header>
                  <text display-inline="yes-display-inline">Align
				and coordinate medical and public health grants and cooperative agreements as
				applicable to preparedness and response activities authorized under this Act,
				to the extent possible, including program requirements, timelines, and
				measurable goals, and in consultation with the Secretary of Homeland Security,
				to—</text>
									<clause commented="no" display-inline="no-display-inline" id="H5AA79E2804DB4AF497D752B6E95F7751">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">optimize and streamline medical and public
				health preparedness and response capabilities and the ability of local
				communities to respond to public health emergencies; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="HF79F40CA751B45E4BC26BBFD00C0EDEF">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">gather and disseminate best practices among
				grant and cooperative agreement recipients, as appropriate.</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H0411A341D9304B59B696C3880A92B77B">
                  <enum>(G)</enum>
                  <header>Drill and
				operational exercises</header>
                  <text display-inline="yes-display-inline">Carry
				out drills and operational exercises, in consultation with the Department of
				Homeland Security, the Department of Defense, the Department of Veterans
				Affairs, and other applicable Federal departments and agencies, as necessary
				and appropriate, to identify, inform, and address gaps in and policies related
				to all-hazards medical and public health preparedness and response, including
				exercises based on—</text>
									<clause commented="no" display-inline="no-display-inline" id="H04E50F17D3224863BC825BD11B1BA149">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">identified threats for which
				countermeasures are available and for which no countermeasures are available;
				and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="HD09CBD3051CD49E28B1342742EDB438C">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">unknown threats for which no
				countermeasures are available.</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H472D9B8209D047BAA43D61B57690AA01">
                  <enum>(H)</enum>
                  <header display-inline="yes-display-inline">National security priority</header>
                  <text display-inline="yes-display-inline">On a periodic basis consult with, as
				applicable and appropriate, the Assistant to the President for National
				Security Affairs, to provide an update on, and discuss, medical and public
				health preparedness and response activities pursuant to this Act and the
				Federal Food, Drug, and Cosmetic Act, including progress on the development,
				approval, clearance, and licensure of medical
				countermeasures.</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H74769FEC13AD406986028C8A1E88504B">
              <enum>(C)</enum>
              <text>by adding at the
			 end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HE681223A80244A179BE9DF552DAC1BC8" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="HAA88A3E8079E4F3BB1EF5A63E53C7665">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Countermeasures budget plan</header>
                  <text display-inline="yes-display-inline">Develop, and update on an annual basis, a
				coordinated 5-year budget plan based on the medical countermeasure priorities
				described in subsection (d). Each such plan shall—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H31FF3DFB0ECE46A1A895C4BE0C48A5B9">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">include consideration of the entire medical
				countermeasures enterprise, including—</text>
										<clause commented="no" display-inline="no-display-inline" id="H209E9965EB87477BB4B17E67978B28EB">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">basic research and advanced research and
				development;</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="HC56B27F4E8B04D9E830DA5FC20C9C49F">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">approval, clearance, licensure, and
				authorized uses of products; and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="HE31819708E654B8995A966432F583FC0">
                      <enum>(iii)</enum>
                      <text display-inline="yes-display-inline">procurement, stockpiling, maintenance, and
				replenishment of all products in the Strategic National Stockpile;</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H8FB88E2FFF1449F1A14C936E392BEFFA">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">inform prioritization of resources and
				include measurable outputs and outcomes to allow for the tracking of the
				progress made toward identified priorities;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H993A89F17FED451F8C6E08193D2EEEC1">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">identify medical countermeasure life-cycle
				costs to inform planning, budgeting, and anticipated needs within the continuum
				of the medical countermeasure enterprise consistent with section 319F–2;
				and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HA54C687641D84AAE95BA8FE24FD8CE94">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">be made available to the appropriate
				committees of Congress upon
				request.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H52BE06650AA44E6282C5E76ED5E81DAC">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by striking subsection (c) and inserting
			 the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HBB63420588434728959EBF0958032B2D" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="HC952A70D0C344409989426F4E5E6BC5F">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Functions</header>
                <text display-inline="yes-display-inline">The Assistant Secretary for Preparedness
				and Response shall—</text>
								<paragraph commented="no" id="H05FF7BDAEA184F56A359324038010DA7">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">have lead responsibility within the
				Department of Health and Human Services for emergency preparedness and response
				policy coordination and strategic direction;</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H22CB9E6B6C9647B896A7F88FB05A9124">
                  <enum>(2)</enum>
                  <text display-inline="yes-display-inline">have authority over and responsibility
				for—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H9E916B0259DC4B539144BE69A496A698">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the National Disaster Medical System
				pursuant to section 2812;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H77A95E35C6D545A8BAFADAF477CF03FB">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the Hospital Preparedness Cooperative
				Agreement Program pursuant to section 319C–2;</text>
									</subparagraph>
                  <subparagraph id="HD0A2FD0985F6449F8E6A43D4AC052EFE">
                    <enum>(C)</enum>
                    <text>the Biomedical
				Advanced Research and Development Authority pursuant to section 319L;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H988D305C7F454BDFB7E24BAFB1B6A56D">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">the Medical Reserve Corps pursuant to
				section 2813;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HB36507FD99A4447E88260AC503F8E125">
                    <enum>(E)</enum>
                    <text display-inline="yes-display-inline">the Emergency System for Advance
				Registration of Volunteer Health Professionals pursuant to section 319I;
				and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H53EE32D413DB4605A6BEB7FFFBB37521">
                    <enum>(F)</enum>
                    <text display-inline="yes-display-inline">administering grants and related
				authorities related to trauma care under parts A through C of title XII, such
				authority to be transferred by the Secretary from the Administrator of the
				Health Resources and Services Administration to such Assistant
				Secretary;</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HFE09F070CDED4950B9F3A8056CAFC7DD">
                  <enum>(3)</enum>
                  <text display-inline="yes-display-inline">exercise the responsibilities and
				authorities of the Secretary with respect to the coordination of—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H82BA0878C10B4D3BBF859D48B7CE0EA5">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the Public Health Emergency Preparedness
				Cooperative Agreement Program pursuant to section 319C–1;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H924FAE836FD54BA8ABE66AA817B2EB5D">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the Strategic National Stockpile pursuant
				to section 319F–2; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H9A73ECB91D4F4CFB8B67EA9BB52FB83C">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">the Cities Readiness Initiative; and</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H018ADFD89074424A84B191239967B0F9">
                  <enum>(4)</enum>
                  <text display-inline="yes-display-inline">assume other duties as determined
				appropriate by the Secretary.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H9A2F9592C9764144A6EC2E0CFD6DC88F">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HF4A377A0316A4E5FA049E3277C0B8A98" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="H8EF00B77EC0E44348C8E71983B459862">
                <enum>(d)</enum>
                <header display-inline="yes-display-inline">Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan</header>
								<paragraph commented="no" display-inline="no-display-inline" id="HF9A92773AA4A4F498898A6241141D79F">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, and every year thereafter, the Assistant
				Secretary for Preparedness and Response shall develop and submit to the
				appropriate committees of Congress a coordinated strategy and accompanying
				implementation plan for medical countermeasures to address chemical,
				biological, radiological, and nuclear threats. In developing such a plan, the
				Assistant Secretary for Preparedness and Response shall consult with the
				Director of the Biomedical Advanced Research and Development Authority, the
				Director of the National Institutes of Health, the Director of the Centers for
				Disease Control and Prevention, and the Commissioner of Food and Drugs. Such
				strategy and plan shall be known as the <quote>Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan</quote>.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HAD5A9DEB96EB40F4AF9A9D09A0B3E793">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Requirements</header>
                  <text display-inline="yes-display-inline">The plan under paragraph (1) shall—</text>
									<subparagraph commented="no" id="HA20C033DCFB8498F86CF5FC227601192">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">describe the chemical, biological,
				radiological, and nuclear agent or agents that may present a threat to the
				Nation and the corresponding efforts to develop qualified countermeasures (as
				defined in section 319F–1), security countermeasures (as defined in section
				319F–2), or qualified pandemic or epidemic products (as defined in section
				319F–3) for each threat;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H1320DAFDC6E8479CACFDC1C9EB695E0D">
                    <enum>(B)</enum>
                    <text>evaluate the
				progress of all activities with respect to such countermeasures or products,
				including research, advanced research, development, procurement, stockpiling,
				deployment, distribution, and utilization;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H83BFA55F54B7449CBE91192F2C691723">
                    <enum>(C)</enum>
                    <text>identify and
				prioritize near-, mid-, and long-term needs with respect to such
				countermeasures or products to address a chemical, biological, radiological,
				and nuclear threat or threats;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H096294197AAE4B79B3E568ECC2E74AD9">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">identify, with respect to each category of
				threat, a summary of all awards and contracts, including advanced research and
				development and procurement, that includes—</text>
										<clause id="H51A6772E14EB48418E181519A3B4874B">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">the time elapsed from the issuance of the
				initial solicitation or request for a proposal to the adjudication (such as the
				award, denial of award, or solicitation termination); and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="HD920F47864DD4C3B8B28E2E21EA45493">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">an identification of projected timelines,
				anticipated funding allocations, benchmarks, and milestones for each medical
				countermeasure priority under subparagraph (C), including projected needs with
				regard to replenishment of the Strategic National Stockpile;</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HB661D9D12E6845A3B254503208CCED19">
                    <enum>(E)</enum>
                    <text display-inline="yes-display-inline">be informed by the recommendations of the
				National Biodefense Science Board pursuant to section 319M;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H1B617D5DACAF47DC8BC50C1D02767C70">
                    <enum>(F)</enum>
                    <text>evaluate progress
				made in meeting timelines, allocations, benchmarks, and milestones identified
				under subparagraph (D)(ii);</text>
									</subparagraph>
                  <subparagraph commented="no" id="H34703CFABB5B4A24A034F57A57F0290E">
                    <enum>(G)</enum>
                    <text>report on the
				amount of funds available for procurement in the special reserve fund as
				defined in section 319F–2(h) and the impact this funding will have on meeting
				the requirements under section 319F–2;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H851D463199634D33B69BACECB74670BF">
                    <enum>(H)</enum>
                    <text>incorporate input
				from Federal, State, local, and tribal stakeholders;</text>
									</subparagraph>
                  <subparagraph id="HBE20B66DFCA449BBBB2DB1B6330956B8">
                    <enum>(I)</enum>
                    <text display-inline="yes-display-inline">identify the progress made in meeting the
				medical countermeasure priorities for at-risk individuals (as defined in
				2802(b)(4)(B)), as applicable under subparagraph (C), including with regard to
				the projected needs for related stockpiling and replenishment of the Strategic
				National Stockpile, including by addressing the needs of pediatric populations
				with respect to such countermeasures and products in the Strategic National
				Stockpile, including—</text>
										<clause id="HEEEFAA4777714F9EA4463E580A66D86B">
                      <enum>(i)</enum>
                      <text>a list of such
				countermeasures and products necessary to address the needs of pediatric
				populations;</text>
										</clause>
                    <clause id="H588528AB1617470889EFDF6AB15A6F88">
                      <enum>(ii)</enum>
                      <text>a description of
				measures taken to coordinate with the Office of Pediatric Therapeutics of the
				Food and Drug Administration to maximize the labeling, dosages, and
				formulations of such countermeasures and products for pediatric
				populations;</text>
										</clause>
                    <clause id="H6C4B53A4BD3D4F66A0C273FC362DEF6B">
                      <enum>(iii)</enum>
                      <text>a description of
				existing gaps in the Strategic National Stockpile and the development of such
				countermeasures and products to address the needs of pediatric populations;
				and</text>
										</clause>
                    <clause id="HF172A591D3F84B2E9D06AFAE1812373C">
                      <enum>(iv)</enum>
                      <text>an evaluation of
				the progress made in addressing priorities identified pursuant to subparagraph
				(C);</text>
										</clause>
                  </subparagraph>
                  <subparagraph id="HC4AE045D52CC49839DD4EFDA36ADBA5C">
                    <enum>(J)</enum>
                    <text display-inline="yes-display-inline">identify the use of authority and
				activities undertaken pursuant to sections 319F–1(b)(1), 319F–1(b)(2),
				319F–1(b)(3), 319F–1(c), 319F–1(d), 319F–1(e), 319F–2(c)(7)(C)(iii),
				319F–2(c)(7)(C)(iv), and 319F–2(c)(7)(C)(v) of this Act, and subsections
				(a)(1), (b)(1), and (e) of section 564 of the Federal Food, Drug, and Cosmetic
				Act, by summarizing—</text>
										<clause id="HE94401F819F74870B10A895BAB397E98">
                      <enum>(i)</enum>
                      <text>the particular
				actions that were taken under the authorities specified, including, as
				applicable, the identification of the threat agent, emergency, or the
				biomedical countermeasure with respect to which the authority was used;</text>
										</clause>
                    <clause id="HDCCCB280F4814B1D8ED5EB37E40841DD">
                      <enum>(ii)</enum>
                      <text>the reasons
				underlying the decision to use such authorities, including, as applicable, the
				options that were considered and rejected with respect to the use of such
				authorities;</text>
										</clause>
                    <clause id="HDFDC2BEECBD24E6D99718FF6B42E316B">
                      <enum>(iii)</enum>
                      <text>the number of,
				nature of, and other information concerning the persons and entities that
				received a grant, cooperative agreement, or contract pursuant to the use of
				such authorities, and the persons and entities that were considered and
				rejected for such a grant, cooperative agreement, or contract, except that the
				report need not disclose the identity of any such person or entity;</text>
										</clause>
                    <clause id="H3022A63E4DAF438C923CA64D99D9AF9B">
                      <enum>(iv)</enum>
                      <text>whether, with
				respect to each procurement that is approved by the President under section
				319F–2(c)(6), a contract was entered into within one year after such approval
				by the President; and</text>
										</clause>
                    <clause id="H07F258C3E87F4CBDB7E7EBDA3055A4D0">
                      <enum>(v)</enum>
                      <text>with respect to
				section 319F–1(d), for the one-year period for which the report is submitted,
				the number of persons who were paid amounts totaling $100,000 or greater and
				the number of persons who were paid amounts totaling at least $50,000 but less
				than $100,000; and</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HAF509174460D4FF3BA2A2CB14E29E399">
                    <enum>(K)</enum>
                    <text display-inline="yes-display-inline">be made publicly available.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HACD85A2097CD413D82099B1C0EA63752">
                  <enum>(3)</enum>
                  <header display-inline="yes-display-inline">GAO report</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="H13E8079FAB5549309B71F9A77A399AD3">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Not later than 1 year after the date of the
				submission to the Congress of the first Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan, the Comptroller
				General of the United States shall conduct an independent evaluation, and
				submit to the appropriate committees of Congress a report, concerning such
				Strategy and Implementation Plan.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H6C1897B50A2E453EAAB4E9C17B629F3B">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Content</header>
                    <text display-inline="yes-display-inline">The report described in subparagraph (A)
				shall review and assess—</text>
										<clause commented="no" display-inline="no-display-inline" id="HA58B858D5E714042A5EF6F8C9E756CA6">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">the near-term, mid-term, and long-term
				medical countermeasure needs and identified priorities of the Federal
				Government pursuant to paragraph (2)(C);</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="H22E1E5459D5B42D5ADF9E1389D11FE9C">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">the activities of the Department of Health
				and Human Services with respect to advanced research and development pursuant
				to section 319L; and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="H9B6F6A9759694574814E57E80BADA661">
                      <enum>(iii)</enum>
                      <text display-inline="yes-display-inline">the progress made toward meeting the
				timelines, allocations, benchmarks, and milestones identified in the Public
				Health Emergency Medical Countermeasures Enterprise Strategy and Implementation
				Plan under this subsection.</text>
										</clause>
                  </subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="H4E481A99022A490F995FE424D3B7A791">
                <enum>(e)</enum>
                <header display-inline="yes-display-inline">Protection of national
				security</header>
                <text display-inline="yes-display-inline">In carrying out
				subsections (b)(7) and (d), the Secretary shall ensure that information and
				items that could compromise national security, contain confidential commercial
				information, or contain proprietary information are not
				disclosed.</text>
							</subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H6E8C37B21A064C6FA8F881F0FCC60071">
          <enum>(b)</enum>
          <header>Interagency
			 coordination plan</header>
          <text>In the first Public Health Emergency
			 Countermeasures Enterprise Strategy and Implementation Plan submitted under
			 subsection (d) of section 2811 of the Public Health Service Act (42 U.S.C.
			 300hh–10) (as added by subsection (a)(3)), the Secretary of Health and Human
			 Services, in consultation with the Secretary of Defense, shall include a
			 description of the manner in which the Department of Health and Human Services
			 is coordinating with the Department of Defense regarding countermeasure
			 activities to address chemical, biological, radiological, and nuclear threats.
			 Such report shall include information with respect to—</text>
					<paragraph id="H114EACA0327344B383BD4439FF6FF479">
            <enum>(1)</enum>
            <text>the research,
			 advanced research, development, procurement, stockpiling, and distribution of
			 countermeasures to meet identified needs; and</text>
					</paragraph>
          <paragraph id="H95042884EE7B4C8E900DE07A69868799">
            <enum>(2)</enum>
            <text>the coordination
			 of efforts between the Department of Health and Human Services and the
			 Department of Defense to address countermeasure needs for various segments of
			 the population.</text>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="HA6F39285D54F4C3AB9635FA5FC74E82C" section-type="subsequent-section">
        <enum>103.</enum>
        <header display-inline="yes-display-inline">National Advisory Committee on Children and
			 Disasters</header>
        <text display-inline="no-display-inline">Subtitle B of title
			 XXVIII of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh">42 U.S.C. 300hh et seq.</external-xref>) is amended by
			 inserting after section 2811 the following:</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H9E60AD3CD975414291868267BCEB1DD0" reported-display-style="strikethrough" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="H17833DB5594B4F3E8B96C14B3975C275" section-type="subsequent-section">
            <enum>2811A.</enum>
            <header display-inline="yes-display-inline">National Advisory Committee on Children and
				Disasters</header>
						<subsection commented="no" display-inline="no-display-inline" id="H72DF73B935284FDAB7329A1AB9DA82C1">
              <enum>(a)</enum>
              <header display-inline="yes-display-inline">Establishment</header>
              <text display-inline="yes-display-inline">The Secretary, in consultation with the
				Secretary of Homeland Security, shall establish an advisory committee to be
				known as the <quote>National Advisory Committee on Children and
				Disasters</quote> (referred to in this section as the <quote>Advisory
				Committee</quote>).</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="H821D3E55890740C69C66A5C7FF7606DD">
              <enum>(b)</enum>
              <header display-inline="yes-display-inline">Duties</header>
              <text display-inline="yes-display-inline">The Advisory Committee shall—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="H477FE303B8D5461297AAE5F2472A8C3A">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">provide advice and consultation with
				respect to the activities carried out pursuant to section 2814, as applicable
				and appropriate;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H1A3179660D4E491FBE1FAB385373096B">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">evaluate and provide input with respect to
				the medical and public health needs of children as they relate to preparation
				for, response to, and recovery from all-hazards emergencies; and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H9D3AD0E049C54FB19CFB3CF2313F73AF">
                <enum>(3)</enum>
                <text display-inline="yes-display-inline">provide advice and consultation with
				respect to State emergency preparedness and response activities and children,
				including related drills and exercises pursuant to the preparedness goals under
				section 2802(b).</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="HAC3B47D6DDF5466D9C8F3F48815FAA2C">
              <enum>(c)</enum>
              <header display-inline="yes-display-inline">Additional duties</header>
              <text display-inline="yes-display-inline">The Advisory Committee may provide advice
				and recommendations to the Secretary with respect to children and the medical
				and public health grants and cooperative agreements as applicable to
				preparedness and response activities authorized under this title and title
				III.</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="H86CEA3DFAC49451A97D4A3CB0AF54800">
              <enum>(d)</enum>
              <header display-inline="yes-display-inline">Membership</header>
							<paragraph commented="no" display-inline="no-display-inline" id="HFC8320901D2145C3AC4DC1F145FD2C9D">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">The Secretary, in consultation with such
				other Secretaries as may be appropriate, shall appoint not to exceed 15 members
				to the Advisory Committee. In appointing such members, the Secretary shall
				ensure that the total membership of the Advisory Committee is an odd
				number.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HA9EA8852DAD4427B9ACEF7D261D9AC72">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Required members</header>
                <text display-inline="yes-display-inline">The Secretary, in consultation with such
				other Secretaries as may be appropriate, may appoint to the Advisory Committee
				under paragraph (1) such individuals as may be appropriate to perform the
				duties described in subsections (b) and (c), which may include—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H7CF54BC28C264EDFA7635F3D2A8C50F1">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">the Assistant Secretary for Preparedness
				and Response;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HB97CE996FAE64A0AA9CE5F195C3EAD2D">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">the Director of the Biomedical Advanced
				Research and Development Authority;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HCF4207AF25354A48922AFECFC333E953">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">the Director of the Centers for Disease
				Control and Prevention;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H717651B2A5934F3AB0247D4CCD0C922B">
                  <enum>(D)</enum>
                  <text display-inline="yes-display-inline">the Commissioner of Food and Drugs;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H924682BE5CED4BCAA68ACC1F7524F2E9">
                  <enum>(E)</enum>
                  <text display-inline="yes-display-inline">the Director of the National Institutes of
				Health;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H0090476AD1094AB89F5AE853552FCF54">
                  <enum>(F)</enum>
                  <text display-inline="yes-display-inline">the Assistant Secretary of the
				Administration for Children and Families;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HE78ACBA173414C15BBE67EBA8238C2E9">
                  <enum>(G)</enum>
                  <text display-inline="yes-display-inline">the Administrator of the Federal Emergency
				Management Agency;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HDC308E4C39FC4CA492E543068566ED72">
                  <enum>(H)</enum>
                  <text display-inline="yes-display-inline">at least two non-Federal health care
				professionals with expertise in pediatric medical disaster planning,
				preparedness, response, or recovery;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H3F23706F2ABB4E55BAAA19F1814F4EB8">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">at least two representatives from State,
				local, territorial, or tribal agencies with expertise in pediatric disaster
				planning, preparedness, response, or recovery; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HBD36EEF9DCB64235ADCF6C63EDAE1FEE">
                  <enum>(J)</enum>
                  <text display-inline="yes-display-inline">representatives from such Federal agencies
				(such as the Department of Education and the Department of Homeland Security)
				as determined necessary to fulfill the duties of the Advisory Committee, as
				established under subsections (b) and (c).</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="H5BD8726907764E6292DB3518746FB89C">
              <enum>(e)</enum>
              <header display-inline="yes-display-inline">Meetings</header>
              <text display-inline="yes-display-inline">The Advisory Committee shall meet not less
				than biannually.</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="HB28929285B164A68B2CFFA6C7EA10E57">
              <enum>(f)</enum>
              <header display-inline="yes-display-inline">Sunset</header>
              <text display-inline="yes-display-inline">The Advisory Committee shall terminate on
				the date that is 5 years after the date of enactment of the
				<short-title>Pandemic and All-Hazards Preparedness
				Reauthorization Act of
				2013</short-title>.</text>
						</subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="HFDBA0EEDB6134A1E80884A45EE3B5D63" section-type="subsequent-section">
        <enum>104.</enum>
        <header display-inline="yes-display-inline">Modernization of the National Disaster
			 Medical System</header>
        <text display-inline="no-display-inline">Section 2812 of
			 the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-11">42 U.S.C. 300hh–11</external-xref>) is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="H1E4B7CB0D8DF4072B574D2B6E6203335">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in subsection (a)(3)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="HB103799368744F5CA489B62AE707B17B">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in subparagraph (A), in clause (i) by
			 inserting <quote>, including at-risk individuals as applicable</quote> after
			 <quote>victims of a public health emergency</quote>;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HF63D6C21CD4C42FE9130B27D96ACF833">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">by redesignating subparagraph (C) as
			 subparagraph (E); and</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="H725A88623421425C8A281375CD53DA3F">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">by inserting after subparagraph (B), the
			 following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H0E36E609D14E47078638536F378C8D3F" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="HA08C16C7EE514CD285502A85A372FA3F">
                <enum>(C)</enum>
                <header display-inline="yes-display-inline">Considerations for at-risk
				populations</header>
                <text display-inline="yes-display-inline">The Secretary
				shall take steps to ensure that an appropriate specialized and focused range of
				public health and medical capabilities are represented in the National Disaster
				Medical System, which take into account the needs of at-risk individuals, in
				the event of a public health
				emergency.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HFCFB888B22CF46BC86A8C1C6FB46E4AA" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="H70C66F32E55D4373B0134908984D8F84">
                <enum>(D)</enum>
                <header display-inline="yes-display-inline">Administration</header>
                <text display-inline="yes-display-inline">The Secretary may determine and pay claims
				for reimbursement for services under subparagraph (A) directly or through
				contracts that provide for payment in advance or by way of
				reimbursement.</text>
							</subparagraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HF3BE725BEE4142C2B0879C53CFF9983D">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in subsection (g), by striking <quote>such
			 sums as may be necessary for each of the fiscal years 2007 through 2011</quote>
			 and inserting <quote>$52,700,000 for each of fiscal years 2013 through
			 2017</quote>.</text>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="HA9DC3FAF242F4381BC7AE2DF046BF804" section-type="subsequent-section">
        <enum>105.</enum>
        <header display-inline="yes-display-inline">Continuing the role of the Department of
			 Veterans Affairs</header>
        <text display-inline="no-display-inline">Section
			 8117(g) of title 38, United States Code, is amended by striking <quote>such
			 sums as may be necessary to carry out this section for each of fiscal years
			 2007 through 2011</quote> and inserting <quote>$155,300,000 for each of fiscal
			 years 2013 through 2017 to carry out this section</quote>.</text>
			</section>
    </title>
    <title changed="deleted" committee-id="SSHR00" id="H21F113B4823343B3B80A1C7F4E6E8D53" reported-display-style="strikethrough">
      <enum>II</enum>
      <header>Optimizing State
			 and local all-hazards preparedness and response</header>
			<section commented="no" id="H984CE0335A204E84A6E9CC47BA2AB678">
        <enum>201.</enum>
        <header>Temporary
			 redeployment of federally funded personnel during a public health
			 emergency</header>
        <text display-inline="no-display-inline">Section 319 of the
			 Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d">42 U.S.C. 247d</external-xref>) is amended by adding at the end the
			 following:</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H8648C597903B4F8F98C05B55771BFB71" reported-display-style="strikethrough" style="OLC">
					<subsection commented="no" id="HA497C31D494D4E8F83673505E3E3BBEB">
            <enum>(e)</enum>
            <header>Temporary
				redeployment of federally funded personnel during a public health
				emergency</header>
						<paragraph commented="no" id="H968C1BCEE3624A799983F27443F22154">
              <enum>(1)</enum>
              <header>Emergency
				redeployment of federally funded personnel</header>
              <text display-inline="yes-display-inline">Notwithstanding any other provision of law,
				and subject to paragraph (2), upon request by the Governor of a State or the
				chief of a tribe or such Governor or chief’s designee, the Secretary may
				authorize the requesting State or tribe to temporarily redeploy, for purposes
				of immediately addressing a public health emergency in the State or tribe,
				non-Federal personnel funded in whole or in part through, as appropriate,
				programs under this Act.</text>
						</paragraph>
            <paragraph commented="no" id="HC317C2147EC04D7E973DDB0ACA9FE8CF">
              <enum>(2)</enum>
              <header>Activation of
				emergency redeployment</header>
							<subparagraph commented="no" id="H8DA3EA17DF294DFBA54382E680A0454C">
                <enum>(A)</enum>
                <header>Public health
				emergency</header>
                <text display-inline="yes-display-inline">The Secretary may
				authorize a temporary redeployment of personnel under paragraph (1) only during
				the period of a public health emergency determined pursuant to subsection
				(a).</text>
							</subparagraph>
              <subparagraph commented="no" id="H44EAC14E178146F78F185768EB784534">
                <enum>(B)</enum>
                <header>Contents of
				request</header>
                <text display-inline="yes-display-inline">To seek authority for
				a temporary redeployment of personnel under paragraph (1), the Governor of a
				State or the chief of a tribe shall submit to the Secretary a request for such
				authority and shall include in the request each of the following:</text>
								<clause commented="no" id="H6FD57B3F39E545888318873A1B887047">
                  <enum>(i)</enum>
                  <text display-inline="yes-display-inline">An assurance that the public health
				emergency in the geographic area of the requesting State or tribe cannot be
				adequately and appropriately addressed by the public health workforce otherwise
				available.</text>
								</clause>
                <clause commented="no" id="H93B67A43BA0B4365B81C679CE742C0EA">
                  <enum>(ii)</enum>
                  <text display-inline="yes-display-inline">An assurance that the public health
				emergency would be addressed more efficiently and effectively through the
				requested temporary redeployment of personnel.</text>
								</clause>
                <clause commented="no" id="H356138C4C0B04E0E9A06090BE946E35F">
                  <enum>(iii)</enum>
                  <text>An assurance
				that the requested temporary redeployment of personnel is consistent with any
				applicable All-Hazards Public Health Emergency Preparedness and Response Plan
				under section 319C–1.</text>
								</clause>
                <clause commented="no" id="H226FBF3C05684D789EA6DA966A84EC36">
                  <enum>(iv)</enum>
                  <text>An identification
				of—</text>
									<subclause id="H0F9F406933A24919BEE43441BEC3B2BA">
                    <enum>(I)</enum>
                    <text>each Federal
				program from which personnel would be temporarily redeployed pursuant to the
				requested authority; and</text>
									</subclause>
                  <subclause id="HF031C500C58D467A9B689B98EF5FFDD1">
                    <enum>(II)</enum>
                    <text>the number of
				personnel who would be so redeployed from each such program.</text>
									</subclause>
                </clause>
                <clause commented="no" id="H3C08765291F54124A4793BA3748DBBDD">
                  <enum>(v)</enum>
                  <text>Such other
				information and assurances as the Secretary may require.</text>
								</clause>
              </subparagraph>
              <subparagraph commented="no" id="HA2F9697E9FAE41919EA24EB541F01E14">
                <enum>(C)</enum>
                <header>Consideration</header>
                <text>In
				reviewing a request for temporary redeployment under paragraph (1) of personnel
				funded through a Federal program, the Secretary shall consider the degree to
				which the program would be adversely affected by the redeployment.</text>
							</subparagraph>
              <subparagraph commented="no" id="HCED087AF84234D11BFD1B67AE4958410">
                <enum>(D)</enum>
                <header>Termination and
				extension</header>
								<clause commented="no" id="H077AABA83AFB4C0196772004185CA443">
                  <enum>(i)</enum>
                  <header>Termination</header>
                  <text display-inline="yes-display-inline">A State or tribe’s authority for a
				temporary redeployment of personnel under paragraph (1) shall terminate upon
				the earlier of the following:</text>
									<subclause commented="no" id="HD6B5190FAD4D45559428DD524A10F5D2">
                    <enum>(I)</enum>
                    <text>The Secretary’s
				determination that the public health emergency no longer exists.</text>
									</subclause>
                  <subclause commented="no" id="H21C0A3694F524502AA3398E2D4FAB745">
                    <enum>(II)</enum>
                    <text>Subject to clause
				(ii), the expiration of the 30-day period following the date on which the
				Secretary approved the State or tribe’s request for such authority.</text>
									</subclause>
                </clause>
                <clause commented="no" id="HD1E8DBFA14364673A53C2DCB200BB295">
                  <enum>(ii)</enum>
                  <header>Extension
				authority</header>
                  <text>The Secretary may extend the authority to authorize a
				temporary redeployment of personnel under paragraph (1) beyond the date
				otherwise applicable under clause (i)(II) if the public health emergency still
				exists as of such date, but only if—</text>
									<subclause id="H1676D5BEC9B244DA956ADC76B0376C1E">
                    <enum>(I)</enum>
                    <text>the State or tribe
				that submitted the initial request for authority for a temporary redeployment
				of personnel submits a request for an extension of such authority; and</text>
									</subclause>
                  <subclause id="H91DDA24FA9C24F008B40CE6D31C78FC7">
                    <enum>(II)</enum>
                    <text>the request for
				an extension contains the same type of information and assurances necessary for
				the approval of an initial request for such authority.</text>
									</subclause>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph commented="no" id="H3D0537705A914AEEA33A90BD61F0050B">
              <enum>(3)</enum>
              <header>Notice to
				personnel of possibility of redeployment</header>
              <text>The Secretary shall
				ensure that, if a State or tribe receives Federal funds for personnel who are
				subject to the Secretary’s redeployment authority under this subsection, the
				State or tribe gives notice to such personnel of the possibility of
				redeployment—</text>
							<subparagraph commented="no" id="HA4809F0CC5274CBD975900BFD20F6632">
                <enum>(A)</enum>
                <text>at the time of
				hiring; or</text>
							</subparagraph>
              <subparagraph commented="no" id="H36C3719A4F6F425B917F2C55363681A6">
                <enum>(B)</enum>
                <text>in the case of
				personnel hired before the date of the enactment of this subsection, as soon as
				practicable.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" id="HB225A316CCF44DDEB9E644012580923F">
              <enum>(4)</enum>
              <header>Notice to
				Congress</header>
              <text>The Secretary shall give notice to the Congress in
				conjunction with the approval under this subsection of—</text>
							<subparagraph commented="no" id="HF2CF73FE62F442019D82A23F6F4544A2">
                <enum>(A)</enum>
                <text>any initial
				request for authority for a temporary redeployment of personnel; and</text>
							</subparagraph>
              <subparagraph commented="no" id="HAA5E330D9DAA43F3A8454A84570B7F1D">
                <enum>(B)</enum>
                <text>any request for an
				extension of such authority.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="HCF62E6BBF64A4C68838B506299A4649F">
              <enum>(5)</enum>
              <header>Guidance</header>
              <text>The
				Secretary shall—</text>
							<subparagraph id="HC960620E70D8453888517EA3D3596C1C">
                <enum>(A)</enum>
                <text>not later than 6
				months after the enactment of this subsection, issue proposed guidance on the
				temporary redeployment of personnel under this subsection; and</text>
							</subparagraph>
              <subparagraph id="H143561974FC84D7C9B2516152CB0958F">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">after providing notice and a 60-day period
				for public comment, finalize such guidance.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="HD9FB9AB528D44A8795EF63A5BB16B319">
              <enum>(6)</enum>
              <header>Report to
				Congress</header>
              <text display-inline="yes-display-inline">Not later than 4
				years after the date of enactment of the <short-title>Pandemic and All-Hazards Preparedness Reauthorization Act
				of 2013</short-title>, the Comptroller General of the United States shall
				conduct an independent evaluation, and submit to the appropriate committees of
				the Congress a report, on the Secretary’s authority under this subsection,
				including—</text>
							<subparagraph id="HD7BF6D482C27424D9B72D1353AE00254">
                <enum>(A)</enum>
                <text>a description of
				how, and under what circumstances, such authority has been used by States and
				tribes;</text>
							</subparagraph>
              <subparagraph id="H1190CF073AF34877A928C6D25956E618">
                <enum>(B)</enum>
                <text>an analysis of how
				such authority has assisted States and tribes in responding to public health
				emergencies;</text>
							</subparagraph>
              <subparagraph id="H17A10682667B4AD38A69969FD51CAA8B">
                <enum>(C)</enum>
                <text>an evaluation of
				how such authority has improved operational efficiencies in responding to
				public health emergencies;</text>
							</subparagraph>
              <subparagraph id="HDC0A0DFDEE4F403E9487FFC23C63701E">
                <enum>(D)</enum>
                <text>an analysis of the
				extent to which, if any, Federal programs from which personnel have been
				temporarily redeployed pursuant to such authority have been adversely affected
				by the redeployment; and</text>
							</subparagraph>
              <subparagraph id="HA845524896374BA78CD1CDA08661E917">
                <enum>(E)</enum>
                <text>recommendations on
				how such authority could be improved to further assist in responding to public
				health emergencies.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="HA1E533E6DF914E58B5C2688FE3CA1996">
              <enum>(7)</enum>
              <header>Definition</header>
              <text>In
				this subsection, the term <term>State</term> includes, in addition to the
				entities listed in the definition of such term in section 2, the Freely
				Associated States.</text>
						</paragraph>
            <paragraph id="H1C0EB736331341C8BC0C927655022490">
              <enum>(8)</enum>
              <header>Sunset</header>
              <text>The
				authority under this subsection shall terminate on the date that is 5 years
				after the date of enactment of the <short-title>Pandemic
				and All-Hazards Preparedness Reauthorization Act of
				2013</short-title>.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section id="H92A6E08877024EBAB6226EE1A00ED9B8">
        <enum>202.</enum>
        <header>Improving State
			 and local public health security</header>
				<subsection id="HAFDD9D233500461EABDBAF4F68D97F5C">
          <enum>(a)</enum>
          <header>Cooperative
			 agreements</header>
          <text display-inline="yes-display-inline">Section 319C–1 of
			 the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-3a">42 U.S.C. 247d–3a</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="HA55BE95D87F0483BA67E94CFB4399062">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (b)(1)(C), by striking
			 <quote>consortium of entities described in subparagraph (A)</quote> and
			 inserting <quote>consortium of States</quote>;</text>
					</paragraph>
          <paragraph id="H63B0639C62F7437FA22E05E283685D8F">
            <enum>(2)</enum>
            <text>in subsection
			 (b)(2)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H56D0C511072746BCB8D85668C4D61F8D">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in subparagraph (A)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H0230E63667EC4128A1D2300389376614">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking clauses (i) and (ii) and
			 inserting the following:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HEF41DF7B7392493293E7AF4A46539E3C" reported-display-style="strikethrough" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="H0FB84C9344D34288A415BBCE2EA7A004">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">a description of the activities such entity
				will carry out under the agreement to meet the goals identified under section
				2802, including with respect to chemical, biological, radiological, or nuclear
				threats, whether naturally occurring, unintentional, or deliberate;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="H88F834E6F7904CB2B05FA0139D4DC45A">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">a description of the activities such entity
				will carry out with respect to pandemic influenza, as a component of the
				activities carried out under clause (i), and consistent with the requirements
				of paragraphs (2) and (5) of subsection
				(g);</text>
									</clause>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H1F8A84EA66F2454DBF18E3884AB0B8CB">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in clause (iv), by striking
			 <quote>and</quote> at the end; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HAFC498FD5A5F4A4F820D457BD08D9493">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HD8B4FC8723DB45A9BFE34730DBF4E877" reported-display-style="strikethrough" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="HEA13318FFA424D32931AD5914B5A008D">
                    <enum>(vi)</enum>
                    <text display-inline="yes-display-inline">a description of how, as appropriate, the
				entity may partner with relevant public and private stakeholders in public
				health emergency preparedness and response;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="HD9322758BC914A9699E096AF3042B9ED">
                    <enum>(vii)</enum>
                    <text display-inline="yes-display-inline">a description of how the entity, as
				applicable and appropriate, will coordinate with State emergency preparedness
				and response plans in public health emergency preparedness, including State
				educational agencies (as defined in section 9101(41) of the Elementary and
				Secondary Education Act of 1965) and State child care lead agencies (designated
				under section 658D of the Child Care and Development Block Grant Act of
				1990);</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="H513D5550AB474B328010EFC70F1D234A">
                    <enum>(viii)</enum>
                    <text display-inline="yes-display-inline">in the case of entities that operate on the
				United States-Mexico border or the United States-Canada border, a description
				of the activities such entity will carry out under the agreement that are
				specific to the border area including disease detection, identification,
				investigation, and preparedness and response activities related to emerging
				diseases and infectious disease outbreaks whether naturally occurring or due to
				bioterrorism, consistent with the requirements of this section; and</text>
									</clause>
                  <clause commented="no" id="H69920A27B4B24B5485C3D08B78FFAB43">
                    <enum>(ix)</enum>
                    <text display-inline="yes-display-inline">a description of any activities that such
				entity will use to analyze real-time clinical specimens for pathogens of public
				health or bioterrorism significance, including any utilization of poison
				control centers;</text>
									</clause>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H75F3FAEDDE4541D9BF44F968974F63EF">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in subparagraph (C), by inserting <quote>,
			 including addressing the needs of at-risk individuals,</quote> after
			 <quote>capabilities of such entity</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph id="H743C2228D2BE4702991DC8A2D42A5206">
            <enum>(3)</enum>
            <text>in subsection
			 (f)—</text>
						<subparagraph id="H8AE43411E3324BD7A35DE9A25726775C">
              <enum>(A)</enum>
              <text>in paragraph (2),
			 by adding <quote>and</quote> at the end;</text>
						</subparagraph>
            <subparagraph id="HD4CA01E5712E4D7595A5AF22E1AE4537">
              <enum>(B)</enum>
              <text>in paragraph (3),
			 by striking <quote>; and</quote> and inserting a period; and</text>
						</subparagraph>
            <subparagraph id="HB41EE634A5BB4F00A92F7575906DB835">
              <enum>(C)</enum>
              <text>by striking
			 paragraph (4);</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H61E1296BA15043D2BFC60C5E260AF6F0">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">in subsection (g)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HB4F5E41B56BF421197610BE71423EDA4">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in paragraph (1), by striking subparagraph
			 (A) and inserting the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HFCF0FDE1067D4F6DBE7A67BC71F98AEE" reported-display-style="strikethrough" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="H3173DAE1626C4BD1A15145BB26AA949F">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">include outcome goals representing
				operational achievements of the National Preparedness Goals developed under
				section 2802(b) with respect to all-hazards, including chemical, biological,
				radiological, or nuclear threats; and</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H7D885830FB3F481BA9AC4865659A016A">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (2)(A), by adding at the end
			 the following: <quote>The Secretary shall periodically update, as necessary and
			 appropriate, such pandemic influenza plan criteria and shall require the
			 integration of such criteria into the benchmarks and standards described in
			 paragraph (1).</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" id="H2397842B43D54F2AB6D3254D72B00A88">
            <enum>(5)</enum>
            <text>by striking
			 subsection (h);</text>
					</paragraph>
          <paragraph id="H7D858B5BC27440DAAC0BAD4306EB861D">
            <enum>(6)</enum>
            <text>in subsection
			 (i)—</text>
						<subparagraph id="H5FFE5B4F534B40098800AFF2E9C80BB5">
              <enum>(A)</enum>
              <text>in paragraph
			 (1)—</text>
							<clause id="HEC2AD7ACB34B4D9E8AF3CCC96480371B">
                <enum>(i)</enum>
                <text>in subparagraph
			 (A)—</text>
								<subclause commented="no" display-inline="no-display-inline" id="H4BFB5CFCCD0D4F28BFA7D39C924C1969">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>$824,000,000 for fiscal
			 year 2007, of which $35,000,000 shall be used to carry out subsection
			 (h),</quote> and inserting <quote>$641,900,000 for fiscal year 2013</quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="H6F09AABC9D9341ECB0A9E1A9999F3278">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>such sums as may be
			 necessary for each of fiscal years 2008 through 2011</quote> and inserting
			 <quote>$641,900,000 for each of fiscal years 2014 through 2017</quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" id="HB02F63DB1691469A9A86E2B78739D239">
                <enum>(ii)</enum>
                <text>by striking
			 subparagraph (B);</text>
							</clause>
              <clause commented="no" id="H3366FF466F9F4993A8D9B79402DD79E9">
                <enum>(iii)</enum>
                <text>by redesignating
			 subparagraphs (C) and (D) as subparagraphs (B) and (C), respectively;
			 and</text>
							</clause>
              <clause id="H527542EB22BF430A8F57F8EE39C472D8">
                <enum>(iv)</enum>
                <text>in subparagraph
			 (C), as so redesignated, by striking <quote>subparagraph (C)</quote> and
			 inserting <quote>subparagraph (B)</quote>;</text>
							</clause>
            </subparagraph>
            <subparagraph id="HD5CCBC3923D9422D998D6331674E5EEB">
              <enum>(B)</enum>
              <text>in subparagraphs
			 (C) and (D) of paragraph (3), by striking <quote>(1)(A)(i)(I)</quote> each
			 place it appears and inserting <quote>(1)(A)</quote>;</text>
						</subparagraph>
            <subparagraph id="H8362D5AFFD154FF49AA0406E4D7EA71D">
              <enum>(C)</enum>
              <text>in paragraph
			 (4)(B), by striking <quote>subsection (c)</quote> and inserting
			 <quote>subsection (b)</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H8AAD4915BBE349EC98CB0D363F2E0231">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H40A5F64B0A6343AD825760AD82C29D6B" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H96D926313167479285CCD4DA30BFDD3B">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Availability of cooperative agreement
				funds</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="H4DEF5F78209F4DB2A01F4791C57F579C">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Amounts provided to an eligible entity
				under a cooperative agreement under subsection (a) for a fiscal year and
				remaining unobligated at the end of such year shall remain available to such
				entity for the next fiscal year for the purposes for which such funds were
				provided.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HFE9BE077D6C942E58C89FEE2FF287D23">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Funds contingent on achieving
				benchmarks</header>
                    <text display-inline="yes-display-inline">The continued
				availability of funds under subparagraph (A) with respect to an entity shall be
				contingent upon such entity achieving the benchmarks and submitting the
				pandemic influenza plan as described in subsection
				(g).</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph id="HEBEC35517A6141CDA33DC79DCE0AB710">
            <enum>(7)</enum>
            <text>in subsection (j),
			 by striking paragraph (3).</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H1E16AE26E72043B6BF3C983AF619DA95">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Vaccine tracking and
			 distribution</header>
          <text display-inline="yes-display-inline">Section 319A(e)
			 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-1">42 U.S.C. 247d–1(e)</external-xref>) is amended by striking
			 <quote>such sums for each of fiscal years 2007 through 2011</quote> and
			 inserting <quote>$30,800,000 for each of fiscal years 2013 through
			 2017</quote>.</text>
				</subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H331F70D3384F4994BAD3667214F7B4A2" section-type="subsequent-section">
        <enum>203.</enum>
        <header display-inline="yes-display-inline">Hospital preparedness and medical surge
			 capacity</header>
				<subsection commented="no" display-inline="no-display-inline" id="HB07247FC3ADD46A99486A89B3D9AE03D">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">All-Hazards public health and medical
			 response curricula and training</header>
          <text display-inline="yes-display-inline">Section 319F(a)(5)(B) of the Public Health
			 Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6">42 U.S.C. 247d–6(a)(5)(B)</external-xref>) is amended by striking <quote>public
			 health or medical</quote> and inserting <quote>public health, medical, or
			 dental</quote>.</text>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H7F9F0018D83541928290006AF7B1DBD0">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Encouraging health professional
			 volunteers</header>
					<paragraph commented="no" display-inline="no-display-inline" id="H0D4478AAB1244C759DB4F1A928316DA6">
            <enum>(1)</enum>
            <header display-inline="yes-display-inline">Emergency system for advance registration
			 of volunteer health professionals</header>
            <text display-inline="yes-display-inline">Section 319I(k) of the Public Health
			 Service Act (42 U.S.C. 247d–7b(k)) is amended by striking <quote>$2,000,000 for
			 fiscal year 2002, and such sums as may be necessary for each of the fiscal
			 years 2003 through 2011</quote> and inserting <quote>$5,000,000 for each of
			 fiscal years 2013 through 2017</quote>.</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HB6AFA3B767EE4EADBA5BB4C5DA08238D">
            <enum>(2)</enum>
            <header display-inline="yes-display-inline">Volunteers</header>
            <text display-inline="yes-display-inline">Section 2813 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-15">42 U.S.C. 300hh–15</external-xref>) is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HD74A6E069B8D4B40B233B4B91DD4E8C7">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in subsection (d)(2), by adding at the end
			 the following: <quote>Such training exercises shall, as appropriate and
			 applicable, incorporate the needs of at-risk individuals in the event of a
			 public health emergency.</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HE364470AF88241E38DDC18D3C7F0E1E3">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in subsection (i), by striking
			 <quote>$22,000,000 for fiscal year 2007, and such sums as may be necessary for
			 each of fiscal years 2008 through 2011</quote> and inserting <quote>$11,200,000
			 for each of fiscal years 2013 through 2017</quote>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H003F581A74664BB5A933197655C98254">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Partnerships for State and regional
			 preparedness To improve surge capacity</header>
          <text display-inline="yes-display-inline">Section 319C–2 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-3b">42 U.S.C. 247d–3b</external-xref>) is amended—</text>
					<paragraph id="HAB170D15AF2F4EE9B4350F0297024630">
            <enum>(1)</enum>
            <text>in subsection (a),
			 by inserting <quote>, including capacity and preparedness to address the needs
			 of pediatric and other at-risk populations</quote> before the period at the
			 end;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H976BBE4FE44249D6B64E82EC4B7E2B84">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subsection (b)(1)(A)(ii), by striking
			 <quote>centers, primary</quote> and inserting <quote>centers, community health
			 centers, primary</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HE5D6043418B94D3B98CA38ECCE95222B">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by striking subsection (c) and inserting
			 the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H0055E227C1B74BA2B467C0BFFC327D4D" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="HF177E3F154284AD79E1F8453AD51DB34">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Use of funds</header>
                <text display-inline="yes-display-inline">An award under subsection (a) shall be
				expended for activities to achieve the preparedness goals described under
				paragraphs (1), (3), (4), (5), and (6) of section 2802(b) with respect to
				all-hazards, including chemical, biological, radiological, or nuclear
				threats.</text>
							</subsection>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H2FE80A75439F4A44958ABA557225D417">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">by striking subsection (g) and inserting
			 the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H7629EBCF5A5E4C08A5CC2A69072F45BB" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="H32DF9B388EAD4CF0B653EB249FD5469F">
                <enum>(g)</enum>
                <header display-inline="yes-display-inline">Coordination</header>
								<paragraph commented="no" display-inline="no-display-inline" id="H622BE4AA7DD047C9A9CD2E906B0AD768">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">Local response capabilities</header>
                  <text display-inline="yes-display-inline">An eligible entity shall, to the extent
				practicable, ensure that activities carried out under an award under subsection
				(a) are coordinated with activities of relevant local Metropolitan Medical
				Response Systems, local Medical Reserve Corps, the local Cities Readiness
				Initiative, and local emergency plans.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HE8EC2DADE9A64A9FB9C99F01F8F47DA1">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">National collaboration</header>
                  <text display-inline="yes-display-inline">Partnerships consisting of one or more
				eligible entities under this section may, to the extent practicable,
				collaborate with other partnerships consisting of one or more eligible entities
				under this section for purposes of national coordination and collaboration with
				respect to activities to achieve the preparedness goals described under
				paragraphs (1), (3), (4), (5), and (6) of section
				2802(b).</text>
								</paragraph>
              </subsection>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph id="HD4ADC0261278498BA62783BFA9DEAF28">
            <enum>(5)</enum>
            <text>in subsection
			 (i)—</text>
						<subparagraph id="HBD1C8448AB6F4E4E88DD7A7758047C4B">
              <enum>(A)</enum>
              <text>by striking
			 <quote>The requirements of</quote> and inserting the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC1D61FD36E604796B4292F37ED381A15" reported-display-style="strikethrough" style="OLC">
								<paragraph id="H3B47D3D35F6E496CA0F958CD5FE57AF8">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">The requirements
				of</text>
								</paragraph>
                <after-quoted-block>; and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph id="H653322ADA57D4541961082007AF707FB">
              <enum>(B)</enum>
              <text>by adding at the
			 end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H034335439E4F492EB5FA1010794E9B56" reported-display-style="strikethrough" style="OLC">
								<paragraph id="H8CF10C3C99DB4EA4A80BCE021A8F1BC5">
                  <enum>(2)</enum>
                  <header>Meeting goals of
				National Health Security Strategy</header>
                  <text display-inline="yes-display-inline">The Secretary shall implement objective,
				evidence-based metrics to ensure that entities receiving awards under this
				section are meeting, to the extent practicable, the applicable goals of the
				National Health Security Strategy under section
				2802.</text>
								</paragraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph id="HF6236DBAB9AE419FAA82C9122D6AF4D3">
            <enum>(6)</enum>
            <text>in subsection
			 (j)—</text>
						<subparagraph id="H18D2E969EBB64E0AB68E74DE0CC615C6">
              <enum>(A)</enum>
              <text>by amending
			 paragraph (1) to read as follows:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H1DD2006CB3CF445A9BD35C68B70E5E6B" reported-display-style="strikethrough" style="OLC">
								<paragraph id="HE3CC9EF6B728483AA1A20EF46EC6A77F">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">For purposes of
				carrying out this section, there is authorized to be appropriated $374,700,000
				for each of fiscal years 2013 through
				2017.</text>
								</paragraph>
                <after-quoted-block>; and
				</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HCA5AC014FFA4460C929F2D2EB04191CF">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC536847D06F44A83AE922B2F745B7488" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H65A5DC763B82422AA717AD63D1466890">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Availability of cooperative agreement
				funds</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="H975D4058FD3B4411986304825E71C931">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Amounts provided to an eligible entity
				under a cooperative agreement under subsection (a) for a fiscal year and
				remaining unobligated at the end of such year shall remain available to such
				entity for the next fiscal year for the purposes for which such funds were
				provided.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H4BF33858818840CBA2566608D650355D">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Funds contingent on achieving
				benchmarks</header>
                    <text display-inline="yes-display-inline">The continued
				availability of funds under subparagraph (A) with respect to an entity shall be
				contingent upon such entity achieving the benchmarks and submitting the
				pandemic influenza plan as required under subsection
				(i).</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H00289191EB104CD5B3B88678C6DADF93" section-type="subsequent-section">
        <enum>204.</enum>
        <header display-inline="yes-display-inline">Enhancing situational awareness and
			 biosurveillance</header>
        <text display-inline="no-display-inline">Section 319D
			 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-4">42 U.S.C. 247d–4</external-xref>) is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="H713E96B3315E45FCA4EFB88F64935C07">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in subsection (b)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="H4B5B804B9B9A4EF38FDC2907E221F0D3">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in paragraph (1)(B), by inserting
			 <quote>poison control centers,</quote> after <quote>hospitals,</quote>;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HFE7E20DFAE2A4473B52F127D4D2599D8">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in paragraph (2), by inserting before the
			 period at the end the following: <quote>, allowing for coordination to maximize
			 all-hazards medical and public health preparedness and response and to minimize
			 duplication of effort</quote>; and</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="H016B3004BB20449284967C7A6A10116B">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">in paragraph (3), by inserting before the
			 period at the end the following: <quote>and update such standards as
			 necessary</quote>;</text>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HE33D8B7CA11F4171B9FB7B62F5776CF0">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">by striking subsection (c); and</text>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="H135FF66450E64C5CB04077F2E710A818">
          <enum>(3)</enum>
          <text display-inline="yes-display-inline">in subsection (d)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="H03F6616F2F0244B6B260AA25D8F3B010">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in the subsection heading, by striking
			 <quote>
                <header-in-text level="subsection" style="OLC">Public Health Situational
			 Awareness</header-in-text>
              </quote> and inserting <quote>
                <header-in-text level="subsection" style="OLC">Modernizing Public Health Situational Awareness
			 and Biosurveillance</header-in-text>
              </quote>;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HC3B739023A4F4CEFBB07745A504988ED">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in paragraph (1)—</text>
						<clause commented="no" display-inline="no-display-inline" id="HD07BDC74C19647618A6E09300AD1C6E3">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">by striking <quote>Pandemic and All-Hazards
			 Preparedness Act</quote> and inserting <quote>
                  <short-title>Pandemic and All-Hazards Preparedness Reauthorization Act
			 of 2013</short-title>
                </quote>; and</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="H93B3EE15CD8343A0A7A6EA91D9A9DB98">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">by inserting <quote>, novel emerging
			 threats,</quote> after <quote>disease outbreaks</quote>;</text>
						</clause>
          </subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="H473FBAE9D765463399E7B8446B6F3538">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">by striking paragraph (2) and inserting the
			 following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HEA34D7F648274CD8AD1BF10FF48CB9CC" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="HB0B04576E174402AB66090F9097FD407">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Strategy and implementation
				plan</header>
                <text display-inline="yes-display-inline">Not later than 180 days
				after the date of enactment of the <short-title>Pandemic
				and All-Hazards Preparedness Reauthorization Act of 2013</short-title>, the
				Secretary shall submit to the appropriate committees of Congress a coordinated
				strategy and an accompanying implementation plan that identifies and
				demonstrates the measurable steps the Secretary will carry out to—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H80C4D6C0B51B44EAB89951CA2A32A1E7">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">develop, implement, and evaluate the
				network described in paragraph (1), utilizing the elements described in
				paragraph (3);</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HD267A2D766CE462CAD7D70F8E9D719AF">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">modernize and enhance biosurveillance
				activities; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HBB49696CE17843E7BD108F05C6C147C4">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">improve information sharing, coordination,
				and communication among disparate biosurveillance systems supported by the
				Department of Health and Human
				Services.</text>
								</subparagraph>
              </paragraph>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="H10C4CA3A6C9E487997A83038E939A816">
            <enum>(D)</enum>
            <text display-inline="yes-display-inline">in paragraph (3)(D), by inserting
			 <quote>community health centers, health centers</quote> after <quote>poison
			 control,</quote>;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HDCCA8447EB0D449DB9EA0BCE457B82FF">
            <enum>(E)</enum>
            <text display-inline="yes-display-inline">in paragraph (5), by striking subparagraph
			 (A) and inserting the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H4E461748276C4ED7BB90C3022883E8B7" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="HE3818D6FE2FF4AD68C2A9AA2BCF77BE9">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">utilize applicable interoperability
				standards as determined by the Secretary, and in consultation with the Office
				of the National Coordinator for Health Information Technology, through a joint
				public and private sector process;</text>
							</subparagraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HBE73B22BB7564546BC1F50FDBB77269E">
            <enum>(F)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HE78AE119116F4165B3F056920987EF45" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="H0CC3C2F64AC448D6B0DA8245B41AC0CE">
                <enum>(6)</enum>
                <header display-inline="yes-display-inline">Consultation with the National Biodefense
				Science Board</header>
                <text display-inline="yes-display-inline">In carrying out
				this section and consistent with section 319M, the National Biodefense Science
				Board shall provide expert advice and guidance, including recommendations,
				regarding the measurable steps the Secretary should take to modernize and
				enhance biosurveillance activities pursuant to the efforts of the Department of
				Health and Human Services to ensure comprehensive, real-time, all-hazards
				biosurveillance capabilities. In complying with the preceding sentence, the
				National Biodefense Science Board shall—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="HE09BA439C87447C3BDC4CE514C2C127D">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">identify the steps necessary to achieve a
				national biosurveillance system for human health, with international
				connectivity, where appropriate, that is predicated on State, regional, and
				community level capabilities and creates a networked system to allow for
				two-way information flow between and among Federal, State, and local government
				public health authorities and clinical health care providers;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H15F5C951816F4626BF4084BF3809C227">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">identify any duplicative surveillance
				programs under the authority of the Secretary, or changes that are necessary to
				existing programs, in order to enhance and modernize such activities, minimize
				duplication, strengthen and streamline such activities under the authority of
				the Secretary, and achieve real-time and appropriate data that relate to
				disease activity, both human and zoonotic; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H549E2E30A102463BA206AA2E53CC6F8F">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">coordinate with applicable existing
				advisory committees of the Director of the Centers for Disease Control and
				Prevention, including such advisory committees consisting of representatives
				from State, local, and tribal public health authorities and appropriate public
				and private sector health care entities and academic institutions, in order to
				provide guidance on public health surveillance
				activities.</text>
								</subparagraph>
              </paragraph>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HEE0A1171771B4E918F3D27C1F473408F">
          <enum>(4)</enum>
          <text display-inline="yes-display-inline">in subsection (e)(5), by striking <quote>4
			 years after the date of enactment of the Pandemic and All-Hazards Preparedness
			 Act</quote> and inserting <quote>3 years after the date of enactment of the
			 <short-title>Pandemic and All-Hazards Preparedness
			 Reauthorization Act of 2013</short-title>
            </quote>;</text>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HC8DCCF06D4F643AFA345C7C432DEB007">
          <enum>(5)</enum>
          <text display-inline="yes-display-inline">in subsection (g), by striking <quote>such
			 sums as may be necessary in each of fiscal years 2007 through 2011</quote> and
			 inserting <quote>$138,300,000 for each of fiscal years 2013 through
			 2017</quote>; and</text>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HC5F9CDF12DA04FADA1CFF3C761100714">
          <enum>(6)</enum>
          <text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H4D06B737B91144D497C80DDDBB918373" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="HBE7BCEA8605149B08D8E9D1F47BB364F">
              <enum>(h)</enum>
              <header display-inline="yes-display-inline">Definition</header>
              <text display-inline="yes-display-inline">For purposes of this section the term
				<term>biosurveillance</term> means the process of gathering near real-time
				biological data that relates to human and zoonotic disease activity and threats
				to human or animal health, in order to achieve early warning and identification
				of such health threats, early detection and prompt ongoing tracking of health
				events, and overall situational awareness of disease
				activity.</text>
						</subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </section>
      <section commented="no" id="HA2F02A10FAA7454990BBCBA5F231D8F1">
        <enum>205.</enum>
        <header>Eliminating
			 duplicative Project Bioshield reports</header>
        <text display-inline="no-display-inline">Section 5 of the Project Bioshield Act of
			 2004 (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6c">42 U.S.C. 247d–6c</external-xref>) is repealed.</text>
			</section>
    </title>
    <title changed="deleted" committee-id="SSHR00" id="H1363D5FC34FB4F998D7C3EE07200011C" reported-display-style="strikethrough">
      <enum>III</enum>
      <header>Enhancing
			 Medical Countermeasure Review</header>
			<section commented="no" display-inline="no-display-inline" id="HC8A5882A0CFD48818F1E125C33B398FE" section-type="subsequent-section">
        <enum>301.</enum>
        <header display-inline="yes-display-inline">Special protocol assessment</header>
        <text display-inline="no-display-inline">Section 505(b)(5)(B) of the Federal Food,
			 Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355(b)(5)(B)</external-xref>) is amended by striking
			 <quote>size of clinical trials intended</quote> and all that follows through
			 <quote>. The sponsor or applicant</quote> and inserting the following:
			 “size—</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H59330D4BD04543E7AA75EF3B10FCD40D" reported-display-style="strikethrough" style="OLC">
					<clause commented="no" display-inline="no-display-inline" id="H8B57E5DE6DF74D379286B9A35376DD86" indent="up2">
            <enum>(i)</enum>
            <subclause commented="no" display-inline="yes-display-inline" id="HCCB7D5ACF12D4B19ABF089A932756A8E">
              <enum>(I)</enum>
              <text display-inline="yes-display-inline">of clinical trials intended to form the
				primary basis of an effectiveness claim; or</text>
						</subclause>
            <subclause changed="deleted" commented="no" committee-id="SSHR00" display-inline="no-display-inline" id="HF5E82B05D25749C2BB2CDBE1B1822125" indent="up1" reported-display-style="strikethrough">
              <enum>(II)</enum>
              <text display-inline="yes-display-inline">in the case where human efficacy studies
				are not ethical or feasible, of animal and any associated clinical trials
				which, in combination, are intended to form the primary basis of an
				effectiveness claim; or</text>
						</subclause>
          </clause>
          <clause commented="no" display-inline="no-display-inline" id="H3DC27629FFE44FBB93FF185938CDD22C" indent="up2">
            <enum>(ii)</enum>
            <text display-inline="yes-display-inline">with respect to an application for approval
				of a biological product under section 351(k) of the Public Health Service Act,
				of any necessary clinical study or studies.</text>
					</clause>
          <quoted-block-continuation-text quoted-block-continuation-text-level="subsection">The
				sponsor or
				applicant</quoted-block-continuation-text>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="HA2709FB2D3784E098AD5D201DD3568CD" section-type="subsequent-section">
        <enum>302.</enum>
        <header display-inline="yes-display-inline">Authorization for medical products for use
			 in emergencies</header>
				<subsection commented="no" display-inline="no-display-inline" id="H12C55247632A4C71B1262EC040A78B18">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">Section 564 of the Federal Food, Drug, and
			 Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-3">21 U.S.C. 360bbb–3</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H583217E2EFB8463A848BFEBD0EC64492">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (a)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H6C7F447D4009411AAE37E28236DBBD81">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in paragraph (1), by striking
			 <quote>sections 505, 510(k), and 515 of this Act</quote> and inserting
			 <quote>any provision of this Act</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H2E4DF99CD3D44657A42F08CD817C1A20">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (2)(A), by striking
			 <quote>under a provision of law referred to in such paragraph</quote> and
			 inserting <quote>under section 505, 510(k), or 515 of this Act or section 351
			 of the Public Health Service Act</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HE943681F5BDA47379865FB3FD9FD7F13">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in paragraph (3), by striking <quote>a
			 provision of law referred to in such paragraph</quote> and inserting <quote>a
			 section of this Act or the Public Health Service Act referred to in paragraph
			 (2)(A)</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HE871BE45E73B452EB45ACBC4074BECBF">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subsection (b)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HB1914FFAC804484A8148DB7DD6FA5892">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the subsection heading, by striking
			 <quote>
                  <header-in-text level="subsection" style="OLC">Emergency</header-in-text>
                </quote> and inserting
			 <quote>
                  <header-in-text level="subsection" style="OLC">Emergency or Threat
			 Justifying Emergency Authorized Use</header-in-text>
                </quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HF55BED6353F747B7813B69B4B10FCDDC">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (1)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H114572DB9DFB4FE8A2B005343D497A87">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in the matter preceding subparagraph (A),
			 by striking <quote>may declare an emergency</quote> and inserting <quote>may
			 make a declaration that the circumstances exist</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HBF933218728A4C838AF935338241B466">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in subparagraph (A), by striking
			 <quote>specified</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H998B7CF3B3374C92871AC1E334F5AFAA">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">in subparagraph (B)—</text>
								<subclause commented="no" display-inline="no-display-inline" id="H3779B3B40CF8413989CD93DFE84F4470">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>specified</quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="HBB42186E880E4C9F902C1509E934E15A">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>; or</quote> and
			 inserting a semicolon;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="H1AE43733DC9E467C9493E7B7048E80AA">
                <enum>(iv)</enum>
                <text display-inline="yes-display-inline">by amending subparagraph (C) to read as
			 follows:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H38131B26292E47FB87364918ACDF6F44" reported-display-style="strikethrough" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="H23EFA3FF66684C3295C170CB80FFF883">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">a determination by the Secretary that there
				is a public health emergency, or a significant potential for a public health
				emergency, that affects, or has a significant potential to affect, national
				security or the health and security of United States citizens living abroad,
				and that involves a biological, chemical, radiological, or nuclear agent or
				agents, or a disease or condition that may be attributable to such agent or
				agents; or</text>
									</subparagraph>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HB56A634F4FB141759EA030B783EC500A">
                <enum>(v)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H0ECC27B14B1D41F6A9EB729943BCB745" reported-display-style="strikethrough" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="H82A748D9DD6C48D68FBFC2D5733912DD">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">the identification of a material threat
				pursuant to section 319F–2 of the Public Health Service Act sufficient to
				affect national security or the health and security of United States citizens
				living
				abroad.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HF78FD05C822D4B8BA37114E3EA151A47">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in paragraph (2)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H9BB7609AAB46456FA64F5E08EA1B0E51">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in subparagraph (A), by amending clause
			 (ii) to read as follows:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC1433A611672489DB69959264E6BD806" reported-display-style="strikethrough" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="HBB5AADDFD10B4272B958361A0258CCB4">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">a change in the approval status of the
				product such that the circumstances described in subsection (a)(2) have ceased
				to exist.</text>
									</clause>
                  <after-quoted-block>;
				</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H031F11EDB83E4B468FB28BBA399C006F">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking subparagraph (B); and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="HDB4FC0E7BB994EB4A70135BD873C1562">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by redesignating subparagraph (C) as
			 subparagraph (B);</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HC12A05D48CD54A6BAE89BE7725C24416">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">in paragraph (4), by striking
			 <quote>advance notice of termination, and renewal under this
			 subsection.</quote> and inserting <quote>, and advance notice of termination
			 under this subsection.</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HC74E5CDB8334423E9C79D104A1C0042C">
              <enum>(E)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H2A6CEF3F500E41AEA0815CCE29972D33" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H92A71194EEE64E6BAA17E9AC60C8E38C">
                  <enum>(5)</enum>
                  <header display-inline="yes-display-inline">Explanation by Secretary</header>
                  <text display-inline="yes-display-inline">If an authorization under this section with
				respect to an unapproved product or an unapproved use of an approved product
				has been in effect for more than 1 year, the Secretary shall provide in writing
				to the sponsor of such product an explanation of the scientific, regulatory, or
				other obstacles to approval, licensure, or clearance of such product or use,
				including specific actions to be taken by the Secretary and the sponsor to
				overcome such
				obstacles.</text>
								</paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H01F9268868B1403DAD074FFC4038DF02">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">in subsection (c)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HA707AB45EDCF4B3DAC6FF4359EFC1B71">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the matter preceding paragraph
			 (1)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H4DCC87E284584031868970BD2A119F50">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by inserting <quote>the Assistant Secretary
			 for Preparedness and Response,</quote> after <quote>consultation
			 with</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H020B78BBA4474C36BA624EBC3A0D9BCB">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>Health and</quote> and
			 inserting <quote>Health, and</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H3DA8667B0D234B019C3BB257B486F0B0">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>circumstances of the
			 emergency involved</quote> and inserting <quote>applicable circumstances
			 described in subsection (b)(1)</quote>;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H7B5BEA1FBDCD42B28C9E1636A76C7844">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (1), by striking
			 <quote>specified</quote> and inserting <quote>referred to</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H070036CDD0AE4786A0FE486AFAF861E6">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in paragraph (2)(B), by inserting <quote>,
			 taking into consideration the material threat posed by the agent or agents
			 identified in a declaration under subsection (b)(1)(D), if applicable</quote>
			 after <quote>risks of the product</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H3972A15BEDEF425684321CA7A8585916">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">in subsection (d)(3), by inserting <quote>,
			 to the extent practicable given the circumstances of the emergency,</quote>
			 after <quote>including</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HDA4F1F42B441498F96F19C2A42A3B295">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">in subsection (e)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H053EFD82555742AAB9683B418DF83477">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in paragraph (1)(A), by striking
			 <quote>circumstances of the emergency</quote> and inserting <quote>applicable
			 circumstances described in subsection (b)(1)</quote>;</text>
						</subparagraph>
            <subparagraph id="HF468BF23A19B47578DFAE6FFC5F81A01">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (1)(B), by amending clause
			 (iii) to read as follows:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H1B007E6C0F88461595057B399F60C5E2" reported-display-style="strikethrough" style="OLC">
								<clause id="H73390FC8E6C04EA88ED30A375146C0C8">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">Appropriate conditions with respect to
				collection and analysis of information concerning the safety and effectiveness
				of the product with respect to the use of such product during the period when
				the authorization is in effect and a reasonable time following such
				period.</text>
								</clause>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H449C640B74244C309C9CFFB2C1971BF6">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in paragraph (2)—</text>
							<clause commented="no" display-inline="no-display-inline" id="HA461E8B5BE8940649C1EDAFFDBD330F0">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in subparagraph (A)—</text>
								<subclause commented="no" display-inline="no-display-inline" id="H5E39498F83144915AC29DEF918591E5C">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>manufacturer of the
			 product</quote> and inserting <quote>person</quote>;</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="H0695FF75DFCE40EE9D0D6F2A27AE5ADD">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>circumstances of the
			 emergency</quote> and inserting <quote>applicable circumstances described in
			 subsection (b)(1)</quote>; and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="HC39BA4D113034EF8BE48A8FB1A822B2D">
                  <enum>(III)</enum>
                  <text display-inline="yes-display-inline">by inserting at the end before the period
			 <quote>or in paragraph (1)(B)</quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="H6D7DD850FB6E40A7A81A4688EED2AE31">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in subparagraph (B)(i), by inserting before
			 the period at the end <quote>, except as provided in section 564A with respect
			 to authorized changes to the product expiration date</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H2A0CE48D1F8F4DAE9D837EA5067C4C0E">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by amending subparagraph (C) to read as
			 follows:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H4805D0F0ABE4437C9BBADE35AA20005A" reported-display-style="strikethrough" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="HE64FBB57F70642F79CF31DFA48C2290F">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">In establishing conditions under this
				paragraph with respect to the distribution and administration of the product
				for the unapproved use, the Secretary shall not impose conditions that would
				restrict distribution or administration of the product when distributed or
				administered for the approved use.</text>
									</subparagraph>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HB98E1C9892EF4D59A9517305FB975A3C">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by amending paragraph (3) to read as
			 follows:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HFC176E423DA3426EA468AE972CB16F08" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H91FA1DC413AC4F45A22DB4A717ED4482">
                  <enum>(3)</enum>
                  <header display-inline="yes-display-inline">Good manufacturing practice;
				prescription</header>
                  <text display-inline="yes-display-inline">With respect to
				the emergency use of a product for which an authorization under this section is
				issued (whether an unapproved product or an unapproved use of an approved
				product), the Secretary may waive or limit, to the extent appropriate given the
				applicable circumstances described in subsection (b)(1)—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="HC821ED63D03740638163313A49D21D52">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">requirements regarding current good
				manufacturing practice otherwise applicable to the manufacture, processing,
				packing, or holding of products subject to regulation under this Act, including
				such requirements established under section 501 or 520(f)(1), and including
				relevant conditions prescribed with respect to the product by an order under
				section 520(f)(2);</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H6B27793F8765409AB840F5CAEE33FD13">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">requirements established under section
				503(b); and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H603EE50A9C264FA28AD824DA783F58EC">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">requirements established under section
				520(e).</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H1155683A3F3E4CCAAF686B124CC4CE4C">
            <enum>(6)</enum>
            <text display-inline="yes-display-inline">in subsection (g)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H07FF8B629F7A4E45804D5DD039281F76">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the subsection heading, by inserting
			 <quote>
                  <header-in-text level="subsection" style="OLC">Review
			 and</header-in-text>
                </quote> before <quote>
                  <header-in-text level="subsection" style="OLC">Revocation</header-in-text>
                </quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H3BF1A13B413D48F3B5E601CADC140AC9">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (1), by inserting after the
			 period at the end the following: “As part of such review, the Secretary shall
			 regularly review the progress made with respect to the approval, licensure, or
			 clearance of—</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HCEBB58FB889E477DA991156A35BE58A9" reported-display-style="strikethrough" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="H85C86D364CC74B02B7E79E77B7009170">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">an unapproved product for which an
				authorization was issued under this section; or</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H783DF0712DEE415688507ECAC22AB148">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">an unapproved use of an approved product
				for which an authorization was issued under this
				section.</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H4ED14895E1324EB6B8A5892EBA852850">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by amending paragraph (2) to read as
			 follows:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HB1124B41B0DB4D88A2295F39374ED621" reported-display-style="strikethrough" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="H810D782FA6CA4DB1A0DA55050B6AB979">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Revision and revocation</header>
                  <text display-inline="yes-display-inline">The Secretary may revise or revoke an
				authorization under this section if—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="HDF89F4BACD1B4E708F172E53BE682B9B">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the circumstances described under
				subsection (b)(1) no longer exist;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="HFB930D0508874202A3B1B01E0A0C3E26">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the criteria under subsection (c) for
				issuance of such authorization are no longer met; or</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H619F2CBD300B479FBC1384FC8028593F">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">other circumstances make such revision or
				revocation appropriate to protect the public health or
				safety.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H12EE0A8F6BE44866B43BEFFF4754411C">
            <enum>(7)</enum>
            <text display-inline="yes-display-inline">in subsection (h)(1), by adding after the
			 period at the end the following: <quote>The Secretary shall make any revisions
			 to an authorization under this section available on the Internet Web site of
			 the Food and Drug Administration.</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HD60E8C4C6D0D4EF19C84EE7F14A903A8">
            <enum>(8)</enum>
            <text display-inline="yes-display-inline">by adding at the end of subsection (j) the
			 following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HB78E4B8ABFC24002B1F455FA987EF731" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="HFC83B83D32674BE58B37B51201A148D1">
                <enum>(4)</enum>
                <text display-inline="yes-display-inline">Nothing in this section shall be construed
				as authorizing a delay in the review or other consideration by the Secretary of
				any application or submission pending before the Food and Drug Administration
				for a product for which an authorization under this section is
				issued.</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" id="H905DB56DFCE642AAB3DFB2FDED11ABF4">
            <enum>(9)</enum>
            <text>by adding at the
			 end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" id="HD74638187F95446ABA5973C2345EA276" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" id="H4FFFB87C870C4A76AD3270329020E929">
                <enum>(m)</enum>
                <header>Categorization
				of laboratory tests associated with devices subject to authorization</header>
								<paragraph commented="no" id="H11BF9F09C2D143F6B1FF301D162ACE50">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text>In issuing an authorization under this section with
				respect to a device, the Secretary may, subject to the provisions of this
				section, determine that a laboratory examination or procedure associated with
				such device shall be deemed, for purposes of section 353 of the Public Health
				Service Act, to be in a particular category of examinations and procedures
				(including the category described by subsection (d)(3) of such section) if,
				based on the totality of scientific evidence available to the Secretary—</text>
									<subparagraph commented="no" id="HBA54B7F3EBC54A5E8A59913EF54E839E">
                    <enum>(A)</enum>
                    <text>such
				categorization would be beneficial to protecting the public health; and</text>
									</subparagraph>
                  <subparagraph commented="no" id="H0101CF6B7F194498AC540D4551BFF99F">
                    <enum>(B)</enum>
                    <text>the known and
				potential benefits of such categorization under the circumstances of the
				authorization outweigh the known and potential risks of the
				categorization.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" id="H9AC6B59C72DD433793189EE0C49AEC21">
                  <enum>(2)</enum>
                  <header>Conditions of
				determination</header>
                  <text>The Secretary may establish appropriate conditions
				on the performance of the examination or procedure pursuant to such
				determination.</text>
								</paragraph>
                <paragraph commented="no" id="H8EA4E8FECE7445419C54A82AB9B6C6E8">
                  <enum>(3)</enum>
                  <header>Effective
				period</header>
                  <text>A determination under this subsection shall be effective
				for purposes of section 353 of the Public Health Service Act notwithstanding
				any other provision of that section during the effective period of the relevant
				declaration under subsection
				(b).</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HC3CFDEF4E37D432DAB315F40A96C221C">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Emergency use of medical
			 products</header>
          <text display-inline="yes-display-inline">Subchapter E of
			 chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb et
			 seq.) is amended by inserting after section 564 the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H7F9029814F664D849C45537B196FDA3B" reported-display-style="strikethrough" style="OLC">
						<section commented="no" display-inline="no-display-inline" id="H66CB87E4E7914793A476172CFC487C05" section-type="subsequent-section">
              <enum>564A.</enum>
              <header display-inline="yes-display-inline">Emergency use of medical products</header>
							<subsection commented="no" display-inline="no-display-inline" id="H769C603F85C94F0393149D82A579F4EE">
                <enum>(a)</enum>
                <header display-inline="yes-display-inline">Definitions</header>
                <text display-inline="yes-display-inline">In this section:</text>
								<paragraph commented="no" display-inline="no-display-inline" id="H0F73C5E564044BFFB4330B4E34C44116">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">Eligible product</header>
                  <text display-inline="yes-display-inline">The term <term>eligible product</term>
				means a product that—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="HE7CF424ABC984E549AEEBAE8619929FB">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">is approved or cleared under this chapter
				or licensed under section 351 of the Public Health Service Act;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H7166591D55FE4AB99CCD2DEEF4112A3F">
                    <enum>(B)</enum>
                    <clause commented="no" display-inline="yes-display-inline" id="H00EA2AF33DA04EF5BBF69B196B2C18BF">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">is intended for use to prevent, diagnose,
				or treat a disease or condition involving a biological, chemical, radiological,
				or nuclear agent or agents; or</text>
										</clause>
                    <clause changed="deleted" commented="no" committee-id="SSHR00" display-inline="no-display-inline" id="HDBE248FC90144FDD9BD728FCB97DF721" indent="up1" reported-display-style="strikethrough">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">is intended for use to prevent, diagnose,
				or treat a serious or life-threatening disease or condition caused by a product
				described in clause (i); and</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H98D14F0F82534FF1B5D149A8A3472522">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">is intended for use during the
				circumstances under which—</text>
										<clause commented="no" display-inline="no-display-inline" id="HF5DEF68892DF4A9183B2D925B6351CC1">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">a determination described in subparagraph
				(A), (B), or (C) of section 564(b)(1) has been made by the Secretary of
				Homeland Security, the Secretary of Defense, or the Secretary, respectively;
				or</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="H683A60F7C62A42189F639335F9079ED6">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">the identification of a material threat
				described in subparagraph (D) of section 564(b)(1) has been made pursuant to
				section 319F–2 of the Public Health Service Act.</text>
										</clause>
                  </subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H3D027FFAFF754828A6F8A3A12764BEC5">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Product</header>
                  <text display-inline="yes-display-inline">The term <term>product</term> means a drug,
				device, or biological product.</text>
								</paragraph>
              </subsection>
              <subsection id="H0CCDE98073EF4437986BDA860B71E93A">
                <enum>(b)</enum>
                <header>Expiration
				dating</header>
								<paragraph id="HA96315D9B1EE43FDA61F69FA2D320A5B">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text>The Secretary may extend the expiration date and
				authorize the introduction or delivery for introduction into interstate
				commerce of an eligible product after the expiration date provided by the
				manufacturer if—</text>
									<subparagraph id="HF752DCB9A30D4E2E859BC2CBD2072772">
                    <enum>(A)</enum>
                    <text>the expiration
				date extension is intended to support the United States ability to
				protect—</text>
										<clause id="H5B39EDDAC4B84F728EFD01B1A737C8CF">
                      <enum>(i)</enum>
                      <text>the public health;
				or</text>
										</clause>
                    <clause id="HC14195F049894B4CAA80B54FD445837E">
                      <enum>(ii)</enum>
                      <text>military
				preparedness and effectiveness; and</text>
										</clause>
                  </subparagraph>
                  <subparagraph id="H4627DE291ACD4469BE6D138F6B3B2B38">
                    <enum>(B)</enum>
                    <text>the expiration
				date extension is supported by an appropriate scientific evaluation that is
				conducted or accepted by the Secretary.</text>
									</subparagraph>
                </paragraph>
                <paragraph id="HD26DFBF54F8F48B88776115C4EADF93B">
                  <enum>(2)</enum>
                  <header>Requirements and
				conditions</header>
                  <text>Any extension of an expiration date under paragraph
				(1) shall, as part of the extension, identify—</text>
									<subparagraph id="H349AD87E70504BFD8139920322C9CB36">
                    <enum>(A)</enum>
                    <text>each specific lot,
				batch, or other unit of the product for which extended expiration is
				authorized;</text>
									</subparagraph>
                  <subparagraph id="HC64579C31BCE4CAE971447A8ADF55005">
                    <enum>(B)</enum>
                    <text>the duration of
				the extension; and</text>
									</subparagraph>
                  <subparagraph id="H5747BBE2DF6C4434883209541DD1017D">
                    <enum>(C)</enum>
                    <text>any other
				requirements or conditions as the Secretary may deem appropriate for the
				protection of the public health, which may include requirements for, or
				conditions on, product sampling, storage, packaging or repackaging, transport,
				labeling, notice to product recipients, recordkeeping, periodic testing or
				retesting, or product disposition.</text>
									</subparagraph>
                </paragraph>
                <paragraph id="H0A450B5325F14D1A92F4FCB2B8E8A4F3">
                  <enum>(3)</enum>
                  <header>Effect</header>
                  <text>Notwithstanding
				any other provision of this Act or the Public Health Service Act, an eligible
				product shall not be considered an unapproved product (as defined in section
				564(a)(2)(A)) and shall not be deemed adulterated or misbranded under this Act
				because, with respect to such product, the Secretary has, under paragraph (1),
				extended the expiration date and authorized the introduction or delivery for
				introduction into interstate commerce of such product after the expiration date
				provided by the manufacturer.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HB1FE0190C08145368F5A901C2DB9FD63">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Expiration date</header>
                  <text display-inline="yes-display-inline">For purposes of this subsection, the term
				<term>expiration date</term> means the date established through appropriate
				stability testing required by the regulations issued by the Secretary to ensure
				that the product meets applicable standards of identity, strength, quality, and
				purity at the time of use.</text>
								</paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="H4614917E1B2947439B36E201E3493396">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Current good manufacturing
				practice</header>
								<paragraph commented="no" display-inline="no-display-inline" id="H470DD4C26E9246D4A5BD99F96EF8879E">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">The Secretary may, when the circumstances
				of a domestic, military, or public health emergency or material threat
				described in subsection (a)(1)(C) so warrant, authorize, with respect to an
				eligible product, deviations from current good manufacturing practice
				requirements otherwise applicable to the manufacture, processing, packing, or
				holding of products subject to regulation under this Act, including
				requirements under section 501 or 520(f)(1) or applicable conditions prescribed
				with respect to the eligible product by an order under section
				520(f)(2).</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HF4DD8C08B98C4E5B8A5A19A71DC6C968">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Effect</header>
                  <text display-inline="yes-display-inline">Notwithstanding any other provision of this
				Act or the Public Health Service Act, an eligible product shall not be
				considered an unapproved product (as defined in section 564(a)(2)(A)) and shall
				not be deemed adulterated or misbranded under this Act because, with respect to
				such product, the Secretary has authorized deviations from current good
				manufacturing practices under paragraph (1).</text>
								</paragraph>
              </subsection>
              <subsection display-inline="no-display-inline" id="HCC1EFC6E4172463FACC3688B29762BF2">
                <enum>(d)</enum>
                <header>Emergency
				dispensing</header>
                <text>The requirements of sections 503(b) and 520(e) shall
				not apply to an eligible product, and the product shall not be considered an
				unapproved product (as defined in section 564(a)(2)(A)) and shall not be deemed
				adulterated or misbranded under this Act because it is dispensed without an
				individual prescription, if—</text>
								<paragraph commented="no" id="HE5B2CE1110DD4993A75E41CC7849DAC2">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">the product is dispensed during the
				circumstances described in subsection (a)(1)(C); and</text>
								</paragraph>
                <paragraph commented="no" id="H17D2F71B5D9A4477AC912D050AD5ADB4">
                  <enum>(2)</enum>
                  <text>such dispensing
				without an individual prescription occurs—</text>
									<subparagraph commented="no" id="HA57F18C1ED4B44B39AB3186FE57B9163">
                    <enum>(A)</enum>
                    <text>as permitted under
				the law of the State in which the product is dispensed; or</text>
									</subparagraph>
                  <subparagraph commented="no" id="HBAED1DFB872945DBA2CF78DE9A5C042E">
                    <enum>(B)</enum>
                    <text>in accordance with
				an order issued by the Secretary, for the purposes and duration of the
				circumstances described in subsection (a)(1)(C).</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="H2DC114F565CA45A6ABEF0AF58F678C4B">
                <enum>(e)</enum>
                <header display-inline="yes-display-inline">Emergency use instructions</header>
								<paragraph commented="no" display-inline="no-display-inline" id="H9C4D8E312D3F420E92183E4029BAFF7D">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">The Secretary, acting through an
				appropriate official within the Department of Health and Human Services, may
				create and issue emergency use instructions to inform health care providers or
				individuals to whom an eligible product is to be administered concerning such
				product's approved, licensed, or cleared conditions of use.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="HA04F0D1BE286403CBA8E91DC64996BF3">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Effect</header>
                  <text display-inline="yes-display-inline">Notwithstanding any other provisions of
				this Act or the Public Health Service Act, a product shall not be considered an
				unapproved product and shall not be deemed adulterated or misbranded under this
				Act because of the issuance of emergency use instructions under paragraph (1)
				with respect to such product or the introduction or delivery for introduction
				of such product into interstate commerce accompanied by such
				instructions—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H0D7A901C775C4DC3B4EB59F2484FF4DC">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">during an emergency response to an actual
				emergency that is the basis for a determination described in subsection
				(a)(1)(C)(i); or</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H91AE55E1ADA748248704A76272A0AFA6">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">by a government entity (including a
				Federal, State, local, or tribal government entity), or a person acting on
				behalf of such a government entity, in preparation for an emergency
				response.</text>
									</subparagraph>
                </paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HFC62DB9A1E3744018E7F0F45076F6A26">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Risk evaluation and mitigation
			 strategies</header>
          <text display-inline="yes-display-inline">Section 505–1 of
			 the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355-1">21 U.S.C. 355–1</external-xref>), is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H70FD9C03DC364E7286651F0A916CBEE7">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (f), by striking paragraph
			 (7); and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H34323F4C3A1847749E845C6073B90952">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HBB769E367FB3423D9E715FD4744D2B76" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="H767C900D579243419FE435A716EE6779">
                <enum>(k)</enum>
                <header display-inline="yes-display-inline">Waiver in public health
				emergencies</header>
                <text display-inline="yes-display-inline">The Secretary may
				waive any requirement of this section with respect to a qualified
				countermeasure (as defined in section 319F–1(a)(2) of the Public Health Service
				Act) to which a requirement under this section has been applied, if the
				Secretary determines that such waiver is required to mitigate the effects of,
				or reduce the severity of, the circumstances under which—</text>
								<paragraph commented="no" display-inline="no-display-inline" id="H4C601B7BD202485BBA7037F588B94B86">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">a determination described in subparagraph
				(A), (B), or (C) of section 564(b)(1) has been made by the Secretary of
				Homeland Security, the Secretary of Defense, or the Secretary, respectively;
				or</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H7E9365D2A8BD4C66B480A130AEE7AC49">
                  <enum>(2)</enum>
                  <text display-inline="yes-display-inline">the identification of a material threat
				described in subparagraph (D) of section 564(b)(1) has been made pursuant to
				section 319F–2 of the Public Health Service
				Act.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H3CDAF99CC5034072B41D8906E7549FA1">
          <enum>(d)</enum>
          <header display-inline="yes-display-inline">Products held for emergency
			 use</header>
          <text display-inline="yes-display-inline">The Federal Food, Drug,
			 and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>) is amended by inserting after section
			 564A, as added by subsection (b), the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H20530D2F9E3D47E78FF2592962C9B4DD" reported-display-style="strikethrough" style="OLC">
						<section commented="no" display-inline="no-display-inline" id="H31C3357DE4D341908E566050F40E070A" section-type="subsequent-section">
              <enum>564B.</enum>
              <header display-inline="yes-display-inline">Products held for emergency
				use</header>
              <text display-inline="no-display-inline">It is not a violation of
				any section of this Act or of the Public Health Service Act for a government
				entity (including a Federal, State, local, or tribal government entity), or a
				person acting on behalf of such a government entity, to introduce into
				interstate commerce a product (as defined in section 564(a)(4)) intended for
				emergency use, if that product—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="H80384647E2AC4C25BC1810AFFECE3B8D">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">is intended to be held and not used;
				and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H0D8FE7AEE8F446F19F03F80C434037BB">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">is held and not used, unless and until that
				product—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H907E324D83E64B33B779C09410C7BDC0">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">is approved, cleared, or licensed under
				section 505, 510(k), or 515 of this Act or section 351 of the Public Health
				Service Act;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HBE3DC84A3DEA42E98453C1BF3DE1D83E">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">is authorized for investigational use under
				section 505 or 520 of this Act or section 351 of the Public Health Service Act;
				or</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H02A5108546544ADB9830DB76E7CECCFB">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">is authorized for use under section
				564.</text>
								</subparagraph>
              </paragraph>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="HEC0BD8048404458DA08A365CA2C15110" section-type="subsequent-section">
        <enum>303.</enum>
        <header display-inline="yes-display-inline">Definitions</header>
        <text display-inline="no-display-inline">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">21 U.S.C. 360bbb–4</external-xref>) is amended by striking <quote>The Secretary,
			 in consultation</quote> and inserting the following:</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HE16706AB258F4D8A97CA76808DE689CF" reported-display-style="strikethrough" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="H80D14EBD737B4106AAA3B31004652BFE">
            <enum>(a)</enum>
            <header display-inline="yes-display-inline">Definitions</header>
            <text display-inline="yes-display-inline">In this section—</text>
						<paragraph commented="no" display-inline="no-display-inline" id="HEAA75ABA7AD14EE69CD058BF82647FF8">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">the term <term>countermeasure</term> means
				a qualified countermeasure, a security countermeasure, and a qualified pandemic
				or epidemic product;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HC96218A1BBB4463BA3A40B345E8E6839">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">the term <term>qualified
				countermeasure</term> has the meaning given such term in section 319F–1 of the
				Public Health Service Act;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HBD555FC72DBC4A5B9243A20C942AC489">
              <enum>(3)</enum>
              <text display-inline="yes-display-inline">the term <term>security
				countermeasure</term> has the meaning given such term in section 319F–2 of such
				Act; and</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HFAF78C0A034647AD83CC79E678E7A9D7">
              <enum>(4)</enum>
              <text display-inline="yes-display-inline">the term <term>qualified pandemic or
				epidemic product</term> means a product that meets the definition given such
				term in section 319F–3 of the Public Health Service Act and—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="H6A99C6135BC94D4B8FB0405DA2231EC0">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">that has been identified by the Department
				of Health and Human Services or the Department of Defense as receiving funding
				directly related to addressing chemical, biological, radiological, or nuclear
				threats, including pandemic influenza; or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H9384A851A63343408FAE80CB5CCB469B">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">is included under this paragraph pursuant
				to a determination by the Secretary.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection commented="no" display-inline="no-display-inline" id="H70E911EE3D2B4E47BE7CB767A4FBC37F">
            <enum>(b)</enum>
            <header display-inline="yes-display-inline">General
				duties</header>
            <text display-inline="yes-display-inline">The Secretary, in
				consultation</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="HFBBB97B5F2094C6B80116CBA431DAD3F" section-type="subsequent-section">
        <enum>304.</enum>
        <header display-inline="yes-display-inline">Enhancing medical countermeasure
			 activities</header>
        <text display-inline="no-display-inline">Section 565 of the
			 Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">21 U.S.C. 360bbb–4</external-xref>), as amended by
			 section 303, is further amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="HCA277F4F7D8349F5BE361366D22280E1">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in the section heading, by striking
			 <quote>
              <header-in-text level="section" style="OLC">Technical
			 Assistance</header-in-text>
            </quote> and inserting <quote>
              <header-in-text level="section" style="OLC">Countermeasure Development, Review, and Technical
			 Assistance</header-in-text>
            </quote>;</text>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HFC047F1A8A404207A0A0361308098158">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in subsection (b), by striking the
			 subsection enumerator and all that follows through <quote>shall
			 establish</quote> and inserting the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H3603B8E417C74561BD40F396E00AB43B" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="H752B7D94782848DBB16AF87C00FF13CC">
              <enum>(b)</enum>
              <header display-inline="yes-display-inline">General
				duties</header>
              <text display-inline="yes-display-inline">In order to accelerate
				the development, stockpiling, approval, licensure, and clearance of qualified
				countermeasures, security countermeasures, and qualified pandemic or epidemic
				products, the Secretary, in consultation with the Assistant Secretary for
				Preparedness and Response, shall—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="H78B2AFE1DDA44A71877AB367FDEF8A7A">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">ensure the appropriate involvement of Food
				and Drug Administration personnel in interagency activities related to
				countermeasure advanced research and development, consistent with sections
				319F, 319F–1, 319F–2, 319F–3, 319L, and 2811 of the Public Health Service
				Act;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HFD0E4199C2B34439BE784B9993C9C92C">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">ensure the appropriate involvement and
				consultation of Food and Drug Administration personnel in any flexible
				manufacturing activities carried out under section 319L of the Public Health
				Service Act, including with respect to meeting regulatory requirements set
				forth in this Act;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HC7D2D5BBDE634F8A9CCE83F85557F4D8">
                <enum>(3)</enum>
                <text display-inline="yes-display-inline">promote countermeasure expertise within the
				Food and Drug Administration by—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="HEAC5B01037D049868D93C98166F1847C">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">ensuring that Food and Drug Administration
				personnel involved in reviewing countermeasures for approval, licensure, or
				clearance are informed by the Assistant Secretary for Preparedness and Response
				on the material threat assessment conducted under section 319F–2 of the Public
				Health Service Act for the agent or agents for which the countermeasure under
				review is intended;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H395940B33EC94B91AFD86702A97F913B">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">training Food and Drug Administration
				personnel regarding review of countermeasures for approval, licensure, or
				clearance;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H66B0A92FFD71442DAB410F96EF31FB61">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">holding public meetings at least twice
				annually to encourage the exchange of scientific ideas; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H7D6F381E3E87479F9EB9BD62699005BE">
                  <enum>(D)</enum>
                  <text display-inline="yes-display-inline">establishing protocols to ensure that
				countermeasure reviewers have sufficient training or experience with
				countermeasures;</text>
								</subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H7D8025623EC84D8BB469EAC19D497716">
                <enum>(4)</enum>
                <text display-inline="yes-display-inline">maintain teams, composed of Food and Drug
				Administration personnel with expertise on countermeasures, including specific
				countermeasures, populations with special clinical needs (including children
				and pregnant women that may use countermeasures, as applicable and
				appropriate), classes or groups of countermeasures, or other
				countermeasure-related technologies and capabilities, that shall—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="HDB5B38B56C4E4B3CBE9E0139C9D31EA6">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">consult with countermeasure experts,
				including countermeasure sponsors and applicants, to identify and help resolve
				scientific issues related to the approval, licensure, or clearance of
				countermeasures, through workshops or public meetings; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H43FF755C5D044A39B444F70D9B7C1BB8">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">improve and advance the science relating to
				the development of new tools, standards, and approaches to assessing and
				evaluating countermeasures—</text>
									<clause commented="no" display-inline="no-display-inline" id="HDFB3A3F4E64E416092E3A6CE59D695CC">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">in order to inform the process for
				countermeasure approval, clearance, and licensure; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="H2F4AF3FB8B494A2C93AB073C232E4467">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">with respect to the development of
				countermeasures for populations with special clinical needs, including children
				and pregnant women, in order to meet the needs of such populations, as
				necessary and appropriate; and</text>
									</clause>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="H52F4982B164E48D0AF6F6E7B02AAA2C3">
                <enum>(5)</enum>
                <text display-inline="yes-display-inline">establish</text>
							</paragraph>
            </subsection>
            <after-quoted-block>;
				and</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="H2894563E024B459DA9B3D46E994D4E9F">
          <enum>(3)</enum>
          <text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H3D13C92024EB43D69184A201E292FFF5" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" id="H5ACAB42501B54348A3D9CA45AB151759">
              <enum>(c)</enum>
              <header>Final Guidance
				on development of animal models</header>
							<paragraph commented="no" id="H6ABD976CBFCA4341A78884FB0EC1D50C">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>Not later than 1 year after the date of the enactment of
				the <short-title>Pandemic and All-Hazards Preparedness
				Reauthorization Act of 2013</short-title>, the Secretary shall provide final
				guidance to industry regarding the development of animal models to support
				approval, clearance, or licensure of countermeasures referred to in subsection
				(a) when human efficacy studies are not ethical or feasible.</text>
							</paragraph>
              <paragraph commented="no" id="H6950BC9B891E4F21A6D2B4E492EBF294">
                <enum>(2)</enum>
                <header>Authority to
				extend deadline</header>
                <text display-inline="yes-display-inline">The Secretary
				may extend the deadline for providing final guidance under paragraph (1) by not
				more than 6 months upon submission by the Secretary of a report on the status
				of such guidance to the Committee on Energy and Commerce of the House of
				Representatives and the Committee on Health, Education, Labor, and Pensions of
				the Senate.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="HB98E13577E4C43DFB9487A1F23150D3F">
              <enum>(d)</enum>
              <header display-inline="yes-display-inline">Development and animal modeling
				procedures</header>
							<paragraph commented="no" display-inline="no-display-inline" id="H94DA49D047D34D74A36EED0A8F071150">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">Availability of animal model
				meetings</header>
                <text display-inline="yes-display-inline">To facilitate the
				timely development of animal models and support the development, stockpiling,
				licensure, approval, and clearance of countermeasures, the Secretary shall, not
				later than 180 days after the enactment of this subsection, establish a
				procedure by which a sponsor or applicant that is developing a countermeasure
				for which human efficacy studies are not ethical or practicable, and that has
				an approved investigational new drug application or investigational device
				exemption, may request and receive—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H64E61E0947FC48FF98C93F635F8DC8E9">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">a meeting to discuss proposed animal model
				development activities; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HC171505EF2154B75BD80E584F61ACB56">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">a meeting prior to initiating pivotal
				animal studies.</text>
								</subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HF7FCE2575AB54891AA6EDE31AA0FE28F">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Pediatric models</header>
                <text display-inline="yes-display-inline">To facilitate the development and selection
				of animal models that could translate to pediatric studies, any meeting
				conducted under paragraph (1) shall include discussion of animal models for
				pediatric populations, as appropriate.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="H910A4CB4B66C4A97813CC8D3FFD7A62C">
              <enum>(e)</enum>
              <header display-inline="yes-display-inline">Review and approval of
				countermeasures</header>
							<paragraph commented="no" display-inline="no-display-inline" id="H0CB4A04CB8024983A2FBE3F46DBCEA46">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">Material threat</header>
                <text display-inline="yes-display-inline">When evaluating an application or
				submission for approval, licensure, or clearance of a countermeasure, the
				Secretary shall take into account the material threat posed by the chemical,
				biological, radiological, or nuclear agent or agents identified under section
				319F–2 of the Public Health Service Act for which the countermeasure under
				review is intended.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HD1C7C9BD51A04E638DB4A88D079BF0BA">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Review expertise</header>
                <text display-inline="yes-display-inline">When practicable and appropriate, teams of
				Food and Drug Administration personnel reviewing applications or submissions
				described under paragraph (1) shall include a reviewer with sufficient training
				or experience with countermeasures pursuant to the protocols established under
				subsection
				(b)(3)(D).</text>
							</paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H2E57CC3BD3CE43CA833392F58FD99ED3" section-type="subsequent-section">
        <enum>305.</enum>
        <header display-inline="yes-display-inline">Regulatory management plans</header>
        <text display-inline="no-display-inline">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">21 U.S.C. 360bbb–4</external-xref>), as amended by section 304, is further
			 amended by adding at the end the following:</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HDC3EF31C7D2A420792B28FE502FB64B9" reported-display-style="strikethrough" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="H8F095E4831D34DAC9E4E9580C1C12F6F">
            <enum>(f)</enum>
            <header display-inline="yes-display-inline">Regulatory management plan</header>
						<paragraph commented="no" display-inline="no-display-inline" id="H9B336BBA0DD64191AC2B9B28A037BF32">
              <enum>(1)</enum>
              <header display-inline="yes-display-inline">Definition</header>
              <text display-inline="yes-display-inline">In this subsection, the term <term>eligible
				countermeasure</term> means—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="H539DC8A5AAFE44B3BCA8A449FF12AB43">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">a security countermeasure with respect to
				which the Secretary has entered into a procurement contract under section
				319F–2(c) of the Public Health Service Act; or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H04C0638AD87E45629F9CD56E74635189">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">a countermeasure with respect to which the
				Biomedical Advanced Research and Development Authority has provided funding
				under section 319L of the Public Health Service Act for advanced research and
				development.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H04A45364F682442CAAF70DA2CC0EC571">
              <enum>(2)</enum>
              <header display-inline="yes-display-inline">Regulatory management plan
				process</header>
              <text display-inline="yes-display-inline">The Secretary, in
				consultation with the Assistant Secretary for Preparedness and Response and the
				Director of the Biomedical Advanced Research and Development Authority, shall
				establish a formal process for obtaining scientific feedback and interactions
				regarding the development and regulatory review of eligible countermeasures by
				facilitating the development of written regulatory management plans in
				accordance with this subsection.</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H74BE3560DA4E4C8C946DBAE287276510">
              <enum>(3)</enum>
              <header display-inline="yes-display-inline">Submission of request and proposed plan by
				sponsor or applicant</header>
							<subparagraph commented="no" display-inline="no-display-inline" id="H11CD141A77124B2CA2B536FF85CCA8BC">
                <enum>(A)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">A sponsor or applicant of an eligible
				countermeasure may initiate the process described under paragraph (2) upon
				submission of a written request to the Secretary. Such request shall include a
				proposed regulatory management plan.</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H5ED05002537D4F81A5D1A064A2326D74">
                <enum>(B)</enum>
                <header display-inline="yes-display-inline">Timing of submission</header>
                <text display-inline="yes-display-inline">A sponsor or applicant may submit a written
				request under subparagraph (A) after the eligible countermeasure has an
				investigational new drug or investigational device exemption in effect.</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H387E85D2EF4440EB941B1FFD98E1D334">
                <enum>(C)</enum>
                <header display-inline="yes-display-inline">Response by Secretary</header>
                <text display-inline="yes-display-inline">The Secretary shall direct the Food and
				Drug Administration, upon submission of a written request by a sponsor or
				applicant under subparagraph (A), to work with the sponsor or applicant to
				agree on a regulatory management plan within a reasonable time not to exceed 90
				days. If the Secretary determines that no plan can be agreed upon, the
				Secretary shall provide to the sponsor or applicant, in writing, the scientific
				or regulatory rationale why such agreement cannot be reached.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H14E6F7B6747C44A9AD7A5E79867F0C9E">
              <enum>(4)</enum>
              <header display-inline="yes-display-inline">Plan</header>
              <text display-inline="yes-display-inline">The content of a regulatory management plan
				agreed to by the Secretary and a sponsor or applicant shall include—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="H22A9313376174C14B9081737F78BAECC">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">an agreement between the Secretary and the
				sponsor or applicant regarding developmental milestones that will trigger
				responses by the Secretary as described in subparagraph (B);</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H6B686728C7B842BA91BD0D29A35D70B6">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">performance targets and goals for timely
				and appropriate responses by the Secretary to the triggers described under
				subparagraph (A), including meetings between the Secretary and the sponsor or
				applicant, written feedback, decisions by the Secretary, and other activities
				carried out as part of the development and review process; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H54B3B7A955054638AD8F50D8F21F1A92">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">an agreement on how the plan shall be
				modified, if needed.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H0F0CCA1EB0EC480D9479ABB515D56EB3">
              <enum>(5)</enum>
              <header display-inline="yes-display-inline">Milestones and performance
				targets</header>
              <text display-inline="yes-display-inline">The developmental
				milestones described in paragraph (4)(A) and the performance targets and goals
				described in paragraph (4)(B) shall include—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="HAFDDFB7A6DC74DEDAFC102D658750C62">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">feedback from the Secretary regarding the
				data required to support the approval, clearance, or licensure of the eligible
				countermeasure involved;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H2F35DE6AA4F444E79EFEDBBAAFB5DF92">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">feedback from the Secretary regarding the
				data necessary to inform any authorization under section 564;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="HEFD416EABC904ADBAA6A3150583C7C9A">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">feedback from the Secretary regarding the
				data necessary to support the positioning and delivery of the eligible
				countermeasure, including to the Strategic National Stockpile;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H264F8B3B70FB47DEA768D59F25373D66">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">feedback from the Secretary regarding the
				data necessary to support the submission of protocols for review under section
				505(b)(5)(B);</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H253832D5720A4BBCB226E8874C32675B">
                <enum>(E)</enum>
                <text display-inline="yes-display-inline">feedback from the Secretary regarding any
				gaps in scientific knowledge that will need resolution prior to approval,
				licensure, or clearance of the eligible countermeasure and plans for conducting
				the necessary scientific research;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="HE613A256756E48B796C0742DDF3D31C0">
                <enum>(F)</enum>
                <text display-inline="yes-display-inline">identification of the population for which
				the countermeasure sponsor or applicant seeks approval, licensure, or clearance
				and the population for which desired labeling would not be appropriate, if
				known; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H2D95EFF5F7EF4F6F9F8A39648847C4C3">
                <enum>(G)</enum>
                <text display-inline="yes-display-inline">as necessary and appropriate, and to the
				extent practicable, a plan for demonstrating safety and effectiveness in
				pediatric populations, and for developing pediatric dosing, formulation, and
				administration with respect to the eligible countermeasure, provided that such
				plan would not delay authorization under section 564, approval, licensure, or
				clearance for adults.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HF4D99FE499494ED5A862065E768B37DA">
              <enum>(6)</enum>
              <header display-inline="yes-display-inline">Prioritization</header>
							<subparagraph commented="no" id="H21FBF5E476F148CD853D804E954728B4">
                <enum>(A)</enum>
                <header>Plans for
				security countermeasures</header>
                <text>The Secretary shall establish regulatory
				management plans for all security countermeasures for which a request is
				submitted under paragraph (3)(A).</text>
							</subparagraph>
              <subparagraph commented="no" id="H35061616655E494294099A4EB9200048">
                <enum>(B)</enum>
                <header>Plans for other
				eligible countermeasures</header>
                <text>The Secretary shall determine whether
				resources are available to establish regulatory management plans for eligible
				countermeasures that are not security countermeasures. If resources are
				available to establish regulatory management plans for eligible countermeasures
				that are not security countermeasures, and if resources are not available to
				establish regulatory management plans for all eligible countermeasures for
				which requests have been submitted, the Director of the Biomedical Advanced
				Research and Development Authority, in consultation with the Commissioner,
				shall prioritize which eligible countermeasures may receive regulatory
				management
				plans.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="HDCB0E8E3FE1F4AA5A76C15B4817D1B97" section-type="subsequent-section">
        <enum>306.</enum>
        <header display-inline="yes-display-inline">Report</header>
        <text display-inline="no-display-inline">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">21 U.S.C. 360bbb–4</external-xref>), as amended by section 305, is further
			 amended by adding at the end the following:</text>
				<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HD4659BB9D30D4DEC84450D6B5100A56D" reported-display-style="strikethrough" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="H47EDB35096CF4AE88A6506939D21CE77">
            <enum>(g)</enum>
            <header display-inline="yes-display-inline">Annual report</header>
            <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, and annually thereafter, the Secretary shall make
				publicly available on the Web site of the Food and Drug Administration a report
				that details the countermeasure development and review activities of the Food
				and Drug Administration, including—</text>
						<paragraph commented="no" display-inline="no-display-inline" id="HA163D13B893C47C5831ACDF5290B10FB">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">with respect to the development of new
				tools, standards, and approaches to assess and evaluate countermeasures—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="H9E57986187544C7EB37963C38007A5C9">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">the identification of the priorities of the
				Food and Drug Administration and the progress made on such priorities;
				and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H610FEA9F48D744D19EBF58F4B5F989C7">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">the identification of scientific gaps that
				impede the development, approval, licensure, or clearance of countermeasures
				for populations with special clinical needs, including children and pregnant
				women, and the progress made on resolving these challenges;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HDDF3B926BFAE4F6298D82F417C180172">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">with respect to countermeasures for which a
				regulatory management plan has been agreed upon under subsection (f), the
				extent to which the performance targets and goals set forth in subsection
				(f)(4)(B) and the regulatory management plan have been met, including, for each
				such countermeasure—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="H80E85545A22A4BFA8305FF737F51D82F">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">whether the regulatory management plan was
				completed within the required timeframe, and the length of time taken to
				complete such plan;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="HDEC60C2ED6EA428A8C08ABE0EC2EE41A">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">whether the Secretary adhered to the timely
				and appropriate response times set forth in such plan; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H728F4D6A66254E5A95A95990FCA97CDC">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">explanations for any failure to meet such
				performance targets and goals;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H08D92F9BF78747E2A7A49FFF05B3DB05">
              <enum>(3)</enum>
              <text display-inline="yes-display-inline">the number of regulatory teams established
				pursuant to subsection (b)(4), the number of products, classes of products, or
				technologies assigned to each such team, and the number of, type of, and any
				progress made as a result of consultations carried out under subsection
				(b)(4)(A);</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="HCBD44B819F164CFAB4A6340E0830E7B4">
              <enum>(4)</enum>
              <text display-inline="yes-display-inline">an estimate of resources obligated to
				countermeasure development and regulatory assessment, including—</text>
							<subparagraph id="H8CB7DE22B48B47D6ABD16FEE8D33B001">
                <enum>(A)</enum>
                <text>Center-specific
				objectives and accomplishments; and</text>
							</subparagraph>
              <subparagraph id="H1BB2C59773EF4B56BC6850AA4E5971C4">
                <enum>(B)</enum>
                <text>the number of
				full-time equivalent employees of the Food and Drug Administration who directly
				support the review of countermeasures;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H650EB2EB1A46497EB89B156FF10ABFD2">
              <enum>(5)</enum>
              <text display-inline="yes-display-inline">the number of countermeasure applications
				and submissions submitted, the number of countermeasures approved, licensed, or
				cleared, the status of remaining submitted applications and submissions, and
				the number of each type of authorization issued pursuant to section 564;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="H905454EB09E4473EB24D51B698B2B2C0">
              <enum>(6)</enum>
              <text display-inline="yes-display-inline">the number of written requests for a
				regulatory management plan submitted under subsection (f)(3)(A), the number of
				regulatory management plans developed, and the number of such plans developed
				for security countermeasures; and</text>
						</paragraph>
            <paragraph commented="no" id="HE878954C126D455F9E4698686DB30678">
              <enum>(7)</enum>
              <text>the number, type,
				and frequency of meetings between the Food and Drug Administration and—</text>
							<subparagraph id="H22C529005FD244C9865CF11417306561">
                <enum>(A)</enum>
                <text>sponsors of a
				countermeasure as defined in subsection (a); or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="H4603DD3FD2AB4B03A251B104FED87FAA">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">another agency engaged in development or
				management of portfolios for such countermeasures, including the Centers for
				Disease Control and Prevention, the Biomedical Advanced Research and
				Development Authority, the National Institutes of Health, and the appropriate
				agencies of the Department of
				Defense.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" id="HCD660DD3C3A34E93B045250C888AF95E">
        <enum>307.</enum>
        <header>Pediatric
			 medical countermeasures</header>
				<subsection commented="no" display-inline="no-display-inline" id="H1657B0E6D7E44BE4BDB8811FCA4D518E">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Pediatric studies of drugs</header>
          <text display-inline="yes-display-inline">Section 505A of the Federal Food, Drug, and
			 Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355a">21 U.S.C. 355a</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H1AF20FCB686C452AB99ED5729E3CB5C6">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subsection (d), by adding at the end the
			 following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H799A8C490CE344A2A493BDD040E809A7" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="H2BBB8DB7B3B94644BEF51F63B5E66925">
                <enum>(5)</enum>
                <header display-inline="yes-display-inline">Consultation</header>
                <text display-inline="yes-display-inline">With respect to a drug that is a qualified
				countermeasure (as defined in section 319F–1 of the Public Health Service Act),
				a security countermeasure (as defined in section 319F–2 of the Public Health
				Service Act), or a qualified pandemic or epidemic product (as defined in
				section 319F–3 of the Public Health Service Act), the Secretary shall solicit
				input from the Assistant Secretary for Preparedness and Response regarding the
				need for and, from the Director of the Biomedical Advanced Research and
				Development Authority regarding the conduct of, pediatric studies under this
				section.</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HF65CAC7A358D41DDBB9607348F8DFC45">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subsection (n)(1), by adding at the end
			 the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H90CAB2EA4E2C438588FD869F3D1FC78B" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="H04C66A652E904CF882C9908CAA34B92C">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">For a drug that is a qualified
				countermeasure (as defined in section 319F–1 of the Public Health Service Act),
				a security countermeasure (as defined in section 319F–2 of the Public Health
				Service Act), or a qualified pandemic or epidemic product (as defined in
				section 319F–3 of such Act), in addition to any action with respect to such
				drug under subparagraph (A) or (B), the Secretary shall notify the Assistant
				Secretary for Preparedness and Response and the Director of the Biomedical
				Advanced Research and Development Authority of all pediatric studies in the
				written request issued by the Commissioner of Food and
				Drugs.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H23006DAF7EDC4F75A7579C2415F09C8F">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Addition to priority list
			 considerations</header>
          <text display-inline="yes-display-inline">Section 409I
			 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284m">42 U.S.C. 284m</external-xref>) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H9D6604AC1F8743A7B81E4B5396DE7D3F">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">by striking subsection (a)(2) and inserting
			 the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HDC7DB21E96404FB9BB84340787167593" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="H440CDC6054CE47ADA9F1764784A5BB97">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Consideration of available
				information</header>
                <text display-inline="yes-display-inline">In developing and
				prioritizing the list under paragraph (1), the Secretary—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H8AADFDF3B812427DABA3AEF299F41F52">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">shall consider—</text>
									<clause commented="no" display-inline="no-display-inline" id="H834B54E8C1854224B11E1334489E33BA">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">therapeutic gaps in pediatrics that may
				include developmental pharmacology, pharmacogenetic determinants of drug
				response, metabolism of drugs and biologics in children, and pediatric clinical
				trials;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="HC8FCAFD06D534338BEF489BFA3A19FC5">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">particular pediatric diseases, disorders or
				conditions where more complete knowledge and testing of therapeutics, including
				drugs and biologics, may be beneficial in pediatric populations; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="H11768944D1BE4D74B491DF7B62E1BA93">
                    <enum>(iii)</enum>
                    <text display-inline="yes-display-inline">the adequacy of necessary infrastructure to
				conduct pediatric pharmacological research, including research networks and
				trained pediatric investigators; and</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="HEED8D97308794E958A6D8D657A479DFE">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">may consider the availability of qualified
				countermeasures (as defined in section 319F–1), security countermeasures (as
				defined in section 319F–2), and qualified pandemic or epidemic products (as
				defined in section 319F–3) to address the needs of pediatric populations, in
				consultation with the Assistant Secretary for Preparedness and Response,
				consistent with the purposes of this
				section.</text>
								</subparagraph>
              </paragraph>
              <after-quoted-block>; and
				</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HAC1D061734964900B3B725866E99CE23">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subsection (b), by striking
			 <quote>subsection (a)</quote> and inserting <quote>paragraphs (1) and (2)(A) of
			 subsection (a)</quote>.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HEBAEDFFBA28C4117B63FD07968F56360">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Advice and recommendations of the pediatric
			 advisory committee regarding countermeasures for pediatric
			 populations</header>
          <text display-inline="yes-display-inline">Subsection (b)(2)
			 of section 14 of the Best Pharmaceuticals for Children Act (42 U.S.C. 284m
			 note) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="HC3EF933173534EDBB2260EAB699DFBED">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subparagraph (C), by striking the period
			 and inserting <quote>; and</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H1FE0E6480195473F85BDD3821917B29D">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HD468B62355014363B29F43C8DB2C2EF6" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="H9C9213EB8E90466CAF0C0441775AA7B9">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">the development of countermeasures (as
				defined in section 565(a) of the Federal Food, Drug, and Cosmetic Act) for
				pediatric
				populations.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
    </title>
    <title changed="deleted" committee-id="SSHR00" id="H4A482682FF8C4C76B83DD4F271686E77" reported-display-style="strikethrough">
      <enum>IV</enum>
      <header>Accelerating
			 medical countermeasure advanced research and development</header>
			<section commented="no" display-inline="no-display-inline" id="H0544928AD668436CBDFFD58997C4EB5A" section-type="subsequent-section">
        <enum>401.</enum>
        <header display-inline="yes-display-inline">BioShield</header>
				<subsection commented="no" display-inline="no-display-inline" id="H7E26C24245294FFEBAF3E026E6E8781D">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Procurement of
			 countermeasures</header>
          <text display-inline="yes-display-inline">Section
			 319F–2(c) of the Public Health Service Act (42 U.S.C. 247d–6b(c)) is
			 amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H946D6CD746EE41C5AF58C6D6D28154CE">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in paragraph (1)(B)(i)(III)(bb), by
			 striking <quote>eight years</quote> and inserting <quote>10
			 years</quote>;</text>
					</paragraph>
          <paragraph id="H190D3CDBCBA043A3AAA6DD4D3BDDF5BB">
            <enum>(2)</enum>
            <text>in paragraph
			 (2)(C), by striking <quote>the designated congressional committees (as defined
			 in paragraph (10))</quote> and inserting <quote>the appropriate committees of
			 Congress</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HCCE11B8C71BD42439429D00FEC561A3E">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">in paragraph (5)(B)(ii), by striking
			 <quote>eight years</quote> and inserting <quote>10 years</quote>;</text>
					</paragraph>
          <paragraph id="H057FF295BFAB45AFA781FDB54BC28F2B">
            <enum>(4)</enum>
            <text>in subparagraph
			 (C) of paragraph (6)—</text>
						<subparagraph id="H20F448A1BAAB4D639848E00125E6D94E">
              <enum>(A)</enum>
              <text>in the
			 subparagraph heading, by striking <quote>
                  <header-in-text level="subparagraph" style="OLC">designated congressional committees</header-in-text>
                </quote> and
			 inserting <quote>
                  <header-in-text level="subparagraph" style="OLC">appropriate
			 congressional committees</header-in-text>
                </quote>; and</text>
						</subparagraph>
            <subparagraph id="H4C9426222EBB4E69A9FCA6BCAEB45C5E">
              <enum>(B)</enum>
              <text>by striking
			 <quote>the designated congressional committees</quote> and inserting <quote>the
			 appropriate congressional committees</quote>; and</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H0C50ADD94A5A4BC1858DBDFDADADFD7D">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">in paragraph (7)(C)—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H1264FE13524E4443928351806DA94909">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in clause (i)(I), by inserting
			 <quote>including advanced research and development,</quote> after <quote>as may
			 reasonably be required,</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H478A098C95814052A236B3EC6EAD2024">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in clause (ii)—</text>
							<clause commented="no" display-inline="no-display-inline" id="HB4E3E8B7EA3E4D70B9DDDD32BD1A3691">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in subclause (III), by striking
			 <quote>eight years</quote> and inserting <quote>10 years</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H876240280A6743C08478D5C084A8772D">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking subclause (IX) and inserting
			 the following:</text>
								<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H4F11FFE8A57A448598B6E6F50506847E" reported-display-style="strikethrough" style="OLC">
									<subclause commented="no" display-inline="no-display-inline" id="HE1841306CE3D479BA99FFB8911511C9F">
                    <enum>(IX)</enum>
                    <header display-inline="yes-display-inline">Contract
				terms</header>
                    <text display-inline="yes-display-inline">The Secretary, in any
				contract for procurement under this section—</text>
										<item commented="no" display-inline="no-display-inline" id="HC5AC134DB57644B1A145232D7AF5417F">
                      <enum>(aa)</enum>
                      <text display-inline="yes-display-inline">may specify—</text>
											<subitem commented="no" display-inline="no-display-inline" id="H11B474C1C4B84714AF137CC09DA11539">
                        <enum>(AA)</enum>
                        <text display-inline="yes-display-inline">the dosing and administration requirements
				for the countermeasure to be developed and procured;</text>
											</subitem>
                      <subitem commented="no" display-inline="no-display-inline" id="H86BF50FCE9F34F20BC17447D941D709E">
                        <enum>(BB)</enum>
                        <text display-inline="yes-display-inline">the amount of funding that will be
				dedicated by the Secretary for advanced research, development, and procurement
				of the countermeasure; and</text>
											</subitem>
                      <subitem commented="no" display-inline="no-display-inline" id="HF355542C05564C4A8D0A96A59EA87CFA">
                        <enum>(CC)</enum>
                        <text display-inline="yes-display-inline">the specifications the countermeasure must
				meet to qualify for procurement under a contract under this section; and</text>
											</subitem>
                    </item>
                    <item commented="no" display-inline="no-display-inline" id="HD32C7DC31AF746678AED765886600ECB">
                      <enum>(bb)</enum>
                      <text display-inline="yes-display-inline">shall provide a clear statement of defined
				Government purpose limited to uses related to a security countermeasure, as
				defined in paragraph (1)(B).</text>
										</item>
                  </subclause>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HD9EFF626265B429BAFDF273860DB68E3">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H7199BF8375DB4A0193EA3EA8E83E9F47" reported-display-style="strikethrough" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="HEE7FCB0C60AB4A5FA1035F72DA668895">
                  <enum>(viii)</enum>
                  <header display-inline="yes-display-inline">Flexibility</header>
                  <text display-inline="yes-display-inline">In carrying out this section, the Secretary
				may, consistent with the applicable provisions of this section, enter into
				contracts and other agreements that are in the best interest of the Government
				in meeting identified security countermeasure needs, including with respect to
				reimbursement of the cost of advanced research and development as a reasonable,
				allowable, and allocable direct cost of the contract
				involved.</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" id="H5715955F7DA14F7CA48DCDC749DE8962">
          <enum>(b)</enum>
          <header>Reauthorization
			 of the special reserve fund</header>
          <text>Section 319F–2 of the Public Health
			 Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6b">42 U.S.C. 247d–6b</external-xref>) is amended—</text>
					<paragraph id="H3B30D907FFF24F2BAF925FD1459A3FA1">
            <enum>(1)</enum>
            <text>in subsection
			 (c)—</text>
						<subparagraph id="H55DCD3531A5A4CEFBFAA7328059FBC36">
              <enum>(A)</enum>
              <text>by striking
			 <quote>special reserve fund under paragraph (10)</quote> each place it appears
			 and inserting <quote>special reserve fund as defined in subsection (h)</quote>;
			 and</text>
						</subparagraph>
            <subparagraph commented="no" id="HD6A1F9DBF0134B67B6FE1FC651127EEE">
              <enum>(B)</enum>
              <text>by striking
			 paragraphs (9) and (10); and</text>
						</subparagraph>
          </paragraph>
          <paragraph id="HBB6D2BDB73B94DCDBE00F8AC19F8A27C">
            <enum>(2)</enum>
            <text>by adding at the
			 end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HCA04284470E244DF9291184476E57960" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" id="HC33179A185BA403B8FC87DDA3EC5F7E7">
                <enum>(g)</enum>
                <header>Special reserve
				fund</header>
								<paragraph id="HBCC27041E4954202A80637C0F0F72AB6">
                  <enum>(1)</enum>
                  <header>Authorization of
				appropriations</header>
                  <text display-inline="yes-display-inline">In addition to
				amounts appropriated to the special reserve fund prior to the date of the
				enactment of this subsection, there is authorized to be appropriated, for the
				procurement of security countermeasures under subsection (c) and for carrying
				out section 319L (relating to the Biomedical Advanced Research and Development
				Authority), $2,800,000,000 for the period of fiscal years 2014 through 2018.
				Amounts appropriated pursuant to the preceding sentence are authorized to
				remain available until September 30, 2019.</text>
								</paragraph>
                <paragraph commented="no" id="H88F25897F564469C9AAA70191C04D867">
                  <enum>(2)</enum>
                  <header>Use of special
				reserve fund for advanced research and development</header>
                  <text display-inline="yes-display-inline">The
				Secretary may utilize not more than 50 percent of the amounts authorized to be
				appropriated under paragraph (1) to carry out section 319L (related to the
				Biomedical Advanced Research and Development Authority). Amounts authorized to
				be appropriated under this subsection to carry out section 319L are in addition
				to amounts otherwise authorized to be appropriated to carry out such
				section.</text>
								</paragraph>
                <paragraph commented="no" id="H33B1DCD843674ED6B6A3BB9F5A34EA3D">
                  <enum>(3)</enum>
                  <header>Restrictions on
				use of funds</header>
                  <text>Amounts in the special reserve fund shall not be
				used to pay costs other than payments made by the Secretary to a vendor for
				advanced development (under section 319L) or for procurement of a security
				countermeasure under subsection (c)(7).</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="H2644EEAE44384B569195DDA2B960C53D">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Report</header>
                  <text display-inline="yes-display-inline">Not later than 30 days after any date on
				which the Secretary determines that the amount of funds in the special reserve
				fund available for procurement is less than $1,500,000,000, the Secretary shall
				submit to the appropriate committees of Congress a report detailing the amount
				of such funds available for procurement and the impact such reduction in
				funding will have—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="H844E336DA24F4FCA89CAAB6D4A321BE3">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">in meeting the security countermeasure
				needs identified under this section; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="H8C6FE881747644B1A3FE60AAA921EA8F">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">on the annual Public Health Emergency
				Medical Countermeasures Enterprise and Strategy Implementation Plan (pursuant
				to section 2811(d)).</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" id="HEB404F6A4CB2444A8D6F41D9F71995CA">
                <enum>(h)</enum>
                <header>Definitions</header>
                <text>In
				this section:</text>
								<paragraph commented="no" id="HC74C995B911E4EB9AF08B088D4036C31">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">The term <term>advanced research and
				development</term> has the meaning given such term in section 319L(a).</text>
								</paragraph>
                <paragraph commented="no" id="H5089749125154F628B5CD7B82AA81F75">
                  <enum>(2)</enum>
                  <text>The term
				<term>special reserve fund</term> means the <term>Biodefense
				Countermeasures</term> appropriations account, any appropriation made available
				pursuant to section 521(a) of the Homeland Security Act of 2002, and any
				appropriation made available pursuant to subsection
				(g)(1).</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H2133264C75B543CF97043CADF6F4E2BD" section-type="subsequent-section">
        <enum>402.</enum>
        <header display-inline="yes-display-inline">Biomedical Advanced Research and
			 Development Authority</header>
				<subsection commented="no" display-inline="no-display-inline" id="H4C93FBCA5C8A447D8C5B4601CD7C86B4">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Duties</header>
          <text display-inline="yes-display-inline">Section 319L(c)(4) of the Public Health
			 Service Act (42 U.S.C. 247d–7e(c)(4)) is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="H3262E38627094DCA93E30B0EE1949C6C">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in subparagraph (B)(iii), by inserting
			 <quote>(which may include advanced research and development for purposes of
			 fulfilling requirements under the Federal Food, Drug, and Cosmetic Act or
			 section 351 of this Act)</quote> after <quote>development</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H39DE9CCF50024C65952C65052CB9456E">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in subparagraph (D)(iii), by striking
			 <quote>and vaccine manufacturing technologies</quote> and inserting
			 <quote>vaccine-manufacturing technologies, dose-sparing technologies,
			 efficacy-increasing technologies, and platform technologies</quote>.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HA4D93CE801904A91A83C955EFBD7EC5D">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Transaction authorities</header>
          <text display-inline="yes-display-inline">Section 319L(c)(5) of the Public Health
			 Service Act (42 U.S.C. 247d–7e(c)(5)) is amended by adding at the end the
			 following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HCBECD22C94B64AE695D1CAABFA0B2E30" reported-display-style="strikethrough" style="OLC">
						<subparagraph commented="no" display-inline="no-display-inline" id="H022BDBA597C04C3585329B0A04B9D214">
              <enum>(G)</enum>
              <header display-inline="yes-display-inline">Government purpose</header>
              <text display-inline="yes-display-inline">In awarding contracts, grants, and
				cooperative agreements under this section, the Secretary shall provide a clear
				statement of defined Government purpose related to activities included in
				subsection (a)(6)(B) for a qualified countermeasure or qualified pandemic or
				epidemic
				product.</text>
						</subparagraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H01C88E322DD74D73906250CE977ED46F">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Fund</header>
          <text display-inline="yes-display-inline">Paragraph (2) of section 319L(d) of the
			 Public Health Service Act (42 U.S.C. 247d–7e(d)(2)) is amended to read as
			 follows:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H3A822C68CA66436B81DD3CFD22D93349" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="H71BEE67BF57B440BAC146DD939DFC2C1">
              <enum>(2)</enum>
              <header display-inline="yes-display-inline">Funding</header>
              <text display-inline="yes-display-inline">To carry out the purposes of this section,
				there is authorized to be appropriated to the Fund $415,000,000 for each of
				fiscal years 2013 through 2017, such amounts to remain available until
				expended.</text>
						</paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HD7F6532D30DB456F8959A30378CD0529">
          <enum>(d)</enum>
          <header display-inline="yes-display-inline">Continued Inapplicability of Certain
			 Provisions</header>
          <text display-inline="yes-display-inline">
            
              Section
			 319L(e)(1)(C) of the Public Health Service Act (42 U.S.C. 247d–7e(e)(1)(C)) is
			 amended by striking <quote>7 years</quote> and inserting <quote>11
			 years</quote>.</text>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H73126C0E70CA43AA9B49A01E401A7AD8">
          <enum>(e)</enum>
          <header display-inline="yes-display-inline">Extension of limited antitrust
			 exemption</header>
					<paragraph id="HD9382139A04944058A896D877FD34360">
            <enum>(1)</enum>
            <header>In
			 general</header>
            <text>
              
                Section 405(b) of the Pandemic and All-Hazards
			 Preparedness Act (42 U.S.C. 247d–6a note) is amended by striking
			 <quote>6-year</quote> and inserting <quote>11-year</quote>.</text>
					</paragraph>
          <paragraph id="HADF4FAFD363E4E7B90742E4212747B7B">
            <enum>(2)</enum>
            <header>Effective
			 date</header>
            <text>This subsection shall take effect as if enacted on December
			 17, 2012.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="HD559C244D05442CEAB9CEC14F6ECB03E">
          <enum>(f)</enum>
          <header display-inline="yes-display-inline">Independent evaluation</header>
          <text display-inline="yes-display-inline">Section 319L of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-7e">42 U.S.C. 247d–7e</external-xref>) is amended by adding at the end the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HAD1E6CC5B5E54C38803F1D2DB9FF666E" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="HFD9A455659DA432C81F11CCEED591B24">
              <enum>(f)</enum>
              <header display-inline="yes-display-inline">Independent evaluation</header>
							<paragraph commented="no" display-inline="no-display-inline" id="H495BDD749EEF407AB6F87BFCDAD9054F">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, the Comptroller General of the United States
				shall conduct an independent evaluation of the activities carried out to
				facilitate flexible manufacturing capacity pursuant to this section.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="HDD07C609CE7A4FFD86CF5C3C48C0A72A">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Report</header>
                <text display-inline="yes-display-inline">Not later than 1 year after the date of
				enactment of this subsection, the Comptroller General of the United States
				shall submit to the appropriate committees of Congress a report concerning the
				results of the evaluation conducted under paragraph (1). Such report shall
				review and assess—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="H88F8512F9B4849D1BB00B3061995C402">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">the extent to which flexible manufacturing
				capacity under this section is dedicated to chemical, biological, radiological,
				and nuclear threats;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H890B6C71BA33483681DAFFC4599064F7">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">the activities supported by flexible
				manufacturing initiatives; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="H7351CF62E9FC487DBDAAB3ABCDE6BBAD">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">the ability of flexible manufacturing
				activities carried out under this section to—</text>
									<clause commented="no" display-inline="no-display-inline" id="HE18941A75D0849F9A6A0AB866E928202">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">secure and leverage leading technical
				expertise with respect to countermeasure advanced research, development, and
				manufacturing processes; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="H56F6745709AF4CAFA7B47B91FA71C6D4">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">meet the surge manufacturing capacity needs
				presented by novel and emerging threats, including chemical, biological,
				radiological, and nuclear
				agents.</text>
									</clause>
                </subparagraph>
              </paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="H0D34D9E75EAC48BE9DE42A49FFF19EFB">
          <enum>(g)</enum>
          <header display-inline="yes-display-inline">Definitions</header>
					<paragraph commented="no" display-inline="no-display-inline" id="H03FE4008A43042BCBEA9BA9C2F042344">
            <enum>(1)</enum>
            <header display-inline="yes-display-inline">Qualified countermeasure</header>
            <text display-inline="yes-display-inline">Section 319F–1(a)(2)(A) of the Public
			 Health Service Act (42 U.S.C. 247d–6a(a)(2)(A)) is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HD9617724A84E47B98AC4950371637EA3">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the matter preceding clause (i), by
			 striking <quote>to—</quote> and inserting <quote>—</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H97CB92F229F145259E34B15641C5B325">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in clause (i)—</text>
							<clause commented="no" display-inline="no-display-inline" id="HC99E3D7954FA411F920AD68D8A19B1AC">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <quote>diagnose</quote> and
			 inserting <quote>to diagnose</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H892CA8AB14B94F269BEDAE5277608EEF">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>; or</quote> and
			 inserting a semicolon;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HAE5EF5A42E9644469E4BD9045A402FBA">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in clause (ii)—</text>
							<clause commented="no" display-inline="no-display-inline" id="H15B48425BA0840FAB2D61F06FDD6C325">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <quote>diagnose</quote> and
			 inserting <quote>to diagnose</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="H7BA655CEAF56447A91E3A207D1E361CD">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking the period at the end and
			 inserting <quote>; or</quote>; and</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H9F3566336A154DFC916A44472B2C3C4A">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HCFFB954D328B417B8280B01C6E745F47" reported-display-style="strikethrough" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="HA038871B6DDB4EEA8BCA7BC46A8034DD">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">is a product or technology intended to
				enhance the use or effect of a drug, biological product, or device described in
				clause (i) or
				(ii).</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="HDE7EB7C5B1AA4EA4B7A7A712AAE8C056">
            <enum>(2)</enum>
            <header display-inline="yes-display-inline">Qualified pandemic or epidemic
			 product</header>
            <text display-inline="yes-display-inline">Section
			 319F–3(i)(7)(A) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(7)(A))
			 is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="HDF8BB90A8D964AB6B45CD957B23260D9">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in clause (i)(II), by striking <quote>;
			 or</quote> and inserting <quote>;</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HD63221413CF64615BCD170EA18461050">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in clause (ii), by striking <quote>;
			 and</quote> and inserting <quote>; or</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="H8155ECE69EBF4012AC7090A92A6648A9">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H812834A511574D1F97327451981EC65D" reported-display-style="strikethrough" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="HDD830FAED882457892D470C820BF5CE8">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">a product or technology intended to enhance
				the use or effect of a drug, biological product, or device described in clause
				(i) or (ii);
				and</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="H3DA101D22B154E58B4AF4E51AC8DF9E6">
            <enum>(3)</enum>
            <header display-inline="yes-display-inline">Technical amendments</header>
            <text display-inline="yes-display-inline">Section 319F–3(i) of the Public Health
			 Service Act (42 U.S.C. 247d–6d(i)) is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="H2ED1A45DA53F44E8876EADA095EAB38E">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in paragraph (1)(C), by inserting <quote>,
			 564A, or 564B</quote> after <quote>564</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="HB3160C80B0034F949B6C75C6AF00B162">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in paragraph (7)(B)(iii), by inserting
			 <quote>, 564A, or 564B</quote> after <quote>564</quote>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="H8C32E3DC40334E2BA73AAE7843482973" section-type="subsequent-section">
        <enum>403.</enum>
        <header display-inline="yes-display-inline">Strategic National Stockpile</header>
        <text display-inline="no-display-inline">Section 319F–2 of the Public Health Service
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6b">42 U.S.C. 247d–6b</external-xref>) is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="HB6AA8A03CBD1489097D05919BFE927DA">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in subsection (a)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="HD5D119FAEF8344429E2B6C96CDDA31C5">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in paragraph (1)—</text>
						<clause commented="no" display-inline="no-display-inline" id="H1D4D901835474E249AC460E1A013B5FF">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">by inserting <quote>consistent with section
			 2811</quote> before <quote>by the Secretary to be appropriate</quote>;
			 and</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="HB282E98303034CCCBA6AEDF5BD5F786E">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">by inserting before the period at the end
			 of the second sentence the following: <quote>and shall submit such review
			 annually to the appropriate congressional committees of jurisdiction to the
			 extent that disclosure of such information does not compromise national
			 security</quote>; and</text>
						</clause>
          </subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HC2414637B674496F9A5AB4595587B2C5">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in paragraph (2)(D), by inserting before
			 the semicolon at the end the following: <quote>and that the potential depletion
			 of countermeasures currently in the stockpile is identified and appropriately
			 addressed, including through necessary replenishment</quote>; and</text>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="HCD3B0E9107B244CEB2C85E9291682FF4">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in subsection (f)(1), by striking
			 <quote>$640,000,000 for fiscal year 2002, and such sums as may be necessary for
			 each of fiscal years 2003 through 2006. Such authorization is in addition to
			 amounts in the special reserve fund referred to in subsection
			 (c)(10)(A).</quote> and inserting <quote>$533,800,000 for each of fiscal years
			 2013 through 2017. Such authorization is in addition to amounts in the special
			 reserve fund referred to in subsection (h).</quote>.</text>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="HB37DEC86CD024C59B0FDE9FDB8F0CDA7" section-type="subsequent-section">
        <enum>404.</enum>
        <header display-inline="yes-display-inline">National Biodefense Science
			 Board</header>
        <text display-inline="no-display-inline">Section 319M(a) of the
			 Public Health Service Act (42 U.S.C. 247d–f(a)) is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="HA858F281B8D94125BA9FD2540F9007F1">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in paragraph (2)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="H5024254FEE8A47EAA2AD41A13A4FBB62">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in subparagraph (D)—</text>
						<clause commented="no" display-inline="no-display-inline" id="HE408A89435674F68B5E942664B8BEFFD">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">in clause (i), by striking
			 <quote>and</quote> at the end;</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="H5155649BBF194897A905748E62BC95CD">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">in clause (ii), by striking the period and
			 inserting a semicolon; and</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="H248D01B25A4C49D08681D69DB4DC2E1F">
              <enum>(iii)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H6100F1E01CFA40049D4CE8EE7F95C767" reported-display-style="strikethrough" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="HD33A7DF212BF4332BE82615775EF4ADC">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">one such member shall be an individual with
				pediatric subject matter expertise; and</text>
								</clause>
                <clause commented="no" display-inline="no-display-inline" id="H2E2AD8632A224CF08AF0F69A7FBF200D">
                  <enum>(iv)</enum>
                  <text display-inline="yes-display-inline">one such member shall be a State, tribal,
				territorial, or local public health
				official.</text>
								</clause>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</clause>
          </subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HBC702725261B4D5081B151FCC9BD41B2">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following flush
			 sentence:</text>
					</subparagraph>
          <continuation-text commented="no" continuation-text-level="paragraph">
            <quote>Nothing in this paragraph
			 shall preclude a member of the Board from satisfying two or more of the
			 requirements described in subparagraph (D).</quote>; and</continuation-text>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="H89613AF40A72402DB4D1A8E405757C58">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in paragraph (5)—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="H20FD6718E5A643C8B8B1C8890F8E8918">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in subparagraph (B), by striking
			 <quote>and</quote> at the end;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HF9FFCECF8CD14783B86B01BB3B24815A">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in subparagraph (C), by striking the period
			 and inserting <quote>; and</quote>; and</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="HB7113AB862AA46038ED3083990ED850D">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HEF8F330E82FC4606B9AF1F7E7896DEDC" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="H8D4BFBDB28D94AC894E3BF9F50536891">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">provide any recommendation, finding, or
				report provided to the Secretary under this paragraph to the appropriate
				committees of
				Congress.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
      </section>
    </title>
  </legis-body>
	<legis-body display-enacting-clause="no-display-enacting-clause">
		<section changed="added" committee-id="SSHR00" id="idd6388ad4-fc89-454a-a653-6141ab65855e" reported-display-style="italic" section-type="section-one">
      <enum>1.</enum>
      <header>Short title; table of
			 contents</header>
			<subsection id="id5c78fb80-d2f4-4bee-8838-c36a0b41d447">
        <enum>(a)</enum>
        <header>Short
			 title</header>
        <text>This Act may be cited as the <quote>
            <short-title>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic and All-Hazards Preparedness Reauthorization Act
			 of 2013</cato:entity-ref>
            </short-title>
          </quote>.</text>
			</subsection>
      <subsection id="id492854be-386f-494d-b06c-67d63c795282">
        <enum>(b)</enum>
        <header>Table of
			 contents</header>
        <text>The table of contents of this Act is as follows:</text>
				<toc changed="added" committee-id="SSHR00" reported-display-style="italic">
					<toc-entry idref="HCCEE00D5C16146D6A80911AD0E17C2BA" level="section">Sec. 1. Short title; table of
				contents.</toc-entry>
					<toc-entry idref="H59FD4838330446079FDC34FC2212514E" level="title">TITLE I—Strengthening national preparedness and
				response for public health emergencies</toc-entry>
					<toc-entry idref="H5ACE905990694789A34D96741F241153" level="section">Sec. 101. National Health Security
				Strategy.</toc-entry>
					<toc-entry idref="H080FF024053947CDBF9B76F71DA4340D" level="section">Sec. 102. Assistant Secretary for Preparedness
				and Response.</toc-entry>
					<toc-entry idref="HA6F39285D54F4C3AB9635FA5FC74E82C" level="section">Sec. 103. National Advisory Committee on
				Children and Disasters.</toc-entry>
					<toc-entry idref="HFDBA0EEDB6134A1E80884A45EE3B5D63" level="section">Sec. 104. Modernization of the National
				Disaster Medical System.</toc-entry>
					<toc-entry idref="HA9DC3FAF242F4381BC7AE2DF046BF804" level="section">Sec. 105. Continuing the role of the Department
				of Veterans Affairs.</toc-entry>
					<toc-entry idref="H21F113B4823343B3B80A1C7F4E6E8D53" level="title">TITLE II—Optimizing State and local all-hazards
				preparedness and response</toc-entry>
					<toc-entry idref="idE9831E5955C24124AB5DE44A182739A7" level="section">Sec. 201. Temporary reassignment of State and
				local personnel during a public health emergency.</toc-entry>
					<toc-entry idref="H92A6E08877024EBAB6226EE1A00ED9B8" level="section">Sec. 202. Improving State and local public
				health security.</toc-entry>
					<toc-entry idref="H331F70D3384F4994BAD3667214F7B4A2" level="section">Sec. 203. Hospital preparedness and medical
				surge capacity.</toc-entry>
					<toc-entry idref="H00289191EB104CD5B3B88678C6DADF93" level="section">Sec. 204. Enhancing situational awareness and
				biosurveillance.</toc-entry>
					<toc-entry idref="HA2F02A10FAA7454990BBCBA5F231D8F1" level="section">Sec. 205. Eliminating duplicative Project
				Bioshield reports.</toc-entry>
					<toc-entry idref="H1363D5FC34FB4F998D7C3EE07200011C" level="title">TITLE III—Enhancing Medical Countermeasure
				Review</toc-entry>
					<toc-entry idref="HC8A5882A0CFD48818F1E125C33B398FE" level="section">Sec. 301. Special protocol
				assessment.</toc-entry>
					<toc-entry idref="HA2709FB2D3784E098AD5D201DD3568CD" level="section">Sec. 302. Authorization for medical products
				for use in emergencies.</toc-entry>
					<toc-entry idref="HEC0BD8048404458DA08A365CA2C15110" level="section">Sec. 303. Definitions.</toc-entry>
					<toc-entry idref="HFBBB97B5F2094C6B80116CBA431DAD3F" level="section">Sec. 304. Enhancing medical countermeasure
				activities.</toc-entry>
					<toc-entry idref="H2E57CC3BD3CE43CA833392F58FD99ED3" level="section">Sec. 305. Regulatory management
				plans.</toc-entry>
					<toc-entry idref="HDCB0E8E3FE1F4AA5A76C15B4817D1B97" level="section">Sec. 306. Report.</toc-entry>
					<toc-entry idref="HCD660DD3C3A34E93B045250C888AF95E" level="section">Sec. 307. Pediatric medical
				countermeasures.</toc-entry>
					<toc-entry idref="H4A482682FF8C4C76B83DD4F271686E77" level="title">TITLE IV—Accelerating medical countermeasure
				advanced research and development</toc-entry>
					<toc-entry idref="H0544928AD668436CBDFFD58997C4EB5A" level="section">Sec. 401. BioShield.</toc-entry>
					<toc-entry idref="H2133264C75B543CF97043CADF6F4E2BD" level="section">Sec. 402. Biomedical Advanced Research and
				Development Authority.</toc-entry>
					<toc-entry idref="H8C32E3DC40334E2BA73AAE7843482973" level="section">Sec. 403. Strategic National
				Stockpile.</toc-entry>
					<toc-entry idref="HB37DEC86CD024C59B0FDE9FDB8F0CDA7" level="section">Sec. 404. National Biodefense Science
				Board.</toc-entry>
				</toc>
			</subsection>
    </section>
    <title changed="added" commented="no" committee-id="SSHR00" id="idd8364152-8c27-417c-a7df-444caf68c370" level-type="subsequent" reported-display-style="italic">
      <enum>I</enum>
      <header display-inline="yes-display-inline">Strengthening national preparedness and
			 response for public health emergencies</header>
			<section commented="no" display-inline="no-display-inline" id="id948202f5-2609-4cdc-81f5-1751112ac39b" section-type="subsequent-section">
        <enum>101.</enum>
        <header display-inline="yes-display-inline">National Health Security Strategy</header>
				<subsection commented="no" display-inline="no-display-inline" id="id022df090-46f5-4674-96c4-5212236ea777">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2802">Section 2802 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-1">
                <cato:entity-ref entity-type="uscode" value="usc/42/300hh–1">42 U.S.C. 300hh–1</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id0b7c0841-a2ae-4e15-aef9-609694b57e98">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:a/p:1">subsection (a)(1)</cato:entity-ref>, by striking
			 <quote>2009</quote> and inserting <quote>2014</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id47b72927-5882-4493-b2d7-2c231c8149ba">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b">subsection (b)</cato:entity-ref>—</text>
						<subparagraph id="idd7657e26-a5a9-4e91-bb62-d383408d1399">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:1/sp:A">paragraph (1)(A)</cato:entity-ref>, by
			 inserting <quote>, including drills and exercises to ensure medical surge
			 capacity for events without notice</quote> after <quote>exercises</quote>;
			 and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id005eb708-5216-49e3-b045-c0343e393fc2">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3">paragraph (3)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id97dd017d-be20-460c-a176-1e89c1616443">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in the matter preceding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:A">subparagraph
			 (A)</cato:entity-ref>—</text>
								<subclause commented="no" display-inline="no-display-inline" id="idfca5b137-49ea-480e-ad8d-8c471541293b">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>facilities), and trauma
			 care</quote> and inserting <quote>and ambulatory care facilities and which may
			 include dental health facilities), and trauma care, critical care,</quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="idf222d31c-6324-420e-a0d1-d5e019c2c17c">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by inserting <quote>(including related
			 availability, accessibility, and coordination)</quote> after <quote>public
			 health emergencies</quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="id78167d78-4da7-4d4b-a975-1c2af6a46bce">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:A">subparagraph (A)</cato:entity-ref>, by inserting
			 <quote>and trauma</quote> after <quote>medical</quote>;</text>
							</clause>
              <clause id="idce211047-b0f7-4bb3-a9ea-62e6eaa9a034">
                <enum>(iii)</enum>
                <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:B">subparagraph (B)</cato:entity-ref>, by
			 striking <quote>Medical evacuation and fatality management</quote> and
			 inserting <quote>Fatality management</quote>;</text>
							</clause>
              <clause id="idec92925a-ddad-4219-bbb9-cc3b51afc46a">
                <enum>(iv)</enum>
                <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:C, D, E">subparagraphs (C), (D), and (E)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:D, E, F" proposed="true">subparagraphs (D), (E), and (F)</cato:entity-ref>,
			 respectively;</text>
							</clause>
              <clause id="idca0db44f-05fb-4e8d-857b-06922c5c7be5">
                <enum>(v)</enum>
                <text>by inserting after
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:B">subparagraph (B)</cato:entity-ref>, the following the new subparagraph:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id3d7a59c1-1a0c-45b0-858f-7ff3d9e5a3c0" reported-display-style="italic" style="OLC">
									<subparagraph id="idb8c6ccc2-f7e2-44e7-8923-e2df7d9d7b34">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">Coordinated medical triage and evacuation
				to appropriate medical institutions based on patient medical need, taking into
				account regionalized systems of
				care.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id2a3ca850-0a73-4078-baca-993a6a2d41b1">
                <enum>(vi)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3/sp:E" proposed="true">subparagraph (E)</cato:entity-ref>, as redesignated by
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013/s:101/ss:a/p:2/sp:B/cl:iv" proposed="true">clause (iv)</cato:entity-ref>, by inserting <quote>(which may include such dental health
			 assets)</quote> after <quote>medical assets</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id0592aeab-2ca8-4bb4-81c0-f930611c342e">
                <enum>(vii)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida6010951-ed8c-4957-9347-0db347cbf4e5" reported-display-style="italic" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="id9dd45ecc-6607-4e9e-a87a-a5cb8199416c">
                    <enum>(G)</enum>
                    <text display-inline="yes-display-inline">Optimizing a coordinated and flexible
				approach to the medical surge capacity of hospitals, other health care
				facilities, critical care, trauma care (which may include trauma centers), and
				emergency medical
				systems.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id5fbca15d-2725-4652-890d-817707d0acc4">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4">paragraph (4)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id597c4698-5269-4f57-acd3-495a779370d1">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4/sp:A">subparagraph (A)</cato:entity-ref>, by inserting <quote>,
			 including the unique needs and considerations of individuals with
			 disabilities,</quote> after <quote>medical needs of at-risk
			 individuals</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id555de4e9-1e29-453a-a83d-40fd92f8821c">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4/sp:B">subparagraph (B)</cato:entity-ref>, by inserting
			 <quote>the</quote> before <quote>purpose of this section</quote>; and</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id816750f7-61d5-4cb2-9cde-06f0b51aa87a">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id9f0f5b0c-8d51-4fc7-83ca-aed3e40e26f9" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id16d683da-5c04-4fac-906e-30a548442ea4">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Countermeasures</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="id735dcd27-50a6-40a2-ac3a-90896b25a7d9">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">Promoting strategic initiatives to advance
				countermeasures to diagnose, mitigate, prevent, or treat harm from any
				biological agent or toxin, chemical, radiological, or nuclear agent or agents,
				whether naturally occurring, unintentional, or deliberate.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idc11cb6fe-0dcc-41ef-8e31-ac50aed0e814">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">For purposes of this paragraph, the term
				<term>countermeasures</term> has the same meaning as the terms <term>qualified
				countermeasures</term> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1</cato:entity-ref>, <quote>qualified pandemic and
				epidemic products</quote> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section 319F–3</cato:entity-ref>, and <quote>security
				countermeasures</quote> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="ide7744520-6b55-40ce-8924-f4ed59be2ac4">
                  <enum>(8)</enum>
                  <header display-inline="yes-display-inline">Medical and public health community
				resiliency</header>
                  <text display-inline="yes-display-inline">Strengthening the
				ability of States, local communities, and tribal communities to prepare for,
				respond to, and be resilient in the event of public health emergencies, whether
				naturally occurring, unintentional, or deliberate by—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id1a8999c8-cba6-4db9-ac3b-19dcacf1449e">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">optimizing alignment and integration of
				medical and public health preparedness and response planning and capabilities
				with and into routine daily activities; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idaf4bf32e-aa85-496e-b9da-333403cf29a4">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">promoting familiarity with local medical
				and public health
				systems.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id9023693f-f231-4935-b5f2-a33366b408b2">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">At-Risk individuals</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2814">Section 2814 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-16">
                <cato:entity-ref entity-type="uscode" value="usc/42/300hh–16">42 U.S.C. 300hh–16</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="idf93b26bf-8e8e-46b4-a00c-1b9bac125aea">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:5">paragraphs (5)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:7">(7)</cato:entity-ref>, and
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:8">(8)</cato:entity-ref>;</text>
					</paragraph>
          <paragraph commented="no" id="id70d61326-5c57-48f8-8acf-0bb022efe6b1">
            <enum>(2)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:4">paragraph (4)</cato:entity-ref>, by
			 striking <quote>2811(b)(3)(B)</quote> and inserting
			 <quote>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4/sp:B">2802(b)(4)(B)</cato:entity-ref>
              </quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id3cbbcd8f-c0b9-451d-a063-c361d98be6f6">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by redesignating <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:1..4">paragraphs (1) through (4)</cato:entity-ref>
			 as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:2..5" proposed="true">paragraphs (2) through (5)</cato:entity-ref>, respectively;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id2dba28ca-831f-4be1-a10a-46eafd7a5328">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">by inserting before <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:2" proposed="true">paragraph (2)</cato:entity-ref> (as so
			 redesignated), the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id135e81ce-72ee-462c-b14a-8f3a4d55f372" reported-display-style="italic" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="id8314ac7b-dd49-4ce6-9e70-625592bf6662">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">monitor emerging issues and concerns as
				they relate to medical and public health preparedness and response for at-risk
				individuals in the event of a public health emergency declared by the Secretary
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319">section
				319</cato:entity-ref>;</text>
							</paragraph>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id03f8f5f0-383d-414f-9f00-0b9f37e4603f">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:2" proposed="true">paragraph (2)</cato:entity-ref> (as so
			 redesignated) to read as follows:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id402b179e-7d10-44ce-8f68-8e9e4dd51bbd" reported-display-style="italic" style="OLC">
							<paragraph commented="no" id="id264e7511-6a99-4182-b54c-357f2e85e6c6">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">oversee the implementation of the
				preparedness goals described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b">section 2802(b)</cato:entity-ref> with respect to the public
				health and medical needs of at-risk individuals in the event of a public health
				emergency, as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4">section
				2802(b)(4)</cato:entity-ref>;</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id6a2574e2-ebd8-4cba-a964-732af5ba418b">
            <enum>(6)</enum>
            <text display-inline="yes-display-inline">by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814/p:6">paragraph (6)</cato:entity-ref>, the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id0b537c6f-d404-424b-90b8-53558fab79a8" reported-display-style="italic" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="id59e8459b-6d14-4f3e-a59a-d6782a215e0f">
                <enum>(7)</enum>
                <text display-inline="yes-display-inline">disseminate and, as appropriate, update
				novel and best practices of outreach to and care of at-risk individuals before,
				during, and following public health emergencies in as timely a manner as is
				practicable, including from the time a public health threat is identified;
				and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id815775d2-4875-4354-8816-9bf98eb60b1b">
                <enum>(8)</enum>
                <text display-inline="yes-display-inline">ensure that public health and medical
				information distributed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref> during a
				public health emergency is delivered in a manner that takes into account the
				range of communication needs of the intended recipients, including at-risk
				individuals.</text>
							</paragraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="id02e81c3b-94a3-43f5-b092-b36b16a4212d" section-type="subsequent-section">
        <enum>102.</enum>
        <header display-inline="yes-display-inline">Assistant Secretary for Preparedness and
			 Response</header>
				<subsection commented="no" display-inline="no-display-inline" id="id8e112403-d85c-418d-8a24-d27d4f90479e">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2811">Section 2811 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-10">
                <cato:entity-ref entity-type="uscode" value="usc/42/300hh–10">42 U.S.C. 300hh–10</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id1e0752b2-f169-4a57-a503-2cf5e08a4a97">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:b">subsection (b)</cato:entity-ref>—</text>
						<subparagraph id="id7e540ab6-1e25-48aa-bc62-dbd99bd3cf72">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:b/p:3">paragraph (3)</cato:entity-ref>, by
			 inserting <quote>, security countermeasures (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section
			 319F–2</cato:entity-ref>),</quote> after <quote>qualified countermeasures (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section
			 319F–1</cato:entity-ref>)</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idb0bc76d6-896b-4079-8602-8472dba23d61">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:b/p:4">paragraph (4)</cato:entity-ref>, by adding at the end the
			 following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idcf829a64-5a30-4235-82ae-4a65a73dbfb6" reported-display-style="italic" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="id71c20fa8-5ee4-43e8-bef0-2d6d104ffb78">
                  <enum>(D)</enum>
                  <header display-inline="yes-display-inline">Policy coordination and strategic
				direction</header>
                  <text display-inline="yes-display-inline">Provide integrated
				policy coordination and strategic direction with respect to all matters related
				to Federal public health and medical preparedness and execution and deployment
				of the Federal response for public health emergencies and incidents covered by
				the National Response Plan developed pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Homeland Security Act of 2002/s:504/p:6">section 504(6) of the Homeland
				Security Act of 2002</cato:entity-ref>, or any successor plan, before, during, and following
				public health emergencies.</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id0bfa3694-9507-4bad-a774-7d26ffa823a1">
                  <enum>(E)</enum>
                  <header>Identification of
				inefficiencies</header>
                  <text>Identify and minimize gaps, duplication, and other
				inefficiencies in medical and public health preparedness and response
				activities and the actions necessary to overcome these obstacles.</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="idf4abc522-a766-49ab-962d-4c19e1837c5d">
                  <enum>(F)</enum>
                  <header>Coordination of grants
				and agreements</header>
                  <text display-inline="yes-display-inline">Align and
				coordinate medical and public health grants and cooperative agreements as
				applicable to preparedness and response activities authorized under this Act,
				to the extent possible, including program requirements, timelines, and
				measurable goals, and in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Secretary of Homeland Security</cato:entity-ref>,
				to—</text>
									<clause commented="no" display-inline="no-display-inline" id="id2bcaa740-3105-464b-b177-db77f36200bd">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">optimize and streamline medical and public
				health preparedness and response capabilities and the ability of local
				communities to respond to public health emergencies; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="idd6231bdf-cea1-4ca7-acc1-a223f2ad82ef">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">gather and disseminate best practices among
				grant and cooperative agreement recipients, as appropriate.</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="iddac8f82e-5119-4003-909c-9cd0b70c8575">
                  <enum>(G)</enum>
                  <header>Drill and operational
				exercises</header>
                  <text display-inline="yes-display-inline">Carry out drills
				and operational exercises, in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Department of Homeland
				Security</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of Defense</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3600">Department of Veterans Affairs</cato:entity-ref>, and
				other applicable Federal departments and agencies, as necessary and
				appropriate, to identify, inform, and address gaps in and policies related to
				all-hazards medical and public health preparedness and response, including
				exercises based on—</text>
									<clause commented="no" display-inline="no-display-inline" id="iddfd735d4-191a-42fe-92d9-909105b020e5">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">identified threats for which
				countermeasures are available and for which no countermeasures are available;
				and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="id86c9031f-7e29-46a9-92f1-4ca68042284b">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">unknown threats for which no
				countermeasures are available.</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id336a9300-bf07-46d3-84f3-e90d02b14f30">
                  <enum>(H)</enum>
                  <header display-inline="yes-display-inline">National security priority</header>
                  <text display-inline="yes-display-inline">On a periodic basis consult with, as
				applicable and appropriate, the Assistant to the President for National
				Security Affairs, to provide an update on, and discuss, medical and public
				health preparedness and response activities pursuant to this Act and the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, including progress on the development,
				approval, clearance, and licensure of medical
				countermeasures.</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id96ab3220-2d4c-4b6d-9b06-75af55aeb0f3">
              <enum>(C)</enum>
              <text>by adding at the end the
			 following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idba7e89ac-ea24-4bfc-a2e4-c19da04e22d2" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id94570737-1db3-46a4-a0bd-df00f09be4e4">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Countermeasures budget plan</header>
                  <text display-inline="yes-display-inline">Develop, and update on an annual basis, a
				coordinated 5-year budget plan based on the medical countermeasure priorities
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d" proposed="true">subsection (d)</cato:entity-ref>. Each such plan shall—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id69f1532e-7179-46e0-8c91-55b392633ff0">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">include consideration of the entire medical
				countermeasures enterprise, including—</text>
										<clause commented="no" display-inline="no-display-inline" id="id5183bbf3-66fb-4b2f-b898-1dbbde9cd6a0">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">basic research and advanced research and
				development;</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="id43b1cb35-930b-4aa3-9869-02f46056acdf">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">approval, clearance, licensure, and
				authorized uses of products; and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="ida5209b41-d004-4ecc-9e8f-16fa4bf91214">
                      <enum>(iii)</enum>
                      <text display-inline="yes-display-inline">procurement, stockpiling, maintenance, and
				replenishment of all products in the Strategic National Stockpile;</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idd9a4f471-54fb-4d0d-81af-a117152ade7d">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">inform prioritization of resources and
				include measurable outputs and outcomes to allow for the tracking of the
				progress made toward identified priorities;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id1e745d86-f837-4030-8085-71a418764ce7">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">identify medical countermeasure life-cycle
				costs to inform planning, budgeting, and anticipated needs within the continuum
				of the medical countermeasure enterprise consistent with section 319F–2;
				and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idee34b6c8-ea4f-449e-befb-f8518657aead">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">be made available to the appropriate
				committees of Congress upon
				request.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id35a35e0b-f8e0-4f45-9ff5-6fd60249246e">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:c">subsection (c)</cato:entity-ref> and inserting
			 the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idaaf48f9f-3232-4b54-981f-6a85d846e31e" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="id72a4d0b3-4051-4ae4-aa1a-0f865849572a">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Functions</header>
                <text display-inline="yes-display-inline">The Assistant Secretary for Preparedness
				and Response shall—</text>
								<paragraph commented="no" id="iddc1963ae-12e8-4e70-b1ab-6ca65a2b8b42">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">have lead responsibility within the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref> for emergency preparedness and response
				policy coordination and strategic direction;</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id8d79c6cb-168f-4654-9861-4313d91aeae2">
                  <enum>(2)</enum>
                  <text display-inline="yes-display-inline">have authority over and responsibility
				for—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="ide47191c3-b054-4f7d-8c70-122bb1b561d0">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the National Disaster Medical System
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812">section 2812</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id23edefb8-208c-46bb-be76-be3a74a10d4f">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the Hospital Preparedness Cooperative
				Agreement Program pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2">section 319C–2</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph id="idbabfd6ba-5292-4147-9bd2-ecf8a5a99d43">
                    <enum>(C)</enum>
                    <text>the Biomedical Advanced
				Research and Development Authority pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id3f59699d-305b-43e0-a6c7-0fd511fddcda">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">the Medical Reserve Corps pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2813">section 2813</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idbcd846c9-d5ff-4e00-ae3d-a99ee217e2ce">
                    <enum>(E)</enum>
                    <text display-inline="yes-display-inline">the Emergency System for Advance
				Registration of Volunteer Health Professionals pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319I">section 319I</cato:entity-ref>;
				and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idf7ec2032-5f6c-42e4-bc15-621ab532e6cf">
                    <enum>(F)</enum>
                    <text display-inline="yes-display-inline">administering grants and related
				authorities related to trauma care under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/t:XII/pt:A..C">parts A through C of title XII</cato:entity-ref>, such
				authority to be transferred by the Secretary from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7526">Administrator of the
				Health Resources and Services Administration</cato:entity-ref> to such Assistant
				Secretary;</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id61301054-9484-476c-9388-be1400543336">
                  <enum>(3)</enum>
                  <text display-inline="yes-display-inline">exercise the responsibilities and
				authorities of the Secretary with respect to the coordination of—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id95a38ded-1d39-46c1-9057-11db5c4316c0">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the Public Health Emergency Preparedness
				Cooperative Agreement Program pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1">section 319C–1</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id31abae31-88a2-45ca-822b-bed85d6c3f07">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the Strategic National Stockpile pursuant
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2</cato:entity-ref>; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id5d2a8319-aaf3-4dda-ba64-dbad1b6f3d6f">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">the Cities Readiness Initiative; and</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id4d2ff54d-2f77-4745-b2fa-6111a63bc009">
                  <enum>(4)</enum>
                  <text display-inline="yes-display-inline">assume other duties as determined
				appropriate by the Secretary.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id3c77db11-8994-419a-9423-cf03e27088be">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id58199370-6f0c-4018-a5ba-cf635d8e8429" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="idb2f9c8e0-62fe-44df-9bc4-a87d4ce6f033">
                <enum>(d)</enum>
                <header display-inline="yes-display-inline">Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan</header>
								<paragraph commented="no" display-inline="no-display-inline" id="ide6e6fb23-7200-48fe-8559-71bee536bd06">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, and every year thereafter, the Assistant
				Secretary for Preparedness and Response shall develop and submit to the
				appropriate committees of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a coordinated strategy and accompanying
				implementation plan for medical countermeasures to address chemical,
				biological, radiological, and nuclear threats. In developing such a plan, the
				Assistant Secretary for Preparedness and Response shall consult with the
				Director of the Biomedical Advanced Research and Development Authority, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the National Institutes of Health</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for
				Disease Control and Prevention</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref>. Such
				strategy and plan shall be known as the <quote>Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan</quote>.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="idacf9bca3-bd04-4914-8cc0-fdd2df07f4b9">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Requirements</header>
                  <text display-inline="yes-display-inline">The plan under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall—</text>
									<subparagraph commented="no" id="id191cf570-bc39-4d08-983d-1196c0a9ba71">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">describe the chemical, biological,
				radiological, and nuclear agent or agents that may present a threat to the
				Nation and the corresponding efforts to develop qualified countermeasures (as
				defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1</cato:entity-ref>), security countermeasures (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section
				319F–2</cato:entity-ref>), or qualified pandemic or epidemic products (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section
				319F–3</cato:entity-ref>) for each threat;</text>
									</subparagraph>
                  <subparagraph commented="no" id="id54f3de21-8f2f-4f39-bb73-fa9a21bca903">
                    <enum>(B)</enum>
                    <text>evaluate the progress of
				all activities with respect to such countermeasures or products, including
				research, advanced research, development, procurement, stockpiling, deployment,
				distribution, and utilization;</text>
									</subparagraph>
                  <subparagraph commented="no" id="idfbbbf140-8de0-409d-ad57-d024d44734ec">
                    <enum>(C)</enum>
                    <text>identify and prioritize
				near-, mid-, and long-term needs with respect to such countermeasures or
				products to address a chemical, biological, radiological, and nuclear threat or
				threats;</text>
									</subparagraph>
                  <subparagraph commented="no" id="id9c89b56d-50a7-48bc-baa7-fbc1ef504ed1">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">identify, with respect to each category of
				threat, a summary of all awards and contracts, including advanced research and
				development and procurement, that includes—</text>
										<clause id="id2ee1eca3-2221-455b-b1b5-cbc8ca7e063e">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">the time elapsed from the issuance of the
				initial solicitation or request for a proposal to the adjudication (such as the
				award, denial of award, or solicitation termination); and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="id0453740f-9253-42c2-ae18-035827d87ec5">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">an identification of projected timelines,
				anticipated funding allocations, benchmarks, and milestones for each medical
				countermeasure priority under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:2/sp:C" proposed="true">subparagraph (C)</cato:entity-ref>, including projected needs with
				regard to replenishment of the Strategic National Stockpile;</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idcb6d37a7-8115-4dc3-97f1-c59ac5ae571c">
                    <enum>(E)</enum>
                    <text display-inline="yes-display-inline">be informed by the recommendations of the
				National Biodefense Science Board pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M">section 319M</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" id="idfe1a3805-5473-45de-a25d-1e3deee84e41">
                    <enum>(F)</enum>
                    <text>evaluate progress made in
				meeting timelines, allocations, benchmarks, and milestones identified under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:2/sp:D/cl:ii" proposed="true">subparagraph (D)(ii)</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" id="id3e0014ca-c863-40ff-8874-907323370bca">
                    <enum>(G)</enum>
                    <text>report on the amount of
				funds available for procurement in the special reserve fund as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:h" proposed="true">section 319F–2(h)</cato:entity-ref> and the impact this funding will have on meeting the
				requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" id="id74223b90-125c-4050-897e-2a9133bdedc6">
                    <enum>(H)</enum>
                    <text>incorporate input from
				Federal, State, local, and tribal stakeholders;</text>
									</subparagraph>
                  <subparagraph id="id7c698708-8558-4113-bd87-952f486d7ecb">
                    <enum>(I)</enum>
                    <text display-inline="yes-display-inline">identify the progress made in meeting the
				medical countermeasure priorities for at-risk individuals (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4/sp:B">2802(b)(4)(B)</cato:entity-ref>), as applicable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:2/sp:C" proposed="true">subparagraph (C)</cato:entity-ref>, including with regard to
				the projected needs for related stockpiling and replenishment of the Strategic
				National Stockpile, including by addressing the needs of pediatric populations
				with respect to such countermeasures and products in the Strategic National
				Stockpile, including—</text>
										<clause id="id65f19995-5b7d-4fb8-8ca4-b4ed6877d2bd">
                      <enum>(i)</enum>
                      <text>a list of such
				countermeasures and products necessary to address the needs of pediatric
				populations;</text>
										</clause>
                    <clause id="idce07fa19-f21b-415c-bda8-f1da9514efba">
                      <enum>(ii)</enum>
                      <text>a description of
				measures taken to coordinate with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of Pediatric Therapeutics" entity-parent-id="7524">Office of Pediatric Therapeutics of the
				Food and Drug Administration</cato:entity-ref> to maximize the labeling, dosages, and
				formulations of such countermeasures and products for pediatric
				populations;</text>
										</clause>
                    <clause id="idf70b9679-4491-4fac-9e25-9428a6e6be0a">
                      <enum>(iii)</enum>
                      <text>a description of
				existing gaps in the Strategic National Stockpile and the development of such
				countermeasures and products to address the needs of pediatric populations;
				and</text>
										</clause>
                    <clause id="id2b82cab5-2114-4d52-82e7-2f876de99f62">
                      <enum>(iv)</enum>
                      <text>an evaluation of the
				progress made in addressing priorities identified pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:2/sp:C" proposed="true">subparagraph
				(C)</cato:entity-ref>;</text>
										</clause>
                  </subparagraph>
                  <subparagraph id="idf0fa727c-08fd-4f55-b6b6-4b278c8b50ac">
                    <enum>(J)</enum>
                    <text display-inline="yes-display-inline">identify the use of authority and
				activities undertaken pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:b/p:1">sections 319F–1(b)(1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:b/p:2">319F–1(b)(2)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:b/p:3">319F–1(b)(3)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:c">319F–1(c)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:d">319F–1(d)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:e">319F–1(e)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:iii">319F–2(c)(7)(C)(iii)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:iv">319F–2(c)(7)(C)(iv)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:v">319F–2(c)(7)(C)(v) of this Act</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:1">subsections
				(a)(1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1">(b)(1)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e">(e) of section 564 of the Federal Food, Drug, and Cosmetic
				Act</cato:entity-ref>, by summarizing—</text>
										<clause id="id3c22f074-e322-4881-82c4-95d1943ded68">
                      <enum>(i)</enum>
                      <text>the particular actions
				that were taken under the authorities specified, including, as applicable, the
				identification of the threat agent, emergency, or the biomedical countermeasure
				with respect to which the authority was used;</text>
										</clause>
                    <clause id="idcf488017-0a70-4ca4-b25f-5680dec9643e">
                      <enum>(ii)</enum>
                      <text>the reasons underlying
				the decision to use such authorities, including, as applicable, the options
				that were considered and rejected with respect to the use of such
				authorities;</text>
										</clause>
                    <clause id="ide7c573a3-b845-49aa-ae86-a207f9ce5b89">
                      <enum>(iii)</enum>
                      <text>the number of, nature
				of, and other information concerning the persons and entities that received a
				grant, cooperative agreement, or contract pursuant to the use of such
				authorities, and the persons and entities that were considered and rejected for
				such a grant, cooperative agreement, or contract, except that the report need
				not disclose the identity of any such person or entity;</text>
										</clause>
                    <clause id="idaaa3d9ee-f4d4-49cb-a38a-715dc8c1efdb">
                      <enum>(iv)</enum>
                      <text>whether, with respect to
				each procurement that is approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1100">President</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:6">section 319F–2(c)(6)</cato:entity-ref>,
				a contract was entered into within one year after such approval by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1100">President</cato:entity-ref>; and</text>
										</clause>
                    <clause id="idc23428f4-2dca-4c0f-967f-ba00c668c408">
                      <enum>(v)</enum>
                      <text>with respect to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:d">section
				319F–1(d)</cato:entity-ref>, for the one-year period for which the report is submitted, the
				number of persons who were paid amounts totaling $100,000 or greater and the
				number of persons who were paid amounts totaling at least $50,000 but less than
				$100,000; and</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id3872a81e-c0c8-402a-9dfc-fdc355a3cc83">
                    <enum>(K)</enum>
                    <text display-inline="yes-display-inline">be made publicly available.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="idc0d3a6fa-ce12-4faa-9427-4eb28b338baa">
                  <enum>(3)</enum>
                  <header display-inline="yes-display-inline">GAO report</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="id8bc5805a-70b7-48a2-b65f-7e86e0a3b8fb">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Not later than 1 year after the date of the
				submission to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> of the first Public Health Emergency Medical
				Countermeasures Enterprise Strategy and Implementation Plan, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller
				General of the United States</cato:entity-ref> shall conduct an independent evaluation, and
				submit to the appropriate committees of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report, concerning such
				Strategy and Implementation Plan.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id37613658-ba43-420b-9e62-2013c6510f1d">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Content</header>
                    <text display-inline="yes-display-inline">The report described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>
				shall review and assess—</text>
										<clause commented="no" display-inline="no-display-inline" id="id986cb8e1-5d89-44d4-88c0-4e4f7a264ce1">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">the near-term, mid-term, and long-term
				medical countermeasure needs and identified priorities of the Federal
				Government pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d/p:2/sp:C" proposed="true">paragraph (2)(C)</cato:entity-ref>;</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="ideefcc0cb-6dd2-409f-8315-ebb29a6be424">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">the activities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health
				and Human Services</cato:entity-ref> with respect to advanced research and development pursuant
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref>; and</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="id66243bf0-827a-4ea3-9553-4046e53ca29a">
                      <enum>(iii)</enum>
                      <text display-inline="yes-display-inline">the progress made toward meeting the
				timelines, allocations, benchmarks, and milestones identified in the Public
				Health Emergency Medical Countermeasures Enterprise Strategy and Implementation
				Plan under this subsection.</text>
										</clause>
                  </subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="id3fe4211a-288f-432b-a4b4-f5172179e870">
                <enum>(e)</enum>
                <header display-inline="yes-display-inline">Protection of national
				security</header>
                <text display-inline="yes-display-inline">In carrying out
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:b/p:7" proposed="true">subsections (b)(7)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d" proposed="true">(d)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall ensure that information and
				items that could compromise national security, contain confidential commercial
				information, or contain proprietary information are not
				disclosed.</text>
							</subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id8e90529a-8648-49df-98e1-f0a75a4429b4">
          <enum>(b)</enum>
          <header>Interagency
			 coordination plan</header>
          <text>In the first Public Health Emergency
			 Countermeasures Enterprise Strategy and Implementation Plan submitted under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d" proposed="true">subsection (d)</cato:entity-ref> of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2811">section 2811 of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/300hh–10">42 U.S.C.
			 300hh–10</cato:entity-ref>)</cato:entity> (as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:a/p:3">subsection (a)(3)</cato:entity-ref>), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
			 Services</cato:entity-ref>, in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Secretary of Defense</cato:entity-ref>, shall include a
			 description of the manner in which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref>
			 is coordinating with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of Defense</cato:entity-ref> regarding countermeasure
			 activities to address chemical, biological, radiological, and nuclear threats.
			 Such report shall include information with respect to—</text>
					<paragraph id="idc0314119-15f4-482b-b117-e7e0537e774b">
            <enum>(1)</enum>
            <text>the research, advanced
			 research, development, procurement, stockpiling, and distribution of
			 countermeasures to meet identified needs; and</text>
					</paragraph>
          <paragraph id="ida43bf630-0213-4705-b7a6-dc4f7518d451">
            <enum>(2)</enum>
            <text>the coordination of
			 efforts between the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department
			 of Defense</cato:entity-ref> to address countermeasure needs for various segments of the
			 population.</text>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="id0402bc50-9265-49ba-a359-8198132ce2b0" section-type="subsequent-section">
        <enum>103.</enum>
        <header display-inline="yes-display-inline">National Advisory Committee on Children and
			 Disasters</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/t:XXVIII/st:B">Subtitle B of title
			 XXVIII of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh">
              <cato:entity-ref entity-type="uscode" value="usc/42/300hh/etseq">42 U.S.C. 300hh et seq.</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by
			 inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811" proposed="true">section 2811</cato:entity-ref> the following:</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id9ea7f73e-a10d-4940-8342-d669c3f055c4" reported-display-style="italic" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="id16ca408d-b09e-416c-a5ef-3a7e9afe7c30" section-type="subsequent-section">
            <enum>2811A.</enum>
            <header display-inline="yes-display-inline">National Advisory Committee on Children and
				Disasters</header>
						<subsection commented="no" display-inline="no-display-inline" id="id1c27d761-b55b-44f9-b700-580888e0bff4">
              <enum>(a)</enum>
              <header display-inline="yes-display-inline">Establishment</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in consultation with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Secretary of Homeland Security</cato:entity-ref>, shall establish an advisory committee to be
				known as the <quote>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">National Advisory Committee on Children and
				Disasters</cato:entity-ref>
                </quote> (referred to in this section as the <quote>Advisory
				Committee</quote>).</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="id494161b2-6860-470c-951a-4c5269808f08">
              <enum>(b)</enum>
              <header display-inline="yes-display-inline">Duties</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref> shall—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="id6e4b4c62-026c-4266-b89b-a69ae044f2dd">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">provide advice and consultation with
				respect to the activities carried out pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2814">section 2814</cato:entity-ref>, as applicable
				and appropriate;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="idb91abc95-b456-449d-80dc-ab13cd718fce">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">evaluate and provide input with respect to
				the medical and public health needs of children as they relate to preparation
				for, response to, and recovery from all-hazards emergencies; and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="idea19e862-b1aa-4b69-bc24-2f08959f9ac3">
                <enum>(3)</enum>
                <text display-inline="yes-display-inline">provide advice and consultation with
				respect to State emergency preparedness and response activities and children,
				including related drills and exercises pursuant to the preparedness goals under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b">section 2802(b)</cato:entity-ref>.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="id5c286f87-e7df-4112-a77d-1d6c73d6ae17">
              <enum>(c)</enum>
              <header display-inline="yes-display-inline">Additional duties</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref> may provide advice
				and recommendations to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> with respect to children and the medical
				and public health grants and cooperative agreements as applicable to
				preparedness and response activities authorized under this title and title
				III.</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="ide2971b67-6189-4de0-8cb1-777938e3d88f">
              <enum>(d)</enum>
              <header display-inline="yes-display-inline">Membership</header>
							<paragraph commented="no" display-inline="no-display-inline" id="id844f5b2d-5415-4986-814c-80f2e0270987">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in consultation with such
				other Secretaries as may be appropriate, shall appoint not to exceed 15 members
				to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref>. In appointing such members, the Secretary shall
				ensure that the total membership of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref> is an odd
				number.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id7a85aad5-b08f-4dec-b341-52f6e0679019">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Required members</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in consultation with such
				other Secretaries as may be appropriate, may appoint to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref>
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811A/ss:d/p:1" proposed="true">paragraph (1)</cato:entity-ref> such individuals as may be appropriate to perform the
				duties described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811A/ss:b" proposed="true">subsections (b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811A/ss:c" proposed="true">(c)</cato:entity-ref>, which may include—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="idec895479-f8de-4aa7-b30c-b65b3813d78a">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Assistant Secretary for Preparedness and Response" entity-parent-id="7500">Assistant Secretary for Preparedness
				and Response</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id324e7fd0-444d-4c3b-be0f-a556506cf12b">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Biomedical Advanced Research and Development Authority" entity-parent-id="7500">Director of the Biomedical Advanced
				Research and Development Authority</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id9e5d62ea-533f-4829-a7ab-5d9df7ec118d">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease
				Control and Prevention</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id21e4da87-c508-4619-b3e9-9e03d8b2debb">
                  <enum>(D)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="idad5892b8-7b82-48c2-8669-042878afcf8a">
                  <enum>(E)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the National Institutes of
				Health</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id5398ab4c-643f-4165-814f-043ed0b3ecbe">
                  <enum>(F)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7590">Assistant Secretary of the
				Administration for Children and Families</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id4dc77126-ef38-4f8c-9f78-865316ef8c5f">
                  <enum>(G)</enum>
                  <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7022">Administrator of the Federal Emergency
				Management Agency</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="idd966653f-d0f9-4c48-98c5-3123c7d9c726">
                  <enum>(H)</enum>
                  <text display-inline="yes-display-inline">at least two non-Federal health care
				professionals with expertise in pediatric medical disaster planning,
				preparedness, response, or recovery;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id89b3ec2b-7705-49a7-b763-995e0a69460a">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">at least two representatives from State,
				local, territorial, or tribal agencies with expertise in pediatric disaster
				planning, preparedness, response, or recovery; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id09c0a11a-0033-4877-ab9f-37996e0d0f1e">
                  <enum>(J)</enum>
                  <text display-inline="yes-display-inline">representatives from such Federal agencies
				(such as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9100">Department of Education</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Department of Homeland Security</cato:entity-ref>)
				as determined necessary to fulfill the duties of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref>, as
				established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811A/ss:b" proposed="true">subsections (b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811A/ss:c" proposed="true">(c)</cato:entity-ref>.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="id7cfd3c37-ef24-4efa-b3be-bc8485366a53">
              <enum>(e)</enum>
              <header display-inline="yes-display-inline">Meetings</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref> shall meet not less
				than biannually.</text>
						</subsection>
            <subsection commented="no" display-inline="no-display-inline" id="id43b48089-183d-426d-b52d-b97c38358d01">
              <enum>(f)</enum>
              <header display-inline="yes-display-inline">Sunset</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Advisory Committee on Children and Disasters" entity-parent-id="7500" proposed="true">Advisory Committee</cato:entity-ref> shall terminate on
				September 30,
				2018.</text>
						</subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="id7341be5f-717d-45df-91b7-33aee5f0cdaa" section-type="subsequent-section">
        <enum>104.</enum>
        <header display-inline="yes-display-inline">Modernization of the National Disaster
			 Medical System</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2812">Section 2812 of
			 the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-11">
              <cato:entity-ref entity-type="uscode" value="usc/42/300hh–11">42 U.S.C. 300hh–11</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="id360fbde1-764f-41ff-b239-eb1ec682e815">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3">subsection (a)(3)</cato:entity-ref>—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="id470c0442-f2a4-42ec-9e77-269796b07258">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:A">subparagraph (A)</cato:entity-ref>, in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:A/cl:i">clause (i)</cato:entity-ref> by
			 inserting <quote>, including at-risk individuals as applicable</quote> after
			 <quote>victims of a public health emergency</quote>;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="idee3fd5b9-bdcd-4cb3-b52d-d9ceedb38632">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">by redesignating <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:C">subparagraph (C)</cato:entity-ref> as
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:E" proposed="true">subparagraph (E)</cato:entity-ref>; and</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="id6da8c9d0-1257-4db5-919c-feff3b69809d">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:B">subparagraph (B)</cato:entity-ref>, the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id1bd1b4af-b176-4011-9b18-356c4b4ec247" reported-display-style="italic" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="id2c73348b-76b3-486c-85d8-f2b0fa7dcdd9">
                <enum>(C)</enum>
                <header display-inline="yes-display-inline">Considerations for at-risk
				populations</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				shall take steps to ensure that an appropriate specialized and focused range of
				public health and medical capabilities are represented in the National Disaster
				Medical System, which take into account the needs of at-risk individuals, in
				the event of a public health
				emergency.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idd54ceee9-137e-47fc-9774-90e54b65787c" reported-display-style="italic" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="id5fbd53f5-46a6-47d1-b9d8-59cb012e7cd3">
                <enum>(D)</enum>
                <header display-inline="yes-display-inline">Administration</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may determine and pay claims
				for reimbursement for services under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:a/p:3/sp:A">subparagraph (A)</cato:entity-ref> directly or through
				contracts that provide for payment in advance or by way of
				reimbursement.</text>
							</subparagraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="id98cd4fef-865a-49a3-9cc5-a3c8e5984d0e">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2812/ss:g">subsection (g)</cato:entity-ref>, by striking <quote>such
			 sums as may be necessary for each of the fiscal years 2007 through 2011</quote>
			 and inserting <quote>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                <cato:funds-and-year amount="52700000" year="2014, 2015, 2016, 2017, 2018">$52,700,000 for each of fiscal years 2014 through
			 2018</cato:funds-and-year>
              </cato:entity>
            </quote>.</text>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="idd7fdd810-aaa9-4bfb-bb0b-000eba3dac05" section-type="subsequent-section">
        <enum>105.</enum>
        <header display-inline="yes-display-inline">Continuing the role of the Department of
			 Veterans Affairs</header>
        <text display-inline="no-display-inline">
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/38/8117/g">Section
			 8117(g) of title 38, United States Code</cato:entity-ref>, is amended by striking <quote>such
			 sums as may be necessary to carry out this section for each of fiscal years
			 2007 through 2011</quote> and inserting <quote>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
              <cato:funds-and-year amount="155300000" year="2014, 2015, 2016, 2017, 2018">$155,300,000 for each of fiscal
			 years 2014 through 2018 to carry out this section</cato:funds-and-year>
            </cato:entity>
          </quote>.</text>
			</section>
    </title>
    <title changed="added" committee-id="SSHR00" id="idf89ceb25-e6bb-414c-9c71-b0144eacd0b8" reported-display-style="italic">
      <enum>II</enum>
      <header>Optimizing State and
			 local all-hazards preparedness and response</header>
			<section id="idE9831E5955C24124AB5DE44A182739A7">
        <enum>201.</enum>
        <header>Temporary reassignment
			 of State and local personnel during a public health emergency</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319">Section 319 of the Public Health Service Act</cato:entity-ref>
			 (<external-xref legal-doc="usc" parsable-cite="usc/42/247d">
              <cato:entity-ref entity-type="uscode" value="usc/42/247d">42 U.S.C. 247d</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idc67032070bc74595be4c9403f696be3f" reported-display-style="italic" style="OLC">
					<subsection id="idD1065BE7A02C41F789683F826E39221D">
            <enum>(e)</enum>
            <header>Temporary reassignment
				of state and local personnel during a public health emergency</header>
						<paragraph id="id33aedf48092f468fb5d4ef17f6f8764d">
              <enum>(1)</enum>
              <header>Emergency reassignment
				of federally funded personnel</header>
              <text>Notwithstanding any
				other provision of law, and subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:2" proposed="true">paragraph (2)</cato:entity-ref>, upon request by the
				Governor of a State or a tribal organization or such Governor or tribal
				organization’s designee, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may authorize the requesting State or
				Indian tribe to temporarily reassign, for purposes of immediately addressing a
				public health emergency in the State or Indian tribe, State and local public
				health department or agency personnel funded in whole or in part through
				programs authorized under this Act, as appropriate.</text>
						</paragraph>
            <paragraph id="id370911ae6ba3465aa19ffe7e9ffa8425">
              <enum>(2)</enum>
              <header>Activation of emergency
				reassignment</header>
							<subparagraph id="id9df2fa6e669549239dce864e4d6d1d2a">
                <enum>(A)</enum>
                <header>Public health
				emergency</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may authorize a temporary reassignment of
				personnel under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref> only during the period of a public health
				emergency determined pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:a">subsection (a)</cato:entity-ref>.</text>
							</subparagraph>
              <subparagraph id="id4ca62c03f6d14d8d9606fb1357970318">
                <enum>(B)</enum>
                <header>Contents of
				request</header>
                <text>To seek authority for a temporary reassignment of
				personnel under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>, the Governor of a State or a tribal organization
				shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> a request for such reassignment flexibility and
				shall include in the request each of the following:</text>
								<clause id="id90abeadbfa0f4abc9ff26754bf7647e8">
                  <enum>(i)</enum>
                  <text>An assurance that the
				public health emergency in the geographic area of the requesting State or
				Indian tribe cannot be adequately and appropriately addressed by the public
				health workforce otherwise available.</text>
								</clause>
                <clause id="id35ec484b6f6e4ae6b9059cc3a8df4b31">
                  <enum>(ii)</enum>
                  <text>An assurance
				that the public health emergency would be addressed more efficiently and
				effectively through the requested temporary reassignment of State and local
				personnel described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>.</text>
								</clause>
                <clause id="idf23038a5b10a47bdb0ee247bd8a77dd0">
                  <enum>(iii)</enum>
                  <text>An assurance
				that the requested temporary reassignment of personnel is consistent with any
				applicable All-Hazards Public Health Emergency Preparedness and Response Plan
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1">section 319C–1</cato:entity-ref>.</text>
								</clause>
                <clause id="id3a253eeb0f144bec861209b22057ee41">
                  <enum>(iv)</enum>
                  <text>An identification
				of—</text>
									<subclause id="id0de7067a4d824f25a20f532a45f22d13">
                    <enum>(I)</enum>
                    <text>each Federal program from
				which personnel would be temporarily reassigned pursuant to the requested
				authority; and</text>
									</subclause>
                  <subclause id="id6d2e57e1b8ab44eea3bad4788c676c2c">
                    <enum>(II)</enum>
                    <text>the number of personnel
				who would be so reassigned from each such program.</text>
									</subclause>
                </clause>
                <clause id="idd79111c99c1a48638d642a04288d08dd">
                  <enum>(v)</enum>
                  <text>Such other
				information and assurances upon which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and Governor of a State or
				tribal organization agree.</text>
								</clause>
              </subparagraph>
              <subparagraph id="idba94415deeae4fa697c54d1fbb859398">
                <enum>(C)</enum>
                <header>Consideration</header>
                <text>In
				reviewing a request for temporary reassignment under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall consider the degree to which the program or programs funded in
				whole or in part by programs authorized under this Act would be adversely
				affected by the reassignment.</text>
							</subparagraph>
              <subparagraph id="ida8b31c839b1e4913ab7dce2da824eba2">
                <enum>(D)</enum>
                <header>Termination and
				extension</header>
								<clause id="id7c1fcb0e4fa8406ab442af1f3bf6e922">
                  <enum>(i)</enum>
                  <header>Termination</header>
                  <text>A
				State or Indian tribe’s temporary reassignment of personnel under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>
				shall terminate upon the earlier of the following:</text>
									<subclause id="id5fa172638dfb413092f3a2bb0a784c0a">
                    <enum>(I)</enum>
                    <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary’s</cato:entity-ref>
				determination that the public health emergency no longer exists.</text>
									</subclause>
                  <subclause id="id2b80ac62fec34a44a54634d0e82c3978">
                    <enum>(II)</enum>
                    <text>Subject to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:2/sp:D/cl:ii" proposed="true">clause (ii)</cato:entity-ref>, the expiration of the 30-day period following the date on which
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> approved the State or Indian tribe’s request for such
				reassignment flexibility.</text>
									</subclause>
                </clause>
                <clause id="id37b837c1e7f245f0bc2ddda91983ead2">
                  <enum>(ii)</enum>
                  <header>Extension of
				reassignment flexibility</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may extend reassignment
				flexibility of personnel under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref> beyond the date otherwise
				applicable under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:2/sp:D/cl:i/scl:II" proposed="true">clause (i)(II)</cato:entity-ref> if the public health emergency still exists as
				of such date, but only if—</text>
									<subclause id="id54eac5212fe4432092aec86e64ef1ef8">
                    <enum>(I)</enum>
                    <text>the State or Indian tribe
				that submitted the initial request for a temporary reassignment of personnel
				submits a request for an extension of such temporary reassignment; and</text>
									</subclause>
                  <subclause id="id3af73a1a88a248488d155734cca475d0">
                    <enum>(II)</enum>
                    <text>the request for
				an extension contains the same information and assurances necessary for the
				approval of an initial request for such temporary reassignment pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:2/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>.</text>
									</subclause>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="id160296debb94437098ed0490354d2d12">
              <enum>(3)</enum>
              <header>Voluntary nature of
				temporary reassignment of state and local personnel</header>
							<subparagraph id="id27D3C1ABF14A4491A91C8A4F28FA214B">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>Unless otherwise provided under the law or regulation of
				the State or Indian tribe that receives authorization for temporary
				reassignment of personnel under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>, personnel eligible for
				reassignment pursuant to such authorization—</text>
								<clause id="id9C4543E61C9A410EACDBE8D40B7D08AE">
                  <enum>(i)</enum>
                  <text>shall have the
				opportunity to volunteer for temporary reassignment; and</text>
								</clause>
                <clause id="id5466D9822AF34319B4F835EA45640985">
                  <enum>(ii)</enum>
                  <text>shall not be required to
				agree to a temporary reassignment.</text>
								</clause>
              </subparagraph>
              <subparagraph id="id7D42CE976B184434B588DE48CC21A400">
                <enum>(B)</enum>
                <header>Prohibition on
				conditioning Federal awards</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may not condition the
				award of a grant, contract, or cooperative agreement under this Act on the
				requirement that a State or Indian tribe require that personnel eligible for
				reassignment pursuant to an authorization under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref> agree to such
				reassignment.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id42a9c0ab525b41b8a76d1c8b4ffcfcc5">
              <enum>(4)</enum>
              <header>Notice to
				congress</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall give notice to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> in
				conjunction with the approval under this subsection of—</text>
							<subparagraph id="id407ac343dea44ab3a9d2ec1dfc92bbc3">
                <enum>(A)</enum>
                <text>any initial request for
				temporary reassignment of personnel; and</text>
							</subparagraph>
              <subparagraph id="idc32d26e38db3437f8c57f5eec5072b1e">
                <enum>(B)</enum>
                <text>any request for an
				extension of such temporary reassignment.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="idf2b632fd9ad24e17b1f03f8e1b96a461">
              <enum>(5)</enum>
              <header>Guidance</header>
              <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall—</text>
							<subparagraph id="idf27c18a3ff5f4a739c3cd3baf3eb3c8f">
                <enum>(A)</enum>
                <text>not later than 6 months
				after the enactment of this subsection, issue proposed guidance on the
				temporary reassignment of personnel under this subsection; and</text>
							</subparagraph>
              <subparagraph id="id34f8f6828066436983427ac0ca78f75d">
                <enum>(B)</enum>
                <text>after providing notice
				and a 60-day period for public comment, finalize such guidance.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id162e8565ccec4f20b1b33b550987d055">
              <enum>(6)</enum>
              <header>Report to
				congress</header>
              <text>Not later than 4 years after the date of enactment of
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic and All-Hazards Preparedness Reauthorization Act of 2013</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General of the United States</cato:entity-ref> shall conduct an independent
				evaluation, and submit to the appropriate committees of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report,
				on temporary reassignment under this subsection, including—</text>
							<subparagraph id="id56f8554e0e014088967a9e277ccc3fed">
                <enum>(A)</enum>
                <text>a description of how, and
				under what circumstances, such temporary reassignment has been used by States
				and Indian tribes;</text>
							</subparagraph>
              <subparagraph id="ida0b63851e9544674868968e3c5fa0891">
                <enum>(B)</enum>
                <text>an analysis of how such
				temporary reassignment has assisted States and Indian tribes in responding to
				public health emergencies;</text>
							</subparagraph>
              <subparagraph id="idd1c45860d76e4a53878ae8e173c0d544">
                <enum>(C)</enum>
                <text>an evaluation of how such
				temporary reassignment has improved operational efficiencies in responding to
				public health emergencies;</text>
							</subparagraph>
              <subparagraph id="idc5352f612b324518ac0ba939a1156a1d">
                <enum>(D)</enum>
                <text>an analysis of the extent
				to which, if any, Federal programs from which personnel have been temporarily
				reassigned have been adversely affected by the reassignment; and</text>
							</subparagraph>
              <subparagraph id="ida9907cf070ee4ecb80e8374be6baa7c5">
                <enum>(E)</enum>
                <text>recommendations on how
				medical surge capacity could be improved in responding to public health
				emergencies and the impact of the reassignment flexibility under this section
				on such surge capacity.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="id5c7b83efd4a042c2ae12171451386693">
              <enum>(7)</enum>
              <header>Definitions</header>
              <text>In
				this subsection—</text>
							<subparagraph id="id36335E0A12AF461990C66909258C4D7A">
                <enum>(A)</enum>
                <text>the terms
				<term>Indian tribe</term> and <term>tribal organization</term> have the
				meanings given such terms in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Indian Self-Determination and Education Assistance Act/s:4">section 4 of the Indian Self-Determination and
				Education Assistance Act</cato:entity-ref>; and</text>
							</subparagraph>
              <subparagraph id="idE655F5DF22674CE0940F076022962FB6">
                <enum>(B)</enum>
                <text>the term
				<term>State</term> includes, in addition to the entities listed in the
				definition of such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2">section 2</cato:entity-ref>, the Freely Associated States.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="idaf205698bcff49d7aefc42cce1a4f697">
              <enum>(8)</enum>
              <header>Sunset</header>
              <text>This
				subsection shall terminate on September 30,
				2018.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section id="idc40742ce-c552-4d81-920d-6b4c84735e57">
        <enum>202.</enum>
        <header>Improving State and
			 local public health security</header>
				<subsection id="idc7485bff-2be4-4310-b7e4-1cc83dbe4a13">
          <enum>(a)</enum>
          <header>Cooperative
			 agreements</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–1">Section 319C–1 of
			 the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-3a">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–3a">42 U.S.C. 247d–3a</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id9ea9d839-84c3-4438-a6ee-bfa7bd43d414">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:1/sp:C">subsection (b)(1)(C)</cato:entity-ref>, by striking
			 <quote>consortium of entities described in subparagraph (A)</quote> and
			 inserting <quote>consortium of States</quote>;</text>
					</paragraph>
          <paragraph id="id83381822-41ea-40be-b17d-2fb1b3e7f6b5">
            <enum>(2)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2">subsection
			 (b)(2)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="idc8fab887-62b4-4ff2-bd1b-d6de665f6a74">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:A">subparagraph (A)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id4c7db8b8-1699-4575-9761-79b4eecc3cd6">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:A/cl:i">clauses (i)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:A/cl:ii">(ii)</cato:entity-ref> and
			 inserting the following:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id1f618235-447c-453d-93c4-36fd1b393517" reported-display-style="italic" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="idd8c6e195-db5e-41a3-b5de-1503728b1fb1">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">a description of the activities such entity
				will carry out under the agreement to meet the goals identified under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802">section
				2802</cato:entity-ref>, including with respect to chemical, biological, radiological, or nuclear
				threats, whether naturally occurring, unintentional, or deliberate;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="idad1dd3c6-3773-4e92-a8ca-d22448113629">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">a description of the activities such entity
				will carry out with respect to pandemic influenza, as a component of the
				activities carried out under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:A/cl:i">clause (i)</cato:entity-ref>, and consistent with the requirements
				of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g/p:2">paragraphs (2)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g/p:5">(5) of subsection
				(g)</cato:entity-ref>;</text>
									</clause>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id9a2f3645-d534-4b56-8166-8bbf0bc9ace0">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:A/cl:iv">clause (iv)</cato:entity-ref>, by striking
			 <quote>and</quote> at the end; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="idb5a1f835-2503-48d7-b839-dbc6af5a7a7a">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id6954b7c0-6fc3-4a45-bb57-6d0e3b02384d" reported-display-style="italic" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="ida0bcdd93-3f72-46d7-908d-89698dd50b4f">
                    <enum>(vi)</enum>
                    <text display-inline="yes-display-inline">a description of how, as appropriate, the
				entity may partner with relevant public and private stakeholders in public
				health emergency preparedness and response;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="id7cc69cd1-c5ce-48fe-a075-6e1fa469ed86">
                    <enum>(vii)</enum>
                    <text display-inline="yes-display-inline">a description of how the entity, as
				applicable and appropriate, will coordinate with State emergency preparedness
				and response plans in public health emergency preparedness, including State
				educational agencies (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Elementary and Secondary Education Act of 1965/s:9101/ss:41">section 9101(41) of the Elementary and
				Secondary Education Act of 1965</cato:entity-ref>) and State child care lead agencies (designated
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Child Care and Development Block Grant Act of 1990/s:658D">section 658D of the Child Care and Development Block Grant Act of
				1990</cato:entity-ref>);</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="id1b84bce6-7c3e-4216-a45f-8bcc36cd5908">
                    <enum>(viii)</enum>
                    <text display-inline="yes-display-inline">in the case of entities that operate on the
				United States-Mexico border or the United States-Canada border, a description
				of the activities such entity will carry out under the agreement that are
				specific to the border area including disease detection, identification,
				investigation, and preparedness and response activities related to emerging
				diseases and infectious disease outbreaks whether naturally occurring or due to
				bioterrorism, consistent with the requirements of this section; and</text>
									</clause>
                  <clause commented="no" id="id0be2126b-5ce7-4730-bd74-3508e1ff631f">
                    <enum>(ix)</enum>
                    <text display-inline="yes-display-inline">a description of any activities that such
				entity will use to analyze real-time clinical specimens for pathogens of public
				health or bioterrorism significance, including any utilization of poison
				control centers;</text>
									</clause>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id0f1aef8e-3c4f-4112-ad21-1f792e2fe1a9">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:C">subparagraph (C)</cato:entity-ref>, by inserting <quote>,
			 including addressing the needs of at-risk individuals,</quote> after
			 <quote>capabilities of such entity</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph id="id002fa063-506f-4101-8c90-65fb43a1f3f9">
            <enum>(3)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:f">subsection (f)</cato:entity-ref>—</text>
						<subparagraph id="id0686bb30-3c3c-42f1-a6c5-095d02c102ff">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:f/p:2">paragraph (2)</cato:entity-ref>, by
			 adding <quote>and</quote> at the end;</text>
						</subparagraph>
            <subparagraph id="id5349eb6f-da78-4acd-b617-ee064a108130">
              <enum>(B)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:f/p:3">paragraph (3)</cato:entity-ref>, by
			 striking <quote>; and</quote> and inserting a period; and</text>
						</subparagraph>
            <subparagraph id="id5233f87b-8064-41a2-bd2a-bb957da55765">
              <enum>(C)</enum>
              <text>by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:f/p:4">paragraph
			 (4)</cato:entity-ref>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id06ba67ae-1812-4e00-963e-21aa24362512">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g">subsection (g)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id547a4cc1-7748-4685-ac24-d2cffc17d26c">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g/p:1">paragraph (1)</cato:entity-ref>, by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g/p:1/sp:A">subparagraph
			 (A)</cato:entity-ref> and inserting the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id33894f3d-1b90-41d1-917d-65e61310fa58" reported-display-style="italic" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="id20e743dd-ac25-4ace-af41-9e0b7d1609e5">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">include outcome goals representing
				operational achievements of the National Preparedness Goals developed under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b">section 2802(b)</cato:entity-ref> with respect to all-hazards, including chemical, biological,
				radiological, or nuclear threats; and</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idc13de70e-c12b-4aae-866d-c3abc4594a2d">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g/p:2/sp:A">paragraph (2)(A)</cato:entity-ref>, by adding at the end
			 the following: <quote>The Secretary shall periodically update, as necessary and
			 appropriate, such pandemic influenza plan criteria and shall require the
			 integration of such criteria into the benchmarks and standards described in
			 paragraph (1).</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" id="id351850b4-645a-4b86-833c-10b1dca1c2e5">
            <enum>(5)</enum>
            <text>by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h">subsection
			 (h)</cato:entity-ref>;</text>
					</paragraph>
          <paragraph id="idaff325cb-0509-4a86-aa5c-8824d56b4b81">
            <enum>(6)</enum>
            <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:i, j, k">subsections (i), (j), and (k)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h, i, j" proposed="true">subsections (h), (i), and (j)</cato:entity-ref>,
			 respectively;</text>
					</paragraph>
          <paragraph id="idAA5800D11AD74D1AA8200D0876B7FBE1">
            <enum>(7)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h" proposed="true">subsection (h)</cato:entity-ref>, as so
			 redesignated—</text>
						<subparagraph id="id02073c63-b3d7-470a-812b-561aa4a095dd">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref>—</text>
							<clause id="idf005e022-8bb1-4aec-9072-1a6170d9c0a7">
                <enum>(i)</enum>
                <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:A" proposed="true">subparagraph
			 (A)</cato:entity-ref>—</text>
								<subclause commented="no" display-inline="no-display-inline" id="id3c86da3b-8285-4c31-b1b4-457408158357">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>$824,000,000 for fiscal
			 year 2007, of which $35,000,000 shall be used to carry out subsection
			 (h),</quote> and inserting <quote>
                      <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                        <cato:funds-and-year amount="641900000" year="2014">$641,900,000 for fiscal year 2014</cato:funds-and-year>
                      </cato:entity>
                    </quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="idfc6b5742-a28f-4075-9e28-0f58bee9ac79">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>such sums as may be
			 necessary for each of fiscal years 2008 through 2011</quote> and inserting
			 <quote>
                      <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                        <cato:funds-and-year amount="641900000" year="2015, 2016, 2017, 2018">$641,900,000 for each of fiscal years 2015 through 2018</cato:funds-and-year>
                      </cato:entity>
                    </quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" id="idd439322f-55ae-4e66-9437-f9c4c67df1bd">
                <enum>(ii)</enum>
                <text>by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:B" proposed="true">subparagraph
			 (B)</cato:entity-ref>;</text>
							</clause>
              <clause commented="no" id="id59fc667d-c759-4855-8e47-080e490cd5c2">
                <enum>(iii)</enum>
                <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:C, D" proposed="true">subparagraphs (C) and (D)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:B, C" proposed="true">subparagraphs (B) and (C)</cato:entity-ref>, respectively;
			 and</text>
							</clause>
              <clause id="ide2d6b1f0-b8cc-4367-af3e-a8ef16d4eea3">
                <enum>(iv)</enum>
                <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:C" proposed="true">subparagraph (C)</cato:entity-ref>, as
			 so redesignated, by striking <quote>subparagraph (C)</quote> and inserting
			 <quote>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:1/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>
                  </quote>;</text>
							</clause>
            </subparagraph>
            <subparagraph id="id21222fb1-1b6e-426d-82ac-c8a9a9c42e56">
              <enum>(B)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:3/sp:C" proposed="true">subparagraphs (C)</cato:entity-ref> and
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:3/sp:D" proposed="true">(D) of paragraph (3)</cato:entity-ref>, by striking <quote>(1)(A)(i)(I)</quote> each place it
			 appears and inserting <quote>(1)(A)</quote>;</text>
						</subparagraph>
            <subparagraph id="idb896080e-cd1d-4e1a-b1ff-4011cc4596f4">
              <enum>(C)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:4/sp:B" proposed="true">paragraph (4)(B)</cato:entity-ref>, by
			 striking <quote>subsection (c)</quote> and inserting <quote>subsection
			 (b)</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id3f4b806b-ede1-43cb-ac84-75b7c8f82433">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ide95fd7d8-6ce9-41c8-8bfb-cbef664c73c7" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="idb093d623-2402-4057-9497-c6d5c662fb77">
                  <enum>(7)</enum>
                  <header display-inline="yes-display-inline">Availability of cooperative agreement
				funds</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="id7a94a598-e44e-4965-9551-9b33b525a709">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Amounts provided to an eligible entity
				under a cooperative agreement under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:a">subsection (a)</cato:entity-ref> for a fiscal year and
				remaining unobligated at the end of such year shall remain available to such
				entity for the next fiscal year for the purposes for which such funds were
				provided.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id5f16e213-cb7e-43c1-9ee8-807465002196">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Funds contingent on achieving
				benchmarks</header>
                    <text display-inline="yes-display-inline">The continued
				availability of funds under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:7/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> with respect to an entity shall be
				contingent upon such entity achieving the benchmarks and submitting the
				pandemic influenza plan as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:g">subsection
				(g)</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph id="idef9a4cd8-2989-4d91-b658-69849f4c3c9d">
            <enum>(8)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:i" proposed="true">subsection (i)</cato:entity-ref>,
			 as so redesignated—</text>
						<subparagraph id="id6148E32619E24A69B4FC4798ADD59198">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:i/p:1/sp:E" proposed="true">paragraph (1)(E)</cato:entity-ref>, by
			 striking <quote>subsection (k)</quote> and inserting <quote>subsection
			 (j)</quote>;</text>
						</subparagraph>
            <subparagraph id="id91A9D6FF641042B48B91B50B765D7512">
              <enum>(B)</enum>
              <text>by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:i/p:3" proposed="true">paragraph
			 (3)</cato:entity-ref>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id49eb462f-4934-4747-b978-8484fd38e5f1">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Vaccine tracking and
			 distribution</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319A/ss:e">Section 319A(e)
			 of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-1">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–1/e">42 U.S.C. 247d–1(e)</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by striking
			 <quote>such sums for each of fiscal years 2007 through 2011</quote> and
			 inserting <quote>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                <cato:funds-and-year amount="30800000" year="2014, 2015, 2016, 2017, 2018">$30,800,000 for each of fiscal years 2014 through
			 2018</cato:funds-and-year>
              </cato:entity>
            </quote>.</text>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="idE5B2BD7AE1034EACA066AC0F5A804538">
          <enum>(c)</enum>
          <header>Technical and
			 conforming amendments</header>
					<paragraph commented="no" display-inline="no-display-inline" id="id7DBE96EBFA8C4E309C25A689B747D7FA">
            <enum>(1)</enum>
            <text>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:1/sp:B">Section
			 319C–1(b)(1)(B) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–3a/b/1/B">42 U.S.C. 247d–3a(b)(1)(B)</cato:entity-ref>)</cato:entity>
			 is amended by striking <quote>subsection (i)(4)</quote> and inserting
			 <quote>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h/p:4" proposed="true">subsection (h)(4)</cato:entity-ref>
              </quote>.</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id10566BD2F96E4827A778600F1DFAD98A">
            <enum>(2)</enum>
            <text>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–2">Section 319C–2 of the
			 Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-3b">
                  <cato:entity-ref entity-type="uscode" value="usc/42/247d–3b">42 U.S.C. 247d–3b</cato:entity-ref>
                </external-xref>)</cato:entity> is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id41D8C88DBFEF43609027E2DAF8D13345">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:i">subsection
			 (i)</cato:entity-ref>, by striking <quote>(j), and (k)</quote> and inserting <quote>(i), and
			 (j)</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idBBEAA86545564157A449CE237DEDADFA">
              <enum>(B)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:j/p:3">subsection
			 (j)(3)</cato:entity-ref>, by striking <quote>319C–1(i)</quote> and inserting
			 <quote>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–1/ss:h" proposed="true">319C–1(h)</cato:entity-ref>
                </quote>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="idbea1977d-c38b-4bbe-aa3f-01951f8110ce" section-type="subsequent-section">
        <enum>203.</enum>
        <header display-inline="yes-display-inline">Hospital preparedness and medical surge
			 capacity</header>
				<subsection commented="no" display-inline="no-display-inline" id="idf422a6c6-7f32-44a2-84ee-b6f0ab343614">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">All-Hazards public health and medical
			 response curricula and training</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F/ss:a/p:5/sp:B">Section 319F(a)(5)(B) of the Public Health
			 Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–6/a/5/B">42 U.S.C. 247d–6(a)(5)(B)</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by striking <quote>public
			 health or medical</quote> and inserting <quote>public health, medical, or
			 dental</quote>.</text>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="iddddbf43c-c47d-49a7-a598-0aa971390b83">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Encouraging health professional
			 volunteers</header>
					<paragraph commented="no" display-inline="no-display-inline" id="id688ead22-5ebf-42cc-b074-f4001b12ce94">
            <enum>(1)</enum>
            <header display-inline="yes-display-inline">Emergency system for advance registration
			 of volunteer health professionals</header>
            <text display-inline="yes-display-inline">
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319I/ss:k">Section 319I(k) of the Public Health
			 Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–7b/k">42 U.S.C. 247d–7b(k)</cato:entity-ref>)</cato:entity> is amended by striking <quote>$2,000,000 for
			 fiscal year 2002, and such sums as may be necessary for each of the fiscal
			 years 2003 through 2011</quote> and inserting <quote>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                  <cato:funds-and-year amount="5000000" year="2014, 2015, 2016, 2017, 2018">$5,000,000 for each of
			 fiscal years 2014 through 2018</cato:funds-and-year>
                </cato:entity>
              </quote>.</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="idf44ee9bd-3ceb-4432-a50c-a5b889cb180b">
            <enum>(2)</enum>
            <header display-inline="yes-display-inline">Volunteers</header>
            <text display-inline="yes-display-inline">
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2813">Section 2813 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300hh-15">
                  <cato:entity-ref entity-type="uscode" value="usc/42/300hh–15">42 U.S.C. 300hh–15</cato:entity-ref>
                </external-xref>)</cato:entity> is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="idf87ac2d2-0ff9-47d4-a08c-3b5d04d84718">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2813/ss:d/p:2">subsection (d)(2)</cato:entity-ref>, by adding at the end
			 the following: <quote>Such training exercises shall, as appropriate and
			 applicable, incorporate the needs of at-risk individuals in the event of a
			 public health emergency.</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id67e29bc4-0310-4501-838a-35493667b6a9">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2813/ss:i">subsection (i)</cato:entity-ref>, by striking
			 <quote>$22,000,000 for fiscal year 2007, and such sums as may be necessary for
			 each of fiscal years 2008 through 2011</quote> and inserting <quote>
                  <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                    <cato:funds-and-year amount="11200000" year="2014, 2015, 2016, 2017, 2018">$11,200,000
			 for each of fiscal years 2014 through 2018</cato:funds-and-year>
                  </cato:entity>
                </quote>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id5303412f-9be5-40f7-9c63-8a805126b84e">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Partnerships for State and regional
			 preparedness To improve surge capacity</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–2">Section 319C–2 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-3b">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–3b">42 U.S.C. 247d–3b</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph id="id4c9f3404-ea67-41ad-9adf-18afcef26cef">
            <enum>(1)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:a">subsection (a)</cato:entity-ref>,
			 by inserting <quote>, including, as appropriate, capacity and preparedness to
			 address the needs of children and other at-risk individuals</quote> before the
			 period at the end;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id2f89ac87-178f-4e28-8386-fde1b89920a8">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:b/p:1/sp:A/cl:ii">subsection (b)(1)(A)(ii)</cato:entity-ref>, by striking
			 <quote>centers, primary</quote> and inserting <quote>centers, community health
			 centers, primary</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id1bce1ec9-ad94-441f-983d-0a0d5580a88d">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:c">subsection (c)</cato:entity-ref> and inserting
			 the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id11c253a0-4822-40b6-850a-852a0370a7fb" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="id782c77b3-1c11-4cb4-87ce-44944a86ce7c">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Use of funds</header>
                <text display-inline="yes-display-inline">An award under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:a">subsection (a)</cato:entity-ref> shall be
				expended for activities to achieve the preparedness goals described under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:1">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3">(3)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4">(4)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:5">(5)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:6">(6) of section 2802(b)</cato:entity-ref> with respect to
				all-hazards, including chemical, biological, radiological, or nuclear
				threats.</text>
							</subsection>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id5c7ae366-4daa-4820-ac85-4df89d944337">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:g">subsection (g)</cato:entity-ref> and inserting
			 the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id3e5ad055-2905-4610-b03e-98aeeb4e627a" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="idbbe5c303-23e4-4177-b512-38e21ea5f9ee">
                <enum>(g)</enum>
                <header display-inline="yes-display-inline">Coordination</header>
								<paragraph commented="no" display-inline="no-display-inline" id="ide505bd7e-37f6-487f-97ce-5fb47579e053">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">Local response capabilities</header>
                  <text display-inline="yes-display-inline">An eligible entity shall, to the extent
				practicable, ensure that activities carried out under an award under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:a">subsection
				(a)</cato:entity-ref> are coordinated with activities of relevant local Metropolitan Medical
				Response Systems, local Medical Reserve Corps, the local Cities Readiness
				Initiative, and local emergency plans.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="ideead0b2a-528d-4a9b-8068-5aec1fe8f456">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">National collaboration</header>
                  <text display-inline="yes-display-inline">Partnerships consisting of one or more
				eligible entities under this section may, to the extent practicable,
				collaborate with other partnerships consisting of one or more eligible entities
				under this section for purposes of national coordination and collaboration with
				respect to activities to achieve the preparedness goals described under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:1">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:3">(3)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:4">(4)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:5">(5)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802/ss:b/p:6">(6) of section
				2802(b)</cato:entity-ref>.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>;</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph id="id12a22049-7b0a-4492-8c99-daff17c3c2e6">
            <enum>(5)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:i">subsection (i)</cato:entity-ref>—</text>
						<subparagraph id="idd16fcc34-0111-4901-a049-683ec0687383">
              <enum>(A)</enum>
              <text>by striking <quote>The
			 requirements of</quote> and inserting the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id29b105e7-88fa-4bd2-a07c-451395662291" reported-display-style="italic" style="OLC">
								<paragraph id="id3bfc4901-daab-4357-8fdb-a5e37b49c20b">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">The requirements
				of</text>
								</paragraph>
                <after-quoted-block>; and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph id="id0c2bdcaf-faaa-495e-bef3-41ad778f6e12">
              <enum>(B)</enum>
              <text>by adding at the end the
			 following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida31359e4-c8ee-478d-a6f0-950356ccb360" reported-display-style="italic" style="OLC">
								<paragraph id="id8969bb2c-6285-4d6c-ac9a-30be9164e81d">
                  <enum>(2)</enum>
                  <header>Meeting goals of
				National Health Security Strategy</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall implement objective,
				evidence-based metrics to ensure that entities receiving awards under this
				section are meeting, to the extent practicable, the applicable goals of the
				National Health Security Strategy under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2802">section
				2802</cato:entity-ref>.</text>
								</paragraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph id="idc167e533-591d-4fb4-8699-f34227950873">
            <enum>(6)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:j">subsection (j)</cato:entity-ref>—</text>
						<subparagraph id="idba8e6ed6-0b09-49bd-aa70-f37af4ab8131">
              <enum>(A)</enum>
              <text>by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:j/p:1">paragraph (1)</cato:entity-ref>
			 to read as follows:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id021c8f6a-cb7b-4fe3-94c9-9a9b80281389" reported-display-style="italic" style="OLC">
								<paragraph id="id60c1a5b8-c3ee-45dd-a61f-e69b9bc01789">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">
                    <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                      <cato:property name="purpose">For purposes of
				carrying out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–2">this section</cato:entity-ref>
                      </cato:property>, there is authorized to be appropriated <cato:funds-and-year amount="374700000" year="2014, 2015, 2016, 2017, 2018">$374,700,000
				for each of fiscal years 2014 through
				2018</cato:funds-and-year>.</cato:entity>
                  </text>
								</paragraph>
                <after-quoted-block>; and
				</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id35754c55-c682-4e1a-a52d-93e0d4305207">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id172f7f87-77ff-4512-81a8-424b6fc1f8a9" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="idaef70b3e-2941-41f9-ac2b-c36bf6394e66">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Availability of cooperative agreement
				funds</header>
									<subparagraph commented="no" display-inline="no-display-inline" id="id69a2612f-0220-48d5-a70b-feaa191464e8">
                    <enum>(A)</enum>
                    <header display-inline="yes-display-inline">In general</header>
                    <text display-inline="yes-display-inline">Amounts provided to an eligible entity
				under a cooperative agreement under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:a">subsection (a)</cato:entity-ref> for a fiscal year and
				remaining unobligated at the end of such year shall remain available to such
				entity for the next fiscal year for the purposes for which such funds were
				provided.</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idc8205557-5ae5-442c-95a0-928cd37d11ce">
                    <enum>(B)</enum>
                    <header display-inline="yes-display-inline">Funds contingent on achieving
				benchmarks</header>
                    <text display-inline="yes-display-inline">The continued
				availability of funds under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:j/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> with respect to an entity shall be
				contingent upon such entity achieving the benchmarks and submitting the
				pandemic influenza plan as required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319C–2/ss:i">subsection
				(i)</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="id6a1ec570-51a6-4050-a218-727ec51a305e" section-type="subsequent-section">
        <enum>204.</enum>
        <header display-inline="yes-display-inline">Enhancing situational awareness and
			 biosurveillance</header>
				<subsection commented="no" display-inline="no-display-inline" id="idCB64988712084F4DA4E4403DB26DB293">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319D">Section 319D of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-4">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–4">42 U.S.C. 247d–4</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id08388a25-2090-4ac4-b96f-92a388b5d160">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:b">subsection (b)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="idf9f6002e-4843-4c48-bf2e-0f7353fa52a6">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:b/p:1/sp:B">paragraph (1)(B)</cato:entity-ref>, by inserting
			 <quote>poison control centers,</quote> after <quote>hospitals,</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id7a9add50-7d4e-468b-95e6-f50f60447a8e">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:b/p:2">paragraph (2)</cato:entity-ref>, by inserting before the
			 period at the end the following: <quote>, allowing for coordination to maximize
			 all-hazards medical and public health preparedness and response and to minimize
			 duplication of effort</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idcddd2fb8-6284-4ad9-a4d4-4a44fde35100">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:b/p:3">paragraph (3)</cato:entity-ref>, by inserting before the
			 period at the end the following: <quote>and update such standards as
			 necessary</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="idbf93e036-fbf4-4548-904c-28d1479a01d5">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c">subsection (c)</cato:entity-ref>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id873804843F504496878046293786194E">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">by redesignating <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:d..g">subsections (d) through
			 (g)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c..f" proposed="true">subsections (c) through (f)</cato:entity-ref>, respectively;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id4b5d1409-8d21-4cea-abd6-a74cbdfbb657">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c" proposed="true">subsection (c)</cato:entity-ref>, as so
			 redesignated—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id823c3e2f-e1b9-4135-b685-49dbdfb9634f">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the subsection heading, by striking
			 <quote>
                  <header-in-text level="subsection" style="OLC">Public Health Situational
			 Awareness</header-in-text>
                </quote> and inserting <quote>
                  <header-in-text level="subsection" style="OLC">Modernizing Public Health Situational Awareness
			 and Biosurveillance</header-in-text>
                </quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idd4dc6570-2188-4085-819e-7b32d2186e04">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id6941c6be-921e-44f1-8ce8-b84edd433fd8">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <quote>Pandemic and All-Hazards
			 Preparedness Act</quote> and inserting <quote>
                    <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic and All-Hazards Preparedness Reauthorization Act
			 of 2013</cato:entity-ref>
                    </short-title>
                  </quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id795f256f-26af-4008-86d9-e96e60d13dd9">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by inserting <quote>, novel emerging
			 threats,</quote> after <quote>disease outbreaks</quote>;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id6a3749a6-fbdb-459a-b673-2474c46a7354">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:2" proposed="true">paragraph (2)</cato:entity-ref> and inserting the
			 following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id8d2c7020-3df1-47a6-8812-99f59905f1c8" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id047d7767-a035-4693-8d19-d036d7a02edf">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Strategy and implementation
				plan</header>
                  <text display-inline="yes-display-inline">Not later than 180 days
				after the date of enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic
				and All-Hazards Preparedness Reauthorization Act of 2013</cato:entity-ref>
                    </short-title>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall submit to the appropriate committees of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a coordinated
				strategy and an accompanying implementation plan that identifies and
				demonstrates the measurable steps the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> will carry out to—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="idc5b8f4ac-9809-4040-b1e4-fc1a5afb0423">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">develop, implement, and evaluate the
				network described in paragraph (1), utilizing the elements described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:3" proposed="true">paragraph (3)</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id480989b9-c25d-446a-a31f-a26222167a8e">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">modernize and enhance biosurveillance
				activities; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id01a924b2-c70e-42dd-94fc-f7f500322285">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">improve information sharing, coordination,
				and communication among disparate biosurveillance systems supported by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human
				Service</cato:entity-ref>s.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idd6d820ac-8263-4c1e-ba18-167fc883844c">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:3/sp:D" proposed="true">paragraph (3)(D)</cato:entity-ref>, by inserting
			 <quote>community health centers, health centers</quote> after <quote>poison
			 control,</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id101a15c4-9b21-4b50-bad7-a6ca51e7250e">
              <enum>(E)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:5" proposed="true">paragraph (5)</cato:entity-ref>, by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:5/sp:A" proposed="true">subparagraph
			 (A)</cato:entity-ref> and inserting the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida38f3e97-cb63-43aa-9e7e-2fa5472a308f" reported-display-style="italic" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="idc2f972c4-b748-41a5-b0c3-91de0864aaa7">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">utilize applicable interoperability
				standards as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, and in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the National Coordinator for Health Information Technology" entity-parent-id="7500">Office
				of the National Coordinator for Health Information Technology</cato:entity-ref>, through a joint
				public and private sector process;</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idb7cdf5b9-42f5-48e5-8828-521193e71eb5">
              <enum>(F)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idda99f575-0e64-469d-b99a-228189d96d06" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id2d2d90c4-dfe8-4c2b-9171-87802224e707">
                  <enum>(6)</enum>
                  <header display-inline="yes-display-inline">Consultation with the National Biodefense
				Science Board</header>
                  <text display-inline="yes-display-inline">In carrying out
				this section and consistent with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M">section 319M</cato:entity-ref>, the National Biodefense Science
				Board shall provide expert advice and guidance, including recommendations,
				regarding the measurable steps the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> should take to modernize and
				enhance biosurveillance activities pursuant to the efforts of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of
				Health and Human Services</cato:entity-ref> to ensure comprehensive, real-time, all-hazards
				biosurveillance capabilities. In complying with the preceding sentence, the
				National Biodefense Science Board shall—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="ideb31113a-f85a-4d60-bc26-4112e99705ad">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">identify the steps necessary to achieve a
				national biosurveillance system for human health, with international
				connectivity, where appropriate, that is predicated on State, regional, and
				community level capabilities and creates a networked system to allow for
				two-way information flow between and among Federal, State, and local government
				public health authorities and clinical health care providers;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id39fd81a1-81f5-49ca-8275-f34f358b18bf">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">identify any duplicative surveillance
				programs under the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, or changes that are necessary to
				existing programs, in order to enhance and modernize such activities, minimize
				duplication, strengthen and streamline such activities under the authority of
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, and achieve real-time and appropriate data that relate to
				disease activity, both human and zoonotic; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idc9b9f050-030e-47fe-a689-877b50e15e67">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">coordinate with applicable existing
				advisory committees of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and
				Prevention</cato:entity-ref>, including such advisory committees consisting of representatives
				from State, local, and tribal public health authorities and appropriate public
				and private sector health care entities and academic institutions, in order to
				provide guidance on public health surveillance
				activities.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="ida33129b1-2130-4271-8544-ed7c21f8dae0">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Public Health Service Act/s:319D/ss:d" entity-type="act" proposed="true">subsection
			 (d)</cato:entity-ref>, as so redesignated—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id21CD301B00F24B5790116D8CFFBFFF11">
              <enum>(A)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:d/p:1" proposed="true">paragraph (1)</cato:entity-ref>, by
			 striking <quote>subsection (d)</quote> and inserting <quote>subsection
			 (c)</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id3E9117D1696A448F8A9370B17649FB4C">
              <enum>(B)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:d/p:4/sp:B" proposed="true">paragraph (4)(B)</cato:entity-ref>, by
			 striking <quote>subsection (d)</quote> and inserting <quote>subsection
			 (c)</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id7C79477DD31A406BB69854CDD01F46B6">
              <enum>(C)</enum>
              <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:d/p:5" proposed="true">paragraph (5)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id6C06319FCA97440C9A8F6353DD51B1ED">
                <enum>(i)</enum>
                <text>by striking <quote>4
			 years after the date of enactment of the Pandemic and All-Hazards Preparedness
			 Act</quote> and inserting <quote>3 years after the date of enactment of the
			 <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic and All-Hazards Preparedness
			 Reauthorization Act of 2013</cato:entity-ref>
                    </short-title>
                  </quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id206995D879074D0A9989514D185EE09E">
                <enum>(ii)</enum>
                <text>by striking
			 <quote>subsection (d)</quote> and inserting <quote>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c" proposed="true">subsection
			 (c)</cato:entity-ref>
                  </quote>;</text>
							</clause>
            </subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id59e3b3be-0a34-4bc7-a567-9afabd5f22b2">
            <enum>(6)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:f" proposed="true">subsection (f)</cato:entity-ref>, as so redesignated, by
			 striking <quote>such sums as may be necessary in each of fiscal years 2007
			 through 2011</quote> and inserting <quote>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                  <cato:funds-and-year amount="138300000" year="2014, 2015, 2016, 2017, 2018">$138,300,000 for each of fiscal years
			 2014 through 2018</cato:funds-and-year>
                </cato:entity>
              </quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id93cb3904-130b-4e7f-adba-909797389323">
            <enum>(7)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idf09086b9-1877-4e23-91b8-575fe39b9f16" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="id8514c8e2-4a57-4ae0-b821-4978744d53b9">
                <enum>(g)</enum>
                <header display-inline="yes-display-inline">Definition</header>
                <text display-inline="yes-display-inline">For purposes of this section the term
				<term>biosurveillance</term> means the process of gathering near real-time
				biological data that relates to human and zoonotic disease activity and threats
				to human or animal health, in order to achieve early warning and identification
				of such health threats, early detection and prompt ongoing tracking of health
				events, and overall situational awareness of disease
				activity.</text>
							</subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id8FA3C104E014426B99029E39CC6FCA9A">
          <enum>(b)</enum>
          <header>Technical and
			 conforming amendment</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319C–1/ss:b/p:2/sp:D">Section 319C–1(b)(2)(D) of the Public Health
			 Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–3a/b/2/D">42 U.S.C. 247d–3a(b)(2)(D)</cato:entity-ref>)</cato:entity> is amended by striking <quote>section
			 319D(d)(3)</quote> and inserting <quote>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319D/ss:c/p:3" proposed="true">section 319D(c)(3)</cato:entity-ref>
            </quote>.</text>
				</subsection>
      </section>
      <section commented="no" id="idfb397942-9c8c-4f14-848d-18dade3dacab">
        <enum>205.</enum>
        <header>Eliminating
			 duplicative Project Bioshield reports</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Project Bioshield Act of 2004/s:5">Section 5 of the Project Bioshield Act of
			 2004</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6c">
              <cato:entity-ref entity-type="uscode" value="usc/42/247d–6c">42 U.S.C. 247d–6c</cato:entity-ref>
            </external-xref>)</cato:entity> is repealed.</text>
			</section>
    </title>
    <title changed="added" committee-id="SSHR00" id="id4d90813a-6173-4aea-965d-d8f86b197744" reported-display-style="italic">
      <enum>III</enum>
      <header>Enhancing Medical
			 Countermeasure Review</header>
			<section commented="no" display-inline="no-display-inline" id="idf6ecf249-a5cc-42fe-af21-4cfeefc62f1c" section-type="subsequent-section">
        <enum>301.</enum>
        <header display-inline="yes-display-inline">Special protocol assessment</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:5/sp:B">Section 505(b)(5)(B) of the Federal Food,
			 Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
              <cato:entity-ref entity-type="uscode" value="usc/21/355/b/5/B">21 U.S.C. 355(b)(5)(B)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by striking
			 <quote>size of clinical trials intended</quote> and all that follows through
			 <quote>. The sponsor or applicant</quote> and inserting the following:
			 “size—</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idf068ea8d-ce4b-418f-ae2f-ff2fe8fad7fe" reported-display-style="italic" style="OLC">
					<clause commented="no" display-inline="no-display-inline" id="id3022666a-3d72-476a-990b-8675414f11cf" indent="up2">
            <enum>(i)</enum>
            <subclause commented="no" display-inline="yes-display-inline" id="id9320d7cd-c72c-48ff-a94b-9fd3b2a22821">
              <enum>(I)</enum>
              <text display-inline="yes-display-inline">of clinical trials intended to form the
				primary basis of an effectiveness claim; or</text>
						</subclause>
            <subclause changed="added" commented="no" committee-id="SSHR00" display-inline="no-display-inline" id="id9ecaa617-38dd-4b03-916c-4db396cc18f9" indent="up1" reported-display-style="italic">
              <enum>(II)</enum>
              <text display-inline="yes-display-inline">in the case where human efficacy studies
				are not ethical or feasible, of animal and any associated clinical trials
				which, in combination, are intended to form the primary basis of an
				effectiveness claim; or</text>
						</subclause>
          </clause>
          <clause commented="no" display-inline="no-display-inline" id="id6566ff71-1b51-454a-bdb7-7981d751e4cd" indent="up2">
            <enum>(ii)</enum>
            <text display-inline="yes-display-inline">with respect to an application for approval
				of a biological product under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351/ss:k">section 351(k) of the Public Health Service Act</cato:entity-ref>,
				of any necessary clinical study or studies.</text>
					</clause>
          <quoted-block-continuation-text quoted-block-continuation-text-level="subsection">The
				sponsor or
				applicant</quoted-block-continuation-text>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="id2476e6f8-e71c-4dda-ab48-cb14e540d94b" section-type="subsequent-section">
        <enum>302.</enum>
        <header display-inline="yes-display-inline">Authorization for medical products for use
			 in emergencies</header>
				<subsection commented="no" display-inline="no-display-inline" id="idd8d0a9a4-45d0-4d71-8499-f9d88ecc33ab">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">In general</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">Section 564 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-3">
                <cato:entity-ref entity-type="uscode" value="usc/21/360bbb–3">21 U.S.C. 360bbb–3</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id38d5da6e-0348-4ccc-b292-e7dde066af36">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a">subsection (a)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id5be62545-5ead-4c0f-bca5-4c516bb080c4">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:1">paragraph (1)</cato:entity-ref>, by striking
			 <quote>sections 505, 510(k), and 515 of this Act</quote> and inserting
			 <quote>any provision of this Act</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id5af924d1-2330-459c-aa9b-9ab092b520cf">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2/sp:A">paragraph (2)(A)</cato:entity-ref>, by striking
			 <quote>under a provision of law referred to in such paragraph</quote> and
			 inserting <quote>under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510/ss:k">510(k)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:515">515 of this Act</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351
			 of the Public Health Service Act</cato:entity-ref>
                </quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id716968b6-d5d1-4b0b-b1f9-aed79bb077a1">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:3">paragraph (3)</cato:entity-ref>, by striking <quote>a
			 provision of law referred to in such paragraph</quote> and inserting <quote>a
			 section of this Act or the Public Health Service Act referred to in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2/sp:A">paragraph
			 (2)(A)</cato:entity-ref>
                </quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id521a832c-bd4c-4589-9b7f-de78c27b3804">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b">subsection (b)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id618eecc0-3d0b-46c8-abd3-5318cfdac6de">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the subsection heading, by striking
			 <quote>
                  <header-in-text level="subsection" style="OLC">Emergency</header-in-text>
                </quote> and inserting
			 <quote>
                  <header-in-text level="subsection" style="OLC">Emergency or Threat
			 Justifying Emergency Authorized Use</header-in-text>
                </quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id87b54225-98b2-42fe-965c-483ecd520c5a">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1">paragraph (1)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="idbfd12e70-444e-4dd5-a3cd-9109162b0979">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in the matter preceding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:A">subparagraph (A)</cato:entity-ref>,
			 by striking <quote>may declare an emergency</quote> and inserting <quote>may
			 make a declaration that the circumstances exist</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="idae96ceb6-bd1e-42b8-bcd3-ce1163ad8397">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:A">subparagraph (A)</cato:entity-ref>, by striking
			 <quote>specified</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id25c23b28-9510-49b0-96d5-ca3e7064c171">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:B">subparagraph (B)</cato:entity-ref>—</text>
								<subclause commented="no" display-inline="no-display-inline" id="id07bb6e49-78b7-4415-acfb-55b4e9cd7322">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>specified</quote>;
			 and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="id39330886-673c-40b2-95fc-b013e549f3df">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>; or</quote> and
			 inserting a semicolon;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="id6de3162f-b726-4a5d-82a1-415a08151339">
                <enum>(iv)</enum>
                <text display-inline="yes-display-inline">by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:C">subparagraph (C)</cato:entity-ref> to read as
			 follows:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id85c2bac8-1756-45bd-8e4c-f6c522520dcc" reported-display-style="italic" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="idc1cd42d1-eb4a-4601-8fe1-77618310b78c">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">a determination by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> that there
				is a public health emergency, or a significant potential for a public health
				emergency, that affects, or has a significant potential to affect, national
				security or the health and security of United States citizens living abroad,
				and that involves a biological, chemical, radiological, or nuclear agent or
				agents, or a disease or condition that may be attributable to such agent or
				agents; or</text>
									</subparagraph>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="idf9ee486a-1757-4709-a5c4-02e1265ad0c2">
                <enum>(v)</enum>
                <text display-inline="yes-display-inline">by adding at the end the following:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idf0628169-1c00-4a6a-abf5-c7bbc4e874cc" reported-display-style="italic" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="id693180aa-84d3-4177-97b7-73a246c06e0a">
                    <enum>(D)</enum>
                    <text display-inline="yes-display-inline">the identification of a material threat
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public Health Service Act</cato:entity-ref> sufficient to
				affect national security or the health and security of United States citizens
				living
				abroad.</text>
									</subparagraph>
                  <after-quoted-block>;</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="ide8b65ce7-2f1b-4972-a7aa-0db71f81f3be">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2">paragraph (2)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id8cf30392-c132-4d91-a9dd-f86029e8d8b2">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2/sp:A">subparagraph (A)</cato:entity-ref>, by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2/sp:A/cl:ii">clause
			 (ii)</cato:entity-ref> to read as follows:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida1f44bf3-2fab-4cb7-87df-e352e8dfcd1a" reported-display-style="italic" style="OLC">
									<clause commented="no" display-inline="no-display-inline" id="ida6c01f6a-c2a0-486d-80a3-b4bfd5b397d6">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">a change in the approval status of the
				product such that the circumstances described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2">subsection (a)(2)</cato:entity-ref> have ceased
				to exist.</text>
									</clause>
                  <after-quoted-block>;
				</after-quoted-block>
                </quoted-block>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id45a6b679-afac-4c4c-b121-12ad42a8132b">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2/sp:B">subparagraph (B)</cato:entity-ref>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id58f3f4b3-5e76-45fa-a34f-4aa2f90162e7">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by redesignating <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2/sp:C">subparagraph (C)</cato:entity-ref> as
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:2/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id76881b8f-9ee1-4e42-b9ba-f381d695c4c1">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:4">paragraph (4)</cato:entity-ref>, by striking
			 <quote>advance notice of termination, and renewal under this
			 subsection.</quote> and inserting <quote>, and advance notice of termination
			 under this subsection.</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idf12a378a-f483-421c-adf0-995886cc91bb">
              <enum>(E)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idfb74f5c8-d6fe-4056-92d8-517de169682b" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id98dbddfe-2c4e-4e04-8c46-880ed034838f">
                  <enum>(5)</enum>
                  <header display-inline="yes-display-inline">Explanation by Secretary</header>
                  <text display-inline="yes-display-inline">If an authorization under this section with
				respect to an unapproved product or an unapproved use of an approved product
				has been in effect for more than 1 year, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide in writing
				to the sponsor of such product an explanation of the scientific, regulatory, or
				other obstacles to approval, licensure, or clearance of such product or use,
				including specific actions to be taken by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and the sponsor to
				overcome such
				obstacles.</text>
								</paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="idc268d9d9-7c32-4268-9d8d-4de2d5b3a49b">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:c">subsection (c)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id1fa8629e-32d7-4090-a3cf-49adb84dc70a">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the matter preceding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:c/p:1">paragraph
			 (1)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="idf029ae4a-8f89-4079-a6b4-64be00b1fadc">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by inserting <quote>the Assistant Secretary
			 for Preparedness and Response,</quote> after <quote>consultation
			 with</quote>;</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="idedd7aa5d-839a-4961-912a-0140b011e824">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>Health and</quote> and
			 inserting <quote>Health, and</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id3bfd94e3-5c85-470d-89dc-ab4801c5bab1">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>circumstances of the
			 emergency involved</quote> and inserting <quote>applicable circumstances
			 described in subsection (b)(1)</quote>;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idc7c3d043-9d82-43a3-aa59-fb9e30ccfd05">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:c/p:1">paragraph (1)</cato:entity-ref>, by striking
			 <quote>specified</quote> and inserting <quote>referred to</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id0f815a5e-5349-47f3-9421-e824aa4d043d">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:c/p:2/sp:B">paragraph (2)(B)</cato:entity-ref>, by inserting <quote>,
			 taking into consideration the material threat posed by the agent or agents
			 identified in a declaration under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:D">subsection (b)(1)(D)</cato:entity-ref>, if applicable</quote>
			 after <quote>risks of the product</quote>;</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id98cfdad8-b8eb-46f9-b585-d68866690677">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:d/p:3">subsection (d)(3)</cato:entity-ref>, by inserting <quote>,
			 to the extent practicable given the circumstances of the emergency,</quote>
			 after <quote>including</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id4c896945-59e9-4da3-beff-84d20c96fcab">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e">subsection (e)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id1c699e4e-0bd6-4f58-befa-4b38e174f87a">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:1/sp:A">paragraph (1)(A)</cato:entity-ref>, by striking
			 <quote>circumstances of the emergency</quote> and inserting <quote>applicable
			 circumstances described in subsection (b)(1)</quote>;</text>
						</subparagraph>
            <subparagraph id="idcaf901f8-d7c5-4c33-b97a-124cb8ac2ba7">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:1/sp:B">paragraph (1)(B)</cato:entity-ref>, by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:1/sp:B/cl:iii">clause
			 (iii)</cato:entity-ref> to read as follows:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id82c05cdd-83da-4a87-998b-36b734f0de20" reported-display-style="italic" style="OLC">
								<clause id="id0a6b3c24-1305-4d3f-986d-d1faac22da41">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">Appropriate conditions with respect to
				collection and analysis of information concerning the safety and effectiveness
				of the product with respect to the use of such product during the period when
				the authorization is in effect and a reasonable time following such
				period.</text>
								</clause>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idee830b4e-ac3f-423f-9b5e-751a1ecf0e66">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:2">paragraph (2)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id6c503702-8f95-4571-9e52-c75c7e56e4d0">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:2/sp:A">subparagraph (A)</cato:entity-ref>—</text>
								<subclause commented="no" display-inline="no-display-inline" id="idf915bf9e-ef40-4eb9-b581-78ede64fab8e">
                  <enum>(I)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>manufacturer of the
			 product</quote> and inserting <quote>person</quote>;</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="ide717a024-e329-4a1c-bbc0-44c391030e4c">
                  <enum>(II)</enum>
                  <text display-inline="yes-display-inline">by striking <quote>circumstances of the
			 emergency</quote> and inserting <quote>applicable circumstances described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1">subsection (b)(1)</cato:entity-ref>
                    </quote>; and</text>
								</subclause>
                <subclause commented="no" display-inline="no-display-inline" id="id3bafd877-c2bb-42a5-bd3f-1e86eb06cbec">
                  <enum>(III)</enum>
                  <text display-inline="yes-display-inline">by inserting at the end before the period
			 <quote>or in paragraph (1)(B)</quote>;</text>
								</subclause>
              </clause>
              <clause commented="no" display-inline="no-display-inline" id="id8b413ac4-3def-48d0-ab00-b9c4b47162c8">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:2/sp:B/cl:i">subparagraph (B)(i)</cato:entity-ref>, by inserting before
			 the period at the end <quote>, except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A" proposed="true">section 564A</cato:entity-ref> with respect
			 to authorized changes to the product expiration date</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id3b5aba9a-336d-4d28-aa69-823851bd077f">
                <enum>(iii)</enum>
                <text display-inline="yes-display-inline">by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:2/sp:C">subparagraph (C)</cato:entity-ref> to read as
			 follows:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id7bb90118-433c-4cde-a2d5-b182add9895c" reported-display-style="italic" style="OLC">
									<subparagraph commented="no" display-inline="no-display-inline" id="id729d5259-8350-405c-8d17-b109d4f042cf">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">In establishing conditions under this
				paragraph with respect to the distribution and administration of the product
				for the unapproved use, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall not impose conditions that would
				restrict distribution or administration of the product when distributed or
				administered for the approved use.</text>
									</subparagraph>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id696e79f6-4656-41cf-9621-e23e61c0a0b7">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:e/p:3">paragraph (3)</cato:entity-ref> to read as
			 follows:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idc9d812a4-2795-4d0a-aa15-81d0276aca27" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="idc13feb22-45b9-46af-8c43-8b2122c1be55">
                  <enum>(3)</enum>
                  <header display-inline="yes-display-inline">Good manufacturing practice;
				prescription</header>
                  <text display-inline="yes-display-inline">With respect to
				the emergency use of a product for which an authorization under this section is
				issued (whether an unapproved product or an unapproved use of an approved
				product), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may waive or limit, to the extent appropriate given the
				applicable circumstances described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1">subsection (b)(1)</cato:entity-ref>—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="idf2c3e565-9a49-4f60-8bed-651874fbf555">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">requirements regarding current good
				manufacturing practice otherwise applicable to the manufacture, processing,
				packing, or holding of products subject to regulation under this Act, including
				such requirements established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:501">section 501</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:f/p:1">520(f)(1)</cato:entity-ref>, and including
				relevant conditions prescribed with respect to the product by an order under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:f/p:2">section 520(f)(2)</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id2d76e793-95cb-4175-b4ec-fe0586b72141">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">requirements established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">section
				503(b)</cato:entity-ref>; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idfe5b196d-7326-48b0-99c4-d437f389be8c">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">requirements established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:e">section
				520(e)</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id2ca1aebd-e6ec-4fdb-b0ed-874983aeb774">
            <enum>(6)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:g">subsection (g)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id1232112f-edc3-4a02-bfb4-6d57eded70fd">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the subsection heading, by inserting
			 <quote>
                  <header-in-text level="subsection" style="OLC">Review
			 and</header-in-text>
                </quote> before <quote>
                  <header-in-text level="subsection" style="OLC">Revocation</header-in-text>
                </quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="ide753052a-25d0-43a4-8d48-5a8c75b77d68">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:g/p:1">paragraph (1)</cato:entity-ref>, by inserting after the
			 period at the end the following: “As part of such review, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall
			 regularly review the progress made with respect to the approval, licensure, or
			 clearance of—</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idef05eeba-dde9-4b57-8934-70eff813db3b" reported-display-style="italic" style="OLC">
								<subparagraph commented="no" display-inline="no-display-inline" id="idbb7908c2-3e1e-42b1-97d1-eb231e92ff5f">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">an unapproved product for which an
				authorization was issued under this section; or</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="ida784c69e-2679-4b18-a54b-b713c5f19ba2">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">an unapproved use of an approved product
				for which an authorization was issued under this
				section.</text>
								</subparagraph>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id4f6b3155-e7ec-43cb-9a92-4ff7a5f4cbf0">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:g/p:2">paragraph (2)</cato:entity-ref> to read as
			 follows:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id440449b2-07b9-44e5-9ce7-fd77b5c4e36a" reported-display-style="italic" style="OLC">
								<paragraph commented="no" display-inline="no-display-inline" id="id59e12d71-311d-41c8-9a9a-9154ffe061bb">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Revision and revocation</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may revise or revoke an
				authorization under this section if—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id4b570728-1671-4106-a670-75536de2fc5d">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">the circumstances described under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1">subsection (b)(1)</cato:entity-ref> no longer exist;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id860441c9-ffe2-4143-a24f-94e2ff718b7b">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the criteria under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:c">subsection (c)</cato:entity-ref> for
				issuance of such authorization are no longer met; or</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="ida726be9e-9d3f-4591-8e50-10da86a695da">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">other circumstances make such revision or
				revocation appropriate to protect the public health or
				safety.</text>
									</subparagraph>
                </paragraph>
                <after-quoted-block>;</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id1ec4898b-36bd-4fa9-b9ac-ed2adb11c81b">
            <enum>(7)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:h/p:1">subsection (h)(1)</cato:entity-ref>, by adding after the
			 period at the end the following: <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall make any revisions
			 to an authorization under this section available on the Internet Web site of
			 the Food and Drug Administration.</quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="ide93d1bc1-bd77-4fc1-bc21-bd5638b43395">
            <enum>(8)</enum>
            <text display-inline="yes-display-inline">by adding at the end of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:j">subsection (j)</cato:entity-ref> the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id57d381a8-d78a-4c74-9e64-b12be6280b8c" reported-display-style="italic" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="idabb8255e-948f-422a-ba36-24fc4c33c2f3">
                <enum>(4)</enum>
                <text display-inline="yes-display-inline">Nothing in this section shall be construed
				as authorizing a delay in the review or other consideration by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> of
				any application or submission pending before the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
				for a product for which an authorization under this section is
				issued.</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" id="id81c7226c-085f-416b-92f7-c997ff526aa0">
            <enum>(9)</enum>
            <text>by adding at the end the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" id="id60adbd0b-fd2e-4f59-8d47-c1ae65e52ca4" reported-display-style="italic" style="OLC">
							<subsection commented="no" id="id152c7e7d-b49e-4222-a735-343e221fa630">
                <enum>(m)</enum>
                <header>Categorization of
				laboratory tests associated with devices subject to authorization</header>
								<paragraph commented="no" id="id6e77c415-037d-40dc-b2b5-4a4a5f5b0fbc">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text>In issuing an authorization under this section with
				respect to a device, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may, subject to the provisions of this
				section, determine that a laboratory examination or procedure associated with
				such device shall be deemed, for purposes of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:353">section 353 of the Public Health
				Service Act</cato:entity-ref>, to be in a particular category of examinations and procedures
				(including the category described by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:353/ss:d/p:3">subsection (d)(3) of such section</cato:entity-ref>) if,
				based on the totality of scientific evidence available to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>—</text>
									<subparagraph commented="no" id="id4015a6f0-c05c-49ee-956f-e08115668ca5">
                    <enum>(A)</enum>
                    <text>such categorization would
				be beneficial to protecting the public health; and</text>
									</subparagraph>
                  <subparagraph commented="no" id="idb8990b41-e519-434a-9318-e98c59008802">
                    <enum>(B)</enum>
                    <text>the known and potential
				benefits of such categorization under the circumstances of the authorization
				outweigh the known and potential risks of the categorization.</text>
									</subparagraph>
                </paragraph>
                <paragraph commented="no" id="id5e164f08-188b-4d25-abf5-80eb31ec8f42">
                  <enum>(2)</enum>
                  <header>Conditions of
				determination</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may establish appropriate conditions
				on the performance of the examination or procedure pursuant to such
				determination.</text>
								</paragraph>
                <paragraph commented="no" id="id692e0bf3-bc8d-4f4f-acee-9296d64947ec">
                  <enum>(3)</enum>
                  <header>Effective
				period</header>
                  <text>A determination under this subsection shall be effective
				for purposes of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:353">section 353 of the Public Health Service Act</cato:entity-ref> notwithstanding
				any other provision of that section during the effective period of the relevant
				declaration under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b">subsection
				(b)</cato:entity-ref>.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="idcf9b2cd5-bdb4-4b65-ad0a-853aca71fa9b">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Emergency use of medical
			 products</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:E">Subchapter E of
			 chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/360bbb/etseq">21 U.S.C. 360bbb et
			 seq.</cato:entity-ref>)</cato:entity> is amended by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">section 564</cato:entity-ref> the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idbc86ec18-d468-4f03-a7e1-8567f1750cff" reported-display-style="italic" style="OLC">
						<section commented="no" display-inline="no-display-inline" id="idc684115e-93ca-43bc-a622-d7ce37dda5e1" section-type="subsequent-section">
              <enum>564A.</enum>
              <header display-inline="yes-display-inline">Emergency use of medical products</header>
							<subsection commented="no" display-inline="no-display-inline" id="id964cbfda-8c3e-4ef3-b977-1f308c4551f6">
                <enum>(a)</enum>
                <header display-inline="yes-display-inline">Definitions</header>
                <text display-inline="yes-display-inline">In this section:</text>
								<paragraph commented="no" display-inline="no-display-inline" id="id1bf8cd15-dc6a-491b-b653-ef7b3944b02e">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">Eligible product</header>
                  <text display-inline="yes-display-inline">The term <term>eligible product</term>
				means a product that—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id4db717bf-07aa-4981-8bbf-260d8f4d6863">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">is approved or cleared under this chapter
				or licensed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service Act</cato:entity-ref>;</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id7ad98e64-02a5-43f4-a3af-c791607fcd32">
                    <enum>(B)</enum>
                    <clause commented="no" display-inline="yes-display-inline" id="id11fa3503-c848-4db0-bbba-ba8880ea5721">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">is intended for use to prevent, diagnose,
				or treat a disease or condition involving a biological, chemical, radiological,
				or nuclear agent or agents; or</text>
										</clause>
                    <clause changed="added" commented="no" committee-id="SSHR00" display-inline="no-display-inline" id="id93ae0f9f-6e8a-4a06-baf2-a36733142701" indent="up1" reported-display-style="italic">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">is intended for use to prevent, diagnose,
				or treat a serious or life-threatening disease or condition caused by a product
				described in clause (i); and</text>
										</clause>
                  </subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id2b0e4c12-6d9e-4278-8b03-6f3bbc7ea769">
                    <enum>(C)</enum>
                    <text display-inline="yes-display-inline">is intended for use during the
				circumstances under which—</text>
										<clause commented="no" display-inline="no-display-inline" id="idd6c36e14-49aa-4d61-95ec-6b88065f79b5">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">a determination described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:A">subparagraph
				(A)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:B">(B)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:C" proposed="true">(C) of section 564(b)(1)</cato:entity-ref> has been made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Secretary of
				Homeland Security</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Secretary of Defense</cato:entity-ref>, or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, respectively;
				or</text>
										</clause>
                    <clause commented="no" display-inline="no-display-inline" id="ide641b698-cdc3-42ae-a231-7273503d84f5">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">the identification of a material threat
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:D" proposed="true">subparagraph (D) of section 564(b)(1)</cato:entity-ref> has been made pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public Health Service Act</cato:entity-ref>.</text>
										</clause>
                  </subparagraph>
                </paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id27c66aed-11fe-4525-9b03-2fbe1684d828">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Product</header>
                  <text display-inline="yes-display-inline">The term <term>product</term> means a drug,
				device, or biological product.</text>
								</paragraph>
              </subsection>
              <subsection id="id76ebe713-7761-4895-9af1-e6ab7c906532">
                <enum>(b)</enum>
                <header>Expiration
				dating</header>
								<paragraph id="id360953a0-c29b-4712-ac8e-1a4c4777ecf4">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may extend the expiration date and
				authorize the introduction or delivery for introduction into interstate
				commerce of an eligible product after the expiration date provided by the
				manufacturer if—</text>
									<subparagraph id="idedf2ba07-3db8-4584-a721-867b230f98bc">
                    <enum>(A)</enum>
                    <text>the expiration date
				extension is intended to support the United States ability to protect—</text>
										<clause id="idade2c465-ba18-4817-b725-1815f6f3aec3">
                      <enum>(i)</enum>
                      <text>the public health;
				or</text>
										</clause>
                    <clause id="idbaba36f5-8140-4fd9-9d46-205e9b483271">
                      <enum>(ii)</enum>
                      <text>military preparedness
				and effectiveness; and</text>
										</clause>
                  </subparagraph>
                  <subparagraph id="iddf759b6f-9e4e-4700-af5f-968bdddfaf07">
                    <enum>(B)</enum>
                    <text>the expiration date
				extension is supported by an appropriate scientific evaluation that is
				conducted or accepted by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
                <paragraph id="id453d1837-9591-41b6-821f-e76e26ae22cb">
                  <enum>(2)</enum>
                  <header>Requirements and
				conditions</header>
                  <text>Any extension of an expiration date under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:b/p:1" proposed="true">paragraph
				(1)</cato:entity-ref> shall, as part of the extension, identify—</text>
									<subparagraph id="idf1dbb990-b99f-404d-83a3-d88a7d68730b">
                    <enum>(A)</enum>
                    <text>each specific lot, batch,
				or other unit of the product for which extended expiration is
				authorized;</text>
									</subparagraph>
                  <subparagraph id="id72c1047c-7a64-4e27-9e79-8d86544803f0">
                    <enum>(B)</enum>
                    <text>the duration of the
				extension; and</text>
									</subparagraph>
                  <subparagraph id="ida659f0cf-73f8-4456-a94e-9fffe32867df">
                    <enum>(C)</enum>
                    <text>any other requirements or
				conditions as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may deem appropriate for the protection of the
				public health, which may include requirements for, or conditions on, product
				sampling, storage, packaging or repackaging, transport, labeling, notice to
				product recipients, recordkeeping, periodic testing or retesting, or product
				disposition.</text>
									</subparagraph>
                </paragraph>
                <paragraph id="id441de81f-d9f0-4f0a-9137-36050e9a7fd1">
                  <enum>(3)</enum>
                  <header>Effect</header>
                  <text>Notwithstanding
				any other provision of this Act or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref>, an eligible
				product shall not be considered an unapproved product (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2/sp:A">section
				564(a)(2)(A)</cato:entity-ref>) and shall not be deemed adulterated or misbranded under this Act
				because, with respect to such product, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> has, under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref>,
				extended the expiration date and authorized the introduction or delivery for
				introduction into interstate commerce of such product after the expiration date
				provided by the manufacturer.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="ida9659b0b-165c-4ae5-a2a5-7fa7416cc9f0">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Expiration date</header>
                  <text display-inline="yes-display-inline">For purposes of this subsection, the term
				<term>expiration date</term> means the date established through appropriate
				stability testing required by the regulations issued by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to ensure
				that the product meets applicable standards of identity, strength, quality, and
				purity at the time of use.</text>
								</paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="id1868e64c-d395-46cd-8c1e-8831ec88ef7f">
                <enum>(c)</enum>
                <header display-inline="yes-display-inline">Current good manufacturing
				practice</header>
								<paragraph commented="no" display-inline="no-display-inline" id="idfab4f574-0cdb-4df8-a97e-6882c41e9201">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may, when the circumstances
				of a domestic, military, or public health emergency or material threat
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:a/p:1/sp:C" proposed="true">subsection (a)(1)(C)</cato:entity-ref> so warrant, authorize, with respect to an
				eligible product, deviations from current good manufacturing practice
				requirements otherwise applicable to the manufacture, processing, packing, or
				holding of products subject to regulation under this Act, including
				requirements under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:501">section 501</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:f/p:1">520(f)(1)</cato:entity-ref> or applicable conditions prescribed
				with respect to the eligible product by an order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:f/p:2">section
				520(f)(2)</cato:entity-ref>.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="idb9b1c59a-d102-4cdf-b96b-2f0ad0e15573">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Effect</header>
                  <text display-inline="yes-display-inline">Notwithstanding any other provision of this
				Act or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref>, an eligible product shall not be
				considered an unapproved product (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2/sp:A">section 564(a)(2)(A)</cato:entity-ref>) and shall
				not be deemed adulterated or misbranded under this Act because, with respect to
				such product, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> has authorized deviations from current good
				manufacturing practices under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref>.</text>
								</paragraph>
              </subsection>
              <subsection display-inline="no-display-inline" id="id7c8612f5-fbd6-4f24-9880-a18e059b39a6">
                <enum>(d)</enum>
                <header>Emergency
				dispensing</header>
                <text>The requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">sections 503(b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520/ss:e">520(e)</cato:entity-ref> shall
				not apply to an eligible product, and the product shall not be considered an
				unapproved product (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:2/sp:A">section 564(a)(2)(A)</cato:entity-ref>) and shall not be deemed
				adulterated or misbranded under this Act because it is dispensed without an
				individual prescription, if—</text>
								<paragraph commented="no" id="idfa8d01ac-22b6-4273-87bc-901a63d03ded">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">the product is dispensed during the
				circumstances described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:a/p:1/sp:C" proposed="true">subsection (a)(1)(C)</cato:entity-ref>; and</text>
								</paragraph>
                <paragraph commented="no" id="ida3e61bdc-1ce6-4d64-9f87-f2685cff2afa">
                  <enum>(2)</enum>
                  <text>such dispensing without
				an individual prescription occurs—</text>
									<subparagraph commented="no" id="idecbd3973-f663-4737-ae42-72e8bef2185f">
                    <enum>(A)</enum>
                    <text>as permitted under the
				law of the State in which the product is dispensed; or</text>
									</subparagraph>
                  <subparagraph commented="no" id="idf9e14a4d-7c44-4c06-b80e-0b67890b4ddf">
                    <enum>(B)</enum>
                    <text>in accordance with an
				order issued by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, for the purposes and duration of the
				circumstances described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:a/p:1/sp:C" proposed="true">subsection (a)(1)(C)</cato:entity-ref>.</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" display-inline="no-display-inline" id="id2a46bb6b-db75-437c-a1c6-611a27bd9518">
                <enum>(e)</enum>
                <header display-inline="yes-display-inline">Emergency use instructions</header>
								<paragraph commented="no" display-inline="no-display-inline" id="ide0cf6d9e-3885-4245-926c-19a4fe040278">
                  <enum>(1)</enum>
                  <header display-inline="yes-display-inline">In general</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through an
				appropriate official within the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref>, may
				create and issue emergency use instructions to inform health care providers or
				individuals to whom an eligible product is to be administered concerning such
				product's approved, licensed, or cleared conditions of use.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id38bff655-90f0-4600-9aa8-abf9a5465cb2">
                  <enum>(2)</enum>
                  <header display-inline="yes-display-inline">Effect</header>
                  <text display-inline="yes-display-inline">Notwithstanding any other provisions of
				this Act or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref>, a product shall not be considered an
				unapproved product and shall not be deemed adulterated or misbranded under this
				Act because of the issuance of emergency use instructions under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref>
				with respect to such product or the introduction or delivery for introduction
				of such product into interstate commerce accompanied by such
				instructions—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id7f29f767-d814-4349-8ce8-e696dba9f73b">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">during an emergency response to an actual
				emergency that is the basis for a determination described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A/ss:a/p:1/sp:C/cl:i" proposed="true">subsection
				(a)(1)(C)(i)</cato:entity-ref>; or</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="idef683b14-2cd4-4e12-b1f1-738f1f76f0e5">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">by a government entity (including a
				Federal, State, local, or tribal government entity), or a person acting on
				behalf of such a government entity, in preparation for an emergency
				response.</text>
									</subparagraph>
                </paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id24b50095-afc2-40a0-8ee6-0d7871af7fa1">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Risk evaluation and mitigation
			 strategies</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505–1">Section 505–1 of
			 the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355-1">
                <cato:entity-ref entity-type="uscode" value="usc/21/355–1">21 U.S.C. 355–1</cato:entity-ref>
              </external-xref>)</cato:entity>, is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id1817208b-3878-454d-b253-ed6f31727a89">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505–1/ss:f">subsection (f)</cato:entity-ref>, by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505–1/ss:f/p:7">paragraph
			 (7)</cato:entity-ref>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id0e133554-fcab-427d-ac52-acfc6d67769e">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id557d3fc3-b840-4e39-a625-ec079c5c832e" reported-display-style="italic" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="idc44a1172-1341-42ef-9990-0e7c2e2fc7fd">
                <enum>(k)</enum>
                <header display-inline="yes-display-inline">Waiver in public health
				emergencies</header>
                <text display-inline="yes-display-inline">The Secretary may
				waive any requirement of this section with respect to a qualified
				countermeasure (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2">section 319F–1(a)(2) of the Public Health Service
				Act</cato:entity-ref>) to which a requirement under this section has been applied, if the
				Secretary determines that such waiver is required to mitigate the effects of,
				or reduce the severity of, the circumstances under which—</text>
								<paragraph commented="no" display-inline="no-display-inline" id="ide4bf2377-79a8-4986-b1af-4d4faeda369e">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">a determination described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:A">subparagraph
				(A)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:B">(B)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:C" proposed="true">(C) of section 564(b)(1)</cato:entity-ref> has been made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Secretary of
				Homeland Security</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Secretary of Defense</cato:entity-ref>, or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, respectively;
				or</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id9ca676b8-9434-448c-8b5c-6d0700519e1b">
                  <enum>(2)</enum>
                  <text display-inline="yes-display-inline">the identification of a material threat
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:b/p:1/sp:D" proposed="true">subparagraph (D) of section 564(b)(1)</cato:entity-ref> has been made pursuant to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public Health Service
				Act</cato:entity-ref>.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id495146ad-63e5-4279-88b4-7d10b9ef13e3">
          <enum>(d)</enum>
          <header display-inline="yes-display-inline">Products held for emergency
			 use</header>
          <text display-inline="yes-display-inline">The <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug,
			 and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/301">
                <cato:entity-ref entity-type="uscode" value="usc/21/301/etseq">21 U.S.C. 301 et seq.</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A" proposed="true">section
			 564A</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013/s:302/ss:b" proposed="true">subsection (b)</cato:entity-ref>, the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="iddee97375-5cc2-4f70-bcbb-eb2337824805" reported-display-style="italic" style="OLC">
						<section commented="no" display-inline="no-display-inline" id="id32da8d1b-3fe3-49e1-a8a8-554b057d1f5a" section-type="subsequent-section">
              <enum>564B.</enum>
              <header display-inline="yes-display-inline">Products held for emergency
				use</header>
              <text display-inline="no-display-inline">It is not a violation of
				any section of this Act or of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref> for a government
				entity (including a Federal, State, local, or tribal government entity), or a
				person acting on behalf of such a government entity, to introduce into
				interstate commerce a product (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564/ss:a/p:4">section 564(a)(4)</cato:entity-ref>) intended for
				emergency use, if that product—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="id21b6bdf8-ef2e-4fc5-b6e5-3a2ec3cc3bc3">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">is intended to be held and not used;
				and</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id9ab5ae49-7f4d-4299-9a42-f5331cb4c78b">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">is held and not used, unless and until that
				product—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="id96952113-79f0-40ff-a83b-18b91ab7b25f">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">is approved, cleared, or licensed under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:510/ss:k">510(k)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:515">515 of this Act</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health
				Service Act</cato:entity-ref>;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="idcac12f4a-ffd3-4ac1-a2da-657ffe7b47c4">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">is authorized for investigational use under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:520">520 of this Act</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service Act</cato:entity-ref>;
				or</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id4043696f-5ae9-4db5-986d-cf82e274be82">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">is authorized for use under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">section
				564</cato:entity-ref>.</text>
								</subparagraph>
              </paragraph>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="idc51a3904-dc87-4ace-b53a-84c72b47f4c6" section-type="subsequent-section">
        <enum>303.</enum>
        <header display-inline="yes-display-inline">Definitions</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">
              <cato:entity-ref entity-type="uscode" value="usc/21/360bbb–4">21 U.S.C. 360bbb–4</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by striking <quote>The Secretary,
			 in consultation</quote> and inserting the following:</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id5199a562-c361-4419-b5cc-d6a359beeb9a" reported-display-style="italic" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="id1e168bc0-b290-4dbe-a821-4fc5b96d1f6a">
            <enum>(a)</enum>
            <header display-inline="yes-display-inline">Definitions</header>
            <text display-inline="yes-display-inline">In this section—</text>
						<paragraph commented="no" display-inline="no-display-inline" id="idb7853802-95a0-4b89-bf64-a637ccab61c4">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">the term <term>countermeasure</term> means
				a qualified countermeasure, a security countermeasure, and a qualified pandemic
				or epidemic product;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="idefa5ff57-49c6-4068-9f5b-b73c70fd6e14">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">the term <term>qualified
				countermeasure</term> has the meaning given such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1 of the
				Public Health Service Act</cato:entity-ref>;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id3e534582-8edb-4ba6-9fc3-c041327fe80b">
              <enum>(3)</enum>
              <text display-inline="yes-display-inline">the term <term>security
				countermeasure</term> has the meaning given such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of such
				Act</cato:entity-ref>; and</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id64965444-7677-4a0a-9a37-72de7a47fadf">
              <enum>(4)</enum>
              <text display-inline="yes-display-inline">the term <term>qualified pandemic or
				epidemic product</term> means a product that meets the definition given such
				term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section 319F–3 of the Public Health Service Act</cato:entity-ref> and—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="id76286a33-284d-483c-8f8a-dcc158c2b849">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">that has been identified by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department
				of Health and Human Services</cato:entity-ref> or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of Defense</cato:entity-ref> as receiving funding
				directly related to addressing chemical, biological, radiological, or nuclear
				threats, including pandemic influenza; or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id9f8d3681-a53c-4c32-9d73-fc21d99fef3e">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">is included under this paragraph pursuant
				to a determination by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection commented="no" display-inline="no-display-inline" id="id68222a0a-0d5a-45fb-b9e1-e9012e6aa801">
            <enum>(b)</enum>
            <header display-inline="yes-display-inline">General
				duties</header>
            <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in
				consultation</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="idd3e375cb-b2f3-45ff-8916-8722043eb2f4" section-type="subsequent-section">
        <enum>304.</enum>
        <header display-inline="yes-display-inline">Enhancing medical countermeasure
			 activities</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565">Section 565 of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">
              <cato:entity-ref entity-type="uscode" value="usc/21/360bbb–4">21 U.S.C. 360bbb–4</cato:entity-ref>
            </external-xref>)</cato:entity>, as amended by
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013/s:303" proposed="true">section 303</cato:entity-ref>, is further amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="id64f145e5-93e5-47dc-b5c8-fc4201d1e541">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in the section heading, by striking
			 <quote>
              <header-in-text level="section" style="OLC">Technical
			 Assistance</header-in-text>
            </quote> and inserting <quote>
              <header-in-text level="section" style="OLC">Countermeasure Development, Review, and Technical
			 Assistance</header-in-text>
            </quote>;</text>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="iddb7365c3-2aa8-42a4-90d9-3ac1cf15a380">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:b">subsection (b)</cato:entity-ref>, by striking the
			 subsection enumerator and all that follows through <quote>shall
			 establish</quote> and inserting the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idf1712e52-32b7-4480-9931-468b31274d07" reported-display-style="italic" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="id55704661-5424-49a8-9cc1-7ddab291e506">
              <enum>(b)</enum>
              <header display-inline="yes-display-inline">General
				duties</header>
              <text display-inline="yes-display-inline">In order to accelerate
				the development, stockpiling, approval, licensure, and clearance of qualified
				countermeasures, security countermeasures, and qualified pandemic or epidemic
				products, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in consultation with the Assistant Secretary for
				Preparedness and Response, shall—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="id51165aa2-019c-41cd-8d4d-0fc93ce4641f">
                <enum>(1)</enum>
                <text display-inline="yes-display-inline">ensure the appropriate involvement of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food
				and Drug Administration</cato:entity-ref> personnel in interagency activities related to
				countermeasure advanced research and development, consistent with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F">sections
				319F</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">319F–1</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">319F–2</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">319F–3</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">319L</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811">2811 of the Public Health Service
				Act</cato:entity-ref>;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id1dfdf648-9913-48de-aa90-2edcbae6b8d3">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">ensure the appropriate involvement and
				consultation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> personnel in any flexible
				manufacturing activities carried out under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L of the Public Health
				Service Act</cato:entity-ref>, including with respect to meeting regulatory requirements set
				forth in this Act;</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id98d65eb9-dcd8-4088-a517-02050bf5cdc2">
                <enum>(3)</enum>
                <text display-inline="yes-display-inline">promote countermeasure expertise within the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> by—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="id0185c009-ad8a-4622-93fe-0cb7f7d50a28">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">ensuring that <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
				personnel involved in reviewing countermeasures for approval, licensure, or
				clearance are informed by the Assistant Secretary for Preparedness and Response
				on the material threat assessment conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public
				Health Service Act</cato:entity-ref> for the agent or agents for which the countermeasure under
				review is intended;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id73db012a-c1fc-4ab1-b901-74efef99ff39">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">training <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>
				personnel regarding review of countermeasures for approval, licensure, or
				clearance;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id58a9d4fe-f2ce-4615-8cdf-519e5059b2f9">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">holding public meetings at least twice
				annually to encourage the exchange of scientific ideas; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id51160d4b-c5b6-4d1d-ba65-17a0d791d3a4">
                  <enum>(D)</enum>
                  <text display-inline="yes-display-inline">establishing protocols to ensure that
				countermeasure reviewers have sufficient training or experience with
				countermeasures;</text>
								</subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id93c4f67b-e5b9-4653-8192-8c66bfff43eb">
                <enum>(4)</enum>
                <text display-inline="yes-display-inline">maintain teams, composed of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug
				Administration</cato:entity-ref> personnel with expertise on countermeasures, including specific
				countermeasures, populations with special clinical needs (including children
				and pregnant women that may use countermeasures, as applicable and
				appropriate), classes or groups of countermeasures, or other
				countermeasure-related technologies and capabilities, that shall—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="idef5e2a53-dc52-47f2-a423-98e1ce692dd8">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">consult with countermeasure experts,
				including countermeasure sponsors and applicants, to identify and help resolve
				scientific issues related to the approval, licensure, or clearance of
				countermeasures, through workshops or public meetings; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id3954e007-59c0-48b6-bf4d-9ae167ba0d6a">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">improve and advance the science relating to
				the development of new tools, standards, and approaches to assessing and
				evaluating countermeasures—</text>
									<clause commented="no" display-inline="no-display-inline" id="idfef55c7e-0c3e-4e91-9029-25e06581da0a">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">in order to inform the process for
				countermeasure approval, clearance, and licensure; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="ida2de7f8f-64e7-4932-a42f-3ffef5ac6524">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">with respect to the development of
				countermeasures for populations with special clinical needs, including children
				and pregnant women, in order to meet the needs of such populations, as
				necessary and appropriate; and</text>
									</clause>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="id837cff64-e089-42ef-89b8-ad39efa82be2">
                <enum>(5)</enum>
                <text display-inline="yes-display-inline">establish</text>
							</paragraph>
            </subsection>
            <after-quoted-block>;
				and</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="id0496282d-2415-4248-bdb1-1674065bccfa">
          <enum>(3)</enum>
          <text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id629b4057-84c1-4fa9-ad5c-c019d6701e0e" reported-display-style="italic" style="OLC">
						<subsection commented="no" id="id460ffc67-5ac9-4f50-8aec-2ef7a13b953e">
              <enum>(c)</enum>
              <header>Final Guidance on
				development of animal models</header>
							<paragraph commented="no" id="id57acd999-3f4d-4feb-9cda-4797c48959a9">
                <enum>(1)</enum>
                <header>In
				general</header>
                <text>Not later than 1 year after the date of the enactment of
				the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013" proposed="true">Pandemic and All-Hazards Preparedness
				Reauthorization Act of 2013</cato:entity-ref>
                  </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide final
				guidance to industry regarding the development of animal models to support
				approval, clearance, or licensure of countermeasures referred to in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:a" proposed="true">subsection
				(a)</cato:entity-ref> when human efficacy studies are not ethical or feasible.</text>
							</paragraph>
              <paragraph commented="no" id="idcddcef23-a7cb-49e4-a834-7b051b3f1c8e">
                <enum>(2)</enum>
                <header>Authority to extend
				deadline</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may
				extend the deadline for providing final guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref> by not
				more than 6 months upon submission by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> of a report on the status
				of such guidance to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HIF00">Committee on Energy and Commerce of the House of
				Representatives</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="SSHR00">Committee on Health, Education, Labor, and Pensions of
				the Senate</cato:entity-ref>.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="id27bff8f4-8470-4137-8619-be8daa16ebfb">
              <enum>(d)</enum>
              <header display-inline="yes-display-inline">Development and animal modeling
				procedures</header>
							<paragraph commented="no" display-inline="no-display-inline" id="id6ed4c6ed-5c84-4503-8664-fb0f91bd84a4">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">Availability of animal model
				meetings</header>
                <text display-inline="yes-display-inline">To facilitate the
				timely development of animal models and support the development, stockpiling,
				licensure, approval, and clearance of countermeasures, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, not
				later than 180 days after the enactment of this subsection, establish a
				procedure by which a sponsor or applicant that is developing a countermeasure
				for which human efficacy studies are not ethical or practicable, and that has
				an approved investigational new drug application or investigational device
				exemption, may request and receive—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="id2ac32cb1-aaa5-4f85-804a-e709f9ef6e42">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">a meeting to discuss proposed animal model
				development activities; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="id88c00099-c6ee-476a-8c12-a124015749e8">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">a meeting prior to initiating pivotal
				animal studies.</text>
								</subparagraph>
              </paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="idb4885ac9-6358-4991-a991-2ef80eabd151">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Pediatric models</header>
                <text display-inline="yes-display-inline">To facilitate the development and selection
				of animal models that could translate to pediatric studies, any meeting
				conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:d/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall include discussion of animal models for
				pediatric populations, as appropriate.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" display-inline="no-display-inline" id="idca111f52-1075-4f36-b0ae-065bcbfec1e8">
              <enum>(e)</enum>
              <header display-inline="yes-display-inline">Review and approval of
				countermeasures</header>
							<paragraph commented="no" display-inline="no-display-inline" id="id4548a91f-5774-4caf-a98f-a93516a19ab6">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">Material threat</header>
                <text display-inline="yes-display-inline">When evaluating an application or
				submission for approval, licensure, or clearance of a countermeasure, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall take into account the material threat posed by the chemical,
				biological, radiological, or nuclear agent or agents identified under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section
				319F–2 of the Public Health Service Act</cato:entity-ref> for which the countermeasure under
				review is intended.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="idb61205be-82ea-4ae7-b63d-d3cda3b34d94">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Review expertise</header>
                <text display-inline="yes-display-inline">When practicable and appropriate, teams of
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> personnel reviewing applications or submissions
				described under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:e/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall include a reviewer with sufficient training
				or experience with countermeasures pursuant to the protocols established under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:b/p:3/sp:D" proposed="true">subsection
				(b)(3)(D)</cato:entity-ref>.</text>
							</paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="id60413177-4bf8-4941-be18-51656dd22d2e" section-type="subsequent-section">
        <enum>305.</enum>
        <header display-inline="yes-display-inline">Regulatory management plans</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">
              <cato:entity-ref entity-type="uscode" value="usc/21/360bbb–4">21 U.S.C. 360bbb–4</cato:entity-ref>
            </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013/s:304" proposed="true">section 304</cato:entity-ref>, is further
			 amended by adding at the end the following:</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id220e164e-b90b-4e30-b9c0-ba61e51b0d2c" reported-display-style="italic" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="id08d58dc2-0e75-474d-9e88-c4f847ec128e">
            <enum>(f)</enum>
            <header display-inline="yes-display-inline">Regulatory management plan</header>
						<paragraph commented="no" display-inline="no-display-inline" id="id88c7f4a9-605a-4ae1-8576-da8ce4a9bc69">
              <enum>(1)</enum>
              <header display-inline="yes-display-inline">Definition</header>
              <text display-inline="yes-display-inline">In this subsection, the term <term>eligible
				countermeasure</term> means—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="iddef08825-9c79-43b5-8fac-9335c967a368">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">a security countermeasure with respect to
				which the Secretary has entered into a procurement contract under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c">section
				319F–2(c) of the Public Health Service Act</cato:entity-ref>; or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id3b11f06a-11f2-4b87-890d-2971da9fd32f">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">a countermeasure with respect to which the
				Biomedical Advanced Research and Development Authority has provided funding
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L of the Public Health Service Act</cato:entity-ref> for advanced research and
				development.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="idb3b805a8-4595-4621-a813-fb1f1b8a7b0d">
              <enum>(2)</enum>
              <header display-inline="yes-display-inline">Regulatory management plan
				process</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in
				consultation with the Assistant Secretary for Preparedness and Response and the
				Director of the Biomedical Advanced Research and Development Authority, shall
				establish a formal process for obtaining scientific feedback and interactions
				regarding the development and regulatory review of eligible countermeasures by
				facilitating the development of written regulatory management plans in
				accordance with this subsection.</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id427407f0-cbe5-4a3e-9df1-cc10fe6e1d24">
              <enum>(3)</enum>
              <header display-inline="yes-display-inline">Submission of request and proposed plan by
				sponsor or applicant</header>
							<subparagraph commented="no" display-inline="no-display-inline" id="idc1a8a0a6-43be-4398-b65e-cb6b7dffe103">
                <enum>(A)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">A sponsor or applicant of an eligible
				countermeasure may initiate the process described under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:2" proposed="true">paragraph (2)</cato:entity-ref> upon
				submission of a written request to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>. Such request shall include a
				proposed regulatory management plan.</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id67e431b8-55dc-499f-8f13-aa414426d6de">
                <enum>(B)</enum>
                <header display-inline="yes-display-inline">Timing of submission</header>
                <text display-inline="yes-display-inline">A sponsor or applicant may submit a written
				request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> after the eligible countermeasure has an
				investigational new drug or investigational device exemption in effect.</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id64e601ff-6366-4f9f-8728-9e86942f95c0">
                <enum>(C)</enum>
                <header display-inline="yes-display-inline">Response by Secretary</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall direct the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and
				Drug Administration</cato:entity-ref>, upon submission of a written request by a sponsor or
				applicant under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:3/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, to work with the sponsor or applicant to
				agree on a regulatory management plan within a reasonable time not to exceed 90
				days. If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines that no plan can be agreed upon, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide to the sponsor or applicant, in writing, the scientific
				or regulatory rationale why such agreement cannot be reached.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id892ff151-b34d-49d8-8470-f2800910cfff">
              <enum>(4)</enum>
              <header display-inline="yes-display-inline">Plan</header>
              <text display-inline="yes-display-inline">The content of a regulatory management plan
				agreed to by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and a sponsor or applicant shall include—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="idbfb6cd14-1b9a-49de-b774-788b1e2679fa">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">an agreement between the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and the
				sponsor or applicant regarding developmental milestones that will trigger
				responses by the Secretary as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:4/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id149f1772-017e-4f7b-bf58-9db7e828fdf5">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">performance targets and goals for timely
				and appropriate responses by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to the triggers described under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, including meetings between the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and the sponsor or
				applicant, written feedback, decisions by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, and other activities
				carried out as part of the development and review process; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id916520a2-db62-4346-9bc7-69319bebd087">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">an agreement on how the plan shall be
				modified, if needed.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id4581fef0-5f5f-4e8c-ac67-4564cc6f40c6">
              <enum>(5)</enum>
              <header display-inline="yes-display-inline">Milestones and performance
				targets</header>
              <text display-inline="yes-display-inline">The developmental
				milestones described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:4/sp:A" proposed="true">paragraph (4)(A)</cato:entity-ref> and the performance targets and goals
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:4/sp:B" proposed="true">paragraph (4)(B)</cato:entity-ref> shall include—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="id9cade232-8b90-4fba-a19a-73ce9a80230b">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">feedback from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding the
				data required to support the approval, clearance, or licensure of the eligible
				countermeasure involved;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id3756ddf9-b3e4-4ad5-90fe-ce1f782fb2e8">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">feedback from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding the
				data necessary to inform any authorization under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">section 564</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id5e3f14fb-a776-4923-b876-d16e668d5518">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">feedback from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding the
				data necessary to support the positioning and delivery of the eligible
				countermeasure, including to the Strategic National Stockpile;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id0ac66678-bf59-42d2-b4d4-50b0da13253b">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">feedback from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding the
				data necessary to support the submission of protocols for review under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:5/sp:B">section
				505(b)(5)(B)</cato:entity-ref>;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id96bf269d-56f2-461e-927f-5e33a796525d">
                <enum>(E)</enum>
                <text display-inline="yes-display-inline">feedback from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding any
				gaps in scientific knowledge that will need resolution prior to approval,
				licensure, or clearance of the eligible countermeasure and plans for conducting
				the necessary scientific research;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="idc0f19fca-a81e-446d-9b2f-52e2a1fcc2f9">
                <enum>(F)</enum>
                <text display-inline="yes-display-inline">identification of the population for which
				the countermeasure sponsor or applicant seeks approval, licensure, or clearance
				and the population for which desired labeling would not be appropriate, if
				known; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id413a0ebf-d248-4dea-aec8-ee28670db72c">
                <enum>(G)</enum>
                <text display-inline="yes-display-inline">as necessary and appropriate, and to the
				extent practicable, a plan for demonstrating safety and effectiveness in
				pediatric populations, and for developing pediatric dosing, formulation, and
				administration with respect to the eligible countermeasure, provided that such
				plan would not delay authorization under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">section 564</cato:entity-ref>, approval, licensure, or
				clearance for adults.</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id8d7a86b8-5d58-470c-aedf-da88168fccdd">
              <enum>(6)</enum>
              <header display-inline="yes-display-inline">Prioritization</header>
							<subparagraph commented="no" id="ide280fa62-a6f3-4176-a4aa-d537515a65a8">
                <enum>(A)</enum>
                <header>Plans for security
				countermeasures</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall establish regulatory
				management plans for all security countermeasures for which a request is
				submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:3/sp:A" proposed="true">paragraph (3)(A)</cato:entity-ref>.</text>
							</subparagraph>
              <subparagraph commented="no" id="id0f4cf264-4642-48ae-9c34-f9bf1ca0681d">
                <enum>(B)</enum>
                <header>Plans for other
				eligible countermeasures</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall determine whether
				resources are available to establish regulatory management plans for eligible
				countermeasures that are not security countermeasures. If resources are
				available to establish regulatory management plans for eligible countermeasures
				that are not security countermeasures, and if resources are not available to
				establish regulatory management plans for all eligible countermeasures for
				which requests have been submitted, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Biomedical Advanced Research and Development Authority" entity-parent-id="7500">Director of the Biomedical Advanced
				Research and Development Authority</cato:entity-ref>, in consultation with the Commissioner,
				shall prioritize which eligible countermeasures may receive regulatory
				management
				plans.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" display-inline="no-display-inline" id="id3b7476c7-d98f-413f-85ee-83e8df619c63" section-type="subsequent-section">
        <enum>306.</enum>
        <header display-inline="yes-display-inline">Report</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565">Section 565 of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">
              <cato:entity-ref entity-type="uscode" value="usc/21/360bbb–4">21 U.S.C. 360bbb–4</cato:entity-ref>
            </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pandemic and All-Hazards Preparedness Reauthorization Act of 2013/s:305" proposed="true">section 305</cato:entity-ref>, is further
			 amended by adding at the end the following:</text>
				<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idafc68183-eb46-4412-a522-d0be7fb1ccff" reported-display-style="italic" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="idf159d0d0-8b42-4425-934e-737c47ccb74d">
            <enum>(g)</enum>
            <header display-inline="yes-display-inline">Annual report</header>
            <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, and annually thereafter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall make
				publicly available on the Web site of the Food and Drug Administration a report
				that details the countermeasure development and review activities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food
				and Drug Administration</cato:entity-ref>, including—</text>
						<paragraph commented="no" display-inline="no-display-inline" id="id46fa74f2-a96c-435d-83e9-d22d3b055d86">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">with respect to the development of new
				tools, standards, and approaches to assess and evaluate countermeasures—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="idd34170a3-aa23-4f69-86cd-9b3935475c4b">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">the identification of the priorities of the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> and the progress made on such priorities;
				and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id8c4c1f06-15ce-4321-ad8a-d35f42650969">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">the identification of scientific gaps that
				impede the development, approval, licensure, or clearance of countermeasures
				for populations with special clinical needs, including children and pregnant
				women, and the progress made on resolving these challenges;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="iddeb91dc2-ec2a-43cb-a643-b30ba8d24456">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">with respect to countermeasures for which a
				regulatory management plan has been agreed upon under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f" proposed="true">subsection (f)</cato:entity-ref>, the
				extent to which the performance targets and goals set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:4/sp:B" proposed="true">subsection
				(f)(4)(B)</cato:entity-ref> and the regulatory management plan have been met, including, for each
				such countermeasure—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="id9b6fdbde-5483-4988-9839-0f73a83113a7">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">whether the regulatory management plan was
				completed within the required timeframe, and the length of time taken to
				complete such plan;</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id2f79b9b6-1306-4534-911a-74cb3b220f07">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">whether the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> adhered to the timely
				and appropriate response times set forth in such plan; and</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id278bfe55-1f18-44d5-993b-1edbb2adad65">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">explanations for any failure to meet such
				performance targets and goals;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="ida7d835ac-56b0-4fc5-9534-862daaae296f">
              <enum>(3)</enum>
              <text display-inline="yes-display-inline">the number of regulatory teams established
				pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:b/p:4" proposed="true">subsection (b)(4)</cato:entity-ref>, the number of products, classes of products, or
				technologies assigned to each such team, and the number of, type of, and any
				progress made as a result of consultations carried out under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:b/p:4/sp:A" proposed="true">subsection
				(b)(4)(A)</cato:entity-ref>;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="ide6d9302e-028b-4173-b65d-a2417fb376d7">
              <enum>(4)</enum>
              <text display-inline="yes-display-inline">an estimate of resources obligated to
				countermeasure development and regulatory assessment, including—</text>
							<subparagraph id="id8c3b263f-28e5-4fc5-81d3-722c0126867f">
                <enum>(A)</enum>
                <text>Center-specific
				objectives and accomplishments; and</text>
							</subparagraph>
              <subparagraph id="idf372c317-2856-4e78-8899-86ded5de2cec">
                <enum>(B)</enum>
                <text>the number of full-time
				equivalent employees of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> who directly support
				the review of countermeasures;</text>
							</subparagraph>
            </paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id9da8f472-988a-4308-8be9-0208a8b0ff07">
              <enum>(5)</enum>
              <text display-inline="yes-display-inline">the number of countermeasure applications
				and submissions submitted, the number of countermeasures approved, licensed, or
				cleared, the status of remaining submitted applications and submissions, and
				the number of each type of authorization issued pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564">section 564</cato:entity-ref>;</text>
						</paragraph>
            <paragraph commented="no" display-inline="no-display-inline" id="id5a218202-a380-4d8d-805b-4455dd099a5d">
              <enum>(6)</enum>
              <text display-inline="yes-display-inline">the number of written requests for a
				regulatory management plan submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:f/p:3/sp:A" proposed="true">subsection (f)(3)(A)</cato:entity-ref>, the number of
				regulatory management plans developed, and the number of such plans developed
				for security countermeasures; and</text>
						</paragraph>
            <paragraph commented="no" id="id02843be3-711b-40b2-8319-98b3a18e1ed1">
              <enum>(7)</enum>
              <text>the number, type, and
				frequency of meetings between the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> and—</text>
							<subparagraph id="id5b1561cb-d420-4e99-affa-0e6eeb4828c3">
                <enum>(A)</enum>
                <text>sponsors of a
				countermeasure as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:a" proposed="true">subsection (a)</cato:entity-ref>; or</text>
							</subparagraph>
              <subparagraph commented="no" display-inline="no-display-inline" id="id02cb3bed-f9e0-42f4-b419-7c7d4fa93489">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">another agency engaged in development or
				management of portfolios for such countermeasures, including the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for
				Disease Control and Prevention</cato:entity-ref>, the Biomedical Advanced Research and
				Development Authority, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref>, and the appropriate
				agencies of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of
				Defense</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</section>
      <section commented="no" id="idd5bd4380-ac36-4166-8878-3d42ab3c1519">
        <enum>307.</enum>
        <header>Pediatric medical
			 countermeasures</header>
				<subsection commented="no" display-inline="no-display-inline" id="id3ff763d3-c1b4-488a-9928-b793677f1cec">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Pediatric studies of drugs</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505A">Section 505A of the Federal Food, Drug, and
			 Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355a">
                <cato:entity-ref entity-type="uscode" value="usc/21/355a">21 U.S.C. 355a</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id95fcb8d4-4682-4c5b-b984-0507cd2b8374">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505A/ss:d">subsection (d)</cato:entity-ref>, by adding at the end the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id360916aa-bf48-4dc3-a5e7-d54bea554c02" reported-display-style="italic" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="idfbcbb3dc-0ea5-4658-b8b1-ae635c886fbf">
                <enum>(5)</enum>
                <header display-inline="yes-display-inline">Consultation</header>
                <text display-inline="yes-display-inline">With respect to a drug that is a qualified
				countermeasure (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1 of the Public Health Service Act</cato:entity-ref>),
				a security countermeasure (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public Health
				Service Act</cato:entity-ref>), or a qualified pandemic or epidemic product (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section 319F–3 of the Public Health Service Act</cato:entity-ref>), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall solicit
				input from the Assistant Secretary for Preparedness and Response regarding the
				need for and, from the Director of the Biomedical Advanced Research and
				Development Authority regarding the conduct of, pediatric studies under this
				section.</text>
							</paragraph>
              <after-quoted-block>;
				and</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id90d4c6e9-d9db-4cf4-a1c7-a6487bd19e56">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505A/ss:n/p:1">subsection (n)(1)</cato:entity-ref>, by adding at the end
			 the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id796b00ee-f8e3-47f0-a513-7239d910f29f" reported-display-style="italic" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="id6c1b482d-00b6-4f08-b0d5-b77ee4fca5a1">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">For a drug that is a qualified
				countermeasure (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1 of the Public Health Service Act</cato:entity-ref>),
				a security countermeasure (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2 of the Public Health
				Service Act</cato:entity-ref>), or a qualified pandemic or epidemic product (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section 319F–3 of such Act</cato:entity-ref>), in addition to any action with respect to such
				drug under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505A/ss:n/p:1/sp:A">subparagraph (A)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505A/ss:n/p:1/sp:B">(B)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall notify the Assistant
				Secretary for Preparedness and Response and the Director of the Biomedical
				Advanced Research and Development Authority of all pediatric studies in the
				written request issued by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and
				Drugs</cato:entity-ref>.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id32c91899-aacb-4443-97d4-0681344674e6">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Addition to priority list
			 considerations</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:409I">Section 409I
			 of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/284m">
                <cato:entity-ref entity-type="uscode" value="usc/42/284m">42 U.S.C. 284m</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="idd583b138-f896-4491-a9db-69563b4c6890">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:409I/ss:a/p:2">subsection (a)(2)</cato:entity-ref> and inserting
			 the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idbade238e-12c5-4b47-b8ff-4bc54675d7b4" reported-display-style="italic" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="id64000c09-9112-4f0c-802d-7342d96c7a60">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Consideration of available
				information</header>
                <text display-inline="yes-display-inline">In developing and
				prioritizing the list under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:409I/ss:a/p:1">paragraph (1)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ida295b435-d893-42a1-bf9b-cecf25fdb254">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">shall consider—</text>
									<clause commented="no" display-inline="no-display-inline" id="ide45dc387-3e29-41e7-a57c-242319288e5a">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">therapeutic gaps in pediatrics that may
				include developmental pharmacology, pharmacogenetic determinants of drug
				response, metabolism of drugs and biologics in children, and pediatric clinical
				trials;</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="id9d02d4e7-fac1-4cea-900c-27e36df5266e">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">particular pediatric diseases, disorders or
				conditions where more complete knowledge and testing of therapeutics, including
				drugs and biologics, may be beneficial in pediatric populations; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="id84cbb7ed-8a58-4bea-86e0-dee93636d5c8">
                    <enum>(iii)</enum>
                    <text display-inline="yes-display-inline">the adequacy of necessary infrastructure to
				conduct pediatric pharmacological research, including research networks and
				trained pediatric investigators; and</text>
									</clause>
                </subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="ide632ab85-ebf6-4424-8421-16101909927f">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">may consider the availability of qualified
				countermeasures (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1">section 319F–1</cato:entity-ref>), security countermeasures (as
				defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2">section 319F–2</cato:entity-ref>), and qualified pandemic or epidemic products (as
				defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3">section 319F–3</cato:entity-ref>) to address the needs of pediatric populations, in
				consultation with the Assistant Secretary for Preparedness and Response,
				consistent with the purposes of this
				section.</text>
								</subparagraph>
              </paragraph>
              <after-quoted-block>; and
				</after-quoted-block>
            </quoted-block>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="ida3fe332f-06be-433a-9a83-7cf19b9fca64">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:409I/ss:b">subsection (b)</cato:entity-ref>, by striking
			 <quote>subsection (a)</quote> and inserting <quote>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:409I/ss:a/p:1">paragraphs (1)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:409I/ss:a/p:2/sp:A" proposed="true">(2)(A) of
			 subsection (a)</cato:entity-ref>
              </quote>.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="idd41e8ad6-6bb0-4a0f-b408-72b1cb0e639c">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Advice and recommendations of the pediatric
			 advisory committee regarding countermeasures for pediatric
			 populations</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Best Pharmaceuticals for Children Act/s:14/ss:b/p:2">Subsection (b)(2)
			 of section 14 of the Best Pharmaceuticals for Children Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/284m/note">42 U.S.C. 284m
			 note</cato:entity-ref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="idacc888f7-a310-499b-9015-423cbe5a2cb4">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Best Pharmaceuticals for Children Act/s:14/ss:b/p:2/sp:C">subparagraph (C)</cato:entity-ref>, by striking the period
			 and inserting <quote>; and</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="idbf881a5c-a12d-4c00-b5d1-86a05a47c668">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idffeee79a-2693-4cb6-a564-135a4d052826" reported-display-style="italic" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="id1ce9003e-2713-468d-8fe9-7e38230bde39">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">the development of countermeasures (as
				defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:565/ss:a" proposed="true">section 565(a) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>) for
				pediatric
				populations.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
    </title>
    <title changed="added" committee-id="SSHR00" id="id39e5ce1b-d564-473e-bcb0-a30c1ee6a26f" reported-display-style="italic">
      <enum>IV</enum>
      <header>Accelerating medical
			 countermeasure advanced research and development</header>
			<section commented="no" display-inline="no-display-inline" id="id7d37b773-64ec-49fa-a285-b1f82e51fefb" section-type="subsequent-section">
        <enum>401.</enum>
        <header display-inline="yes-display-inline">BioShield</header>
				<subsection commented="no" display-inline="no-display-inline" id="id331482f5-b1ca-4965-96a4-78c67b9807c2">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Procurement of
			 countermeasures</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–2/ss:c">Section
			 319F–2(c) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–6b/c">42 U.S.C. 247d–6b(c)</cato:entity-ref>)</cato:entity> is
			 amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="id71d57948-1caf-4498-b001-36d91e99f343">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:1/sp:B/cl:i/scl:III/i:bb">paragraph (1)(B)(i)(III)(bb)</cato:entity-ref>, by
			 striking <quote>eight years</quote> and inserting <quote>10
			 years</quote>;</text>
					</paragraph>
          <paragraph id="id607595ba-f751-4f5e-b62d-07f3fb457bd7">
            <enum>(2)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:2/sp:C">paragraph (2)(C)</cato:entity-ref>, by
			 striking <quote>the designated congressional committees (as defined in
			 paragraph (10))</quote> and inserting <quote>the appropriate committees of
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>
              </quote>;</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="idc87f40af-589c-46f4-921b-3559717b4ef2">
            <enum>(3)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:5/sp:B/cl:ii">paragraph (5)(B)(ii)</cato:entity-ref>, by striking
			 <quote>eight years</quote> and inserting <quote>10 years</quote>;</text>
					</paragraph>
          <paragraph id="idd6ec6901-461b-4d61-975d-48a077acd3bd">
            <enum>(4)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:6/sp:C">subparagraph (C) of
			 paragraph (6)</cato:entity-ref>—</text>
						<subparagraph id="idc32532fa-7713-4327-a4b0-3c668983a4d6">
              <enum>(A)</enum>
              <text>in the subparagraph
			 heading, by striking <quote>
                  <header-in-text level="subparagraph" style="OLC">designated congressional committees</header-in-text>
                </quote> and
			 inserting <quote>
                  <header-in-text level="subparagraph" style="OLC">appropriate
			 congressional committees</header-in-text>
                </quote>; and</text>
						</subparagraph>
            <subparagraph id="id38eee277-4535-4529-9559-7cebd47f5dea">
              <enum>(B)</enum>
              <text>by striking <quote>the
			 designated congressional committees</quote> and inserting <quote>the
			 appropriate congressional committees</quote>; and</text>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id19bd8a3e-aafb-4b38-b2c9-5e217d3d2970">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C">paragraph (7)(C)</cato:entity-ref>—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id706d02a2-78c1-46f8-aa91-1f321dd87357">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:i/scl:I">clause (i)(I)</cato:entity-ref>, by inserting
			 <quote>including advanced research and development,</quote> after <quote>as may
			 reasonably be required,</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="iddecbfd8e-7c05-40b3-b0ab-355fbb66b6fd">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:ii">clause (ii)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id57d44e4a-17bb-4107-88e0-44b84839790a">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:ii/scl:III">subclause (III)</cato:entity-ref>, by striking
			 <quote>eight years</quote> and inserting <quote>10 years</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id711e137f-feb4-4ef4-8a85-6e4065b89e15">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7/sp:C/cl:ii/scl:IX">subclause (IX)</cato:entity-ref> and inserting
			 the following:</text>
								<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id4e8423e2-e22b-4d90-9285-3bf55b663d9a" reported-display-style="italic" style="OLC">
									<subclause commented="no" display-inline="no-display-inline" id="ida6cf928d-11f2-46f2-a3af-22819e74d905">
                    <enum>(IX)</enum>
                    <header display-inline="yes-display-inline">Contract
				terms</header>
                    <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in any
				contract for procurement under this section—</text>
										<item commented="no" display-inline="no-display-inline" id="id8adbbe69-d1be-4f17-a89e-76e42c510d57">
                      <enum>(aa)</enum>
                      <text display-inline="yes-display-inline">may specify—</text>
											<subitem commented="no" display-inline="no-display-inline" id="id16109a19-76c5-416c-adc4-e1655ca9df80">
                        <enum>(AA)</enum>
                        <text display-inline="yes-display-inline">the dosing and administration requirements
				for the countermeasure to be developed and procured;</text>
											</subitem>
                      <subitem commented="no" display-inline="no-display-inline" id="id906d32a7-305c-4518-ba07-4bed34b890b5">
                        <enum>(BB)</enum>
                        <text display-inline="yes-display-inline">the amount of funding that will be
				dedicated by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> for advanced research, development, and procurement
				of the countermeasure; and</text>
											</subitem>
                      <subitem commented="no" display-inline="no-display-inline" id="idd3d9fd24-e496-483c-9cb6-95b360243434">
                        <enum>(CC)</enum>
                        <text display-inline="yes-display-inline">the specifications the countermeasure must
				meet to qualify for procurement under a contract under this section; and</text>
											</subitem>
                    </item>
                    <item commented="no" display-inline="no-display-inline" id="id7228fca5-d7f2-4823-827e-2570685240a8">
                      <enum>(bb)</enum>
                      <text display-inline="yes-display-inline">shall provide a clear statement of defined
				Government purpose limited to uses related to a security countermeasure, as
				defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:1/sp:B">paragraph (1)(B)</cato:entity-ref>.</text>
										</item>
                  </subclause>
                  <after-quoted-block>;
				and</after-quoted-block>
                </quoted-block>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id690e1516-babf-4df7-b944-94c2742a2068">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idd4bb2b6f-73dd-4839-a390-125462f2360a" reported-display-style="italic" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="id06776f91-f962-492c-8041-19ff49373ce8">
                  <enum>(viii)</enum>
                  <header display-inline="yes-display-inline">Flexibility</header>
                  <text display-inline="yes-display-inline">In carrying out this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				may, consistent with the applicable provisions of this section, enter into
				contracts and other agreements that are in the best interest of the Government
				in meeting identified security countermeasure needs, including with respect to
				reimbursement of the cost of advanced research and development as a reasonable,
				allowable, and allocable direct cost of the contract
				involved.</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
        </subsection>
        <subsection commented="no" id="id4739c26a-8791-40e7-83e8-4b1a40bf8e2b">
          <enum>(b)</enum>
          <header>Reauthorization of the
			 special reserve fund</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–2">Section 319F–2 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6b">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–6b">42 U.S.C. 247d–6b</cato:entity-ref>
              </external-xref>)</cato:entity> is amended—</text>
					<paragraph id="id19b07852-2027-40a8-b81a-2310bf55666b">
            <enum>(1)</enum>
            <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c">subsection (c)</cato:entity-ref>—</text>
						<subparagraph id="id262deaa4-76d1-492f-bf4f-339e8843a05a">
              <enum>(A)</enum>
              <text>by striking
			 <quote>special reserve fund under paragraph (10)</quote> each place it appears
			 and inserting <quote>special reserve fund as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:h">subsection (h)</cato:entity-ref>
                </quote>;
			 and</text>
						</subparagraph>
            <subparagraph commented="no" id="id3b18fd89-2415-4927-a938-39e1aa1c6351">
              <enum>(B)</enum>
              <text>by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:9">paragraphs
			 (9)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:10">(10)</cato:entity-ref>; and</text>
						</subparagraph>
          </paragraph>
          <paragraph id="id272bb88e-35e6-4640-8004-a101a295bee7">
            <enum>(2)</enum>
            <text>by adding at the end the
			 following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idae36e4a5-84bd-43ff-bfd6-34a8b10e7b0b" reported-display-style="italic" style="OLC">
							<subsection commented="no" id="id7126cfcd-c504-41fa-8f24-4195f3fc04e5">
                <enum>(g)</enum>
                <header>Special reserve
				fund</header>
								<paragraph id="id8606a0ad-73d0-45d9-9f26-162f6aca1c40">
                  <enum>(1)</enum>
                  <header>Authorization of
				appropriations</header>
                  <text display-inline="yes-display-inline">
                    <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">In addition to
				amounts appropriated to the special reserve fund prior to the date of the
				enactment of this subsection, there is authorized to be appropriated, <cato:property name="purpose">for the
				procurement of security countermeasures under <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–2/ss:c">subsection (c)</cato:entity-ref> and for carrying
				out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref> (relating to the Biomedical Advanced Research and Development
				Authority)</cato:property>, <cato:funds-and-year amount="2800000000" year="2014, 2015, 2016, 2017, 2018">$2,800,000,000 for the period of fiscal years 2014 through 2018</cato:funds-and-year>.
				Amounts appropriated pursuant to the preceding sentence are authorized to
				remain available until September 30, 2019.</cato:entity>
                  </text>
								</paragraph>
                <paragraph commented="no" id="id9f8c2857-e9e0-4d26-be44-d7391da82e2c">
                  <enum>(2)</enum>
                  <header>Use of special reserve
				fund for advanced research and development</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may utilize not more than 50
				percent of the amounts authorized to be appropriated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:g/p:1" proposed="true">paragraph (1)</cato:entity-ref> to
				carry out <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref> (related to the Biomedical Advanced Research and
				Development Authority). Amounts authorized to be appropriated under this
				subsection to carry out <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref> are in addition to amounts otherwise
				authorized to be appropriated to carry out such section.</text>
								</paragraph>
                <paragraph commented="no" id="id02489f4b-7b04-4912-9b3b-58bb07892640">
                  <enum>(3)</enum>
                  <header>Restrictions on use of
				funds</header>
                  <text>Amounts in the special reserve fund shall not be used to
				pay costs other than payments made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to a vendor for advanced
				development (under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L">section 319L</cato:entity-ref>) or for procurement of a security
				countermeasure under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:c/p:7">subsection (c)(7)</cato:entity-ref>.</text>
								</paragraph>
                <paragraph commented="no" display-inline="no-display-inline" id="id5aa42856-fdac-4c79-9a9a-e68dc56bfe6c">
                  <enum>(4)</enum>
                  <header display-inline="yes-display-inline">Report</header>
                  <text display-inline="yes-display-inline">Not later than 30 days after any date on
				which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines that the amount of funds in the special reserve
				fund available for procurement is less than $1,500,000,000, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall
				submit to the appropriate committees of Congress a report detailing the amount
				of such funds available for procurement and the impact such reduction in
				funding will have—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="id9854908e-4ebe-40e5-aa80-d0e11eef61f2">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">in meeting the security countermeasure
				needs identified under this section; and</text>
									</subparagraph>
                  <subparagraph commented="no" display-inline="no-display-inline" id="id7797a98a-18f3-4def-8e1c-2e6e19ea12b1">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">on the annual Public Health Emergency
				Medical Countermeasures Enterprise and Strategy Implementation Plan (pursuant
				to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811/ss:d" proposed="true">section 2811(d)</cato:entity-ref>).</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection commented="no" id="id06f69307-b5ea-4aa2-a659-91961e72a40e">
                <enum>(h)</enum>
                <header>Definitions</header>
                <text>In
				this section:</text>
								<paragraph commented="no" id="idb385c23f-bb24-4a0e-89e6-1b97750cd37c">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">The term <term>advanced research and
				development</term> has the meaning given such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L/ss:a">section 319L(a)</cato:entity-ref>.</text>
								</paragraph>
                <paragraph commented="no" id="id29bbd315-8f31-4ea0-992e-d43874742132">
                  <enum>(2)</enum>
                  <text>The term <term>special
				reserve fund</term> means the <term>Biodefense Countermeasures</term>
				appropriations account, any appropriation made available pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Homeland Security Act of 2002/s:521/ss:a">section
				521(a) of the Homeland Security Act of 2002</cato:entity-ref>, and any appropriation made
				available pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F-2/ss:g/p:1" proposed="true">subsection
				(g)(1)</cato:entity-ref>.</text>
								</paragraph>
              </subsection>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="idb59a2bca-7bc6-415a-be95-0a30502ac0c0" section-type="subsequent-section">
        <enum>402.</enum>
        <header display-inline="yes-display-inline">Biomedical Advanced Research and
			 Development Authority</header>
				<subsection commented="no" display-inline="no-display-inline" id="id365fe9ea-fc69-4a33-9ce2-c0f6f818155d">
          <enum>(a)</enum>
          <header display-inline="yes-display-inline">Duties</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L/ss:c/p:4">Section 319L(c)(4) of the Public Health
			 Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–7e/c/4">42 U.S.C. 247d–7e(c)(4)</cato:entity-ref>)</cato:entity> is amended—</text>
					<paragraph commented="no" display-inline="no-display-inline" id="idc16614aa-bf80-40de-994e-01a3eb7cb3b7">
            <enum>(1)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L/ss:c/p:4/sp:B/cl:iii">subparagraph (B)(iii)</cato:entity-ref>, by inserting
			 <quote>(which may include advanced research and development for purposes of
			 fulfilling requirements under the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref> or
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351">section 351 of this Act</cato:entity-ref>)</quote> after <quote>development</quote>; and</text>
					</paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id0bdab644-69f1-44cf-b4a8-f1953c8b9ed5">
            <enum>(2)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L/ss:c/p:4/sp:D/cl:iii">subparagraph (D)(iii)</cato:entity-ref>, by striking
			 <quote>and vaccine manufacturing technologies</quote> and inserting
			 <quote>vaccine-manufacturing technologies, dose-sparing technologies,
			 efficacy-increasing technologies, and platform technologies</quote>.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id764a9ad2-f19c-4da2-92ee-b16f6d141041">
          <enum>(b)</enum>
          <header display-inline="yes-display-inline">Transaction authorities</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L/ss:c/p:5">Section 319L(c)(5) of the Public Health
			 Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–7e/c/5">42 U.S.C. 247d–7e(c)(5)</cato:entity-ref>)</cato:entity> is amended by adding at the end the
			 following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id1b3a0ad0-24d6-4c5b-858a-a531d82677de" reported-display-style="italic" style="OLC">
						<subparagraph commented="no" display-inline="no-display-inline" id="id6ebf3690-4e9f-4f72-910f-2b43eebe6a01">
              <enum>(G)</enum>
              <header display-inline="yes-display-inline">Government purpose</header>
              <text display-inline="yes-display-inline">In awarding contracts, grants, and
				cooperative agreements under this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall provide a clear
				statement of defined Government purpose related to activities included in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L/ss:a/p:6/sp:B">subsection (a)(6)(B)</cato:entity-ref> for a qualified countermeasure or qualified pandemic or
				epidemic
				product.</text>
						</subparagraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="idf4c756de-2a9d-4cc2-aafa-5a6c45a3ef7f">
          <enum>(c)</enum>
          <header display-inline="yes-display-inline">Fund</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L/ss:d/p:2">Paragraph (2) of section 319L(d) of the
			 Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–7e/d/2">42 U.S.C. 247d–7e(d)(2)</cato:entity-ref>)</cato:entity> is amended to read as
			 follows:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id1cef4551-d147-473d-97ef-ed2cb1e4b7ea" reported-display-style="italic" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="idaffbff2d-e674-4ac3-859a-413f35b6eaba">
              <enum>(2)</enum>
              <header display-inline="yes-display-inline">Funding</header>
              <text display-inline="yes-display-inline">
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                  <cato:property name="purpose">To carry out the purposes of <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L">this section</cato:entity-ref>
                  </cato:property>,
				there is authorized to be appropriated to the Fund <cato:funds-and-year amount="415000000" year="2014, 2015, 2016, 2017, 2018">$415,000,000 for each of
				fiscal years 2014 through 2018, such amounts to remain available until
				expended</cato:funds-and-year>.</cato:entity>
              </text>
						</paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id6701ace1-68f2-4e99-bb68-7f3cff849ea4">
          <enum>(d)</enum>
          <header display-inline="yes-display-inline">Continued Inapplicability of Certain
			 Provisions</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L/ss:e/p:1/sp:C">Section
			 319L(e)(1)(C) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–7e/e/1/C">42 U.S.C. 247d–7e(e)(1)(C)</cato:entity-ref>)</cato:entity> is
			 amended by striking <quote>7 years</quote> and inserting <quote>12
			 years</quote>.</text>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id88b4eb1b-805c-4ae6-97ba-03c2a90596ee">
          <enum>(e)</enum>
          <header display-inline="yes-display-inline">Extension of limited antitrust
			 exemption</header>
					<paragraph id="id7c855273-f72f-48ac-b092-42b4282d4b5b">
            <enum>(1)</enum>
            <header>In
			 general</header>
            <text>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Pandemic and All-Hazards Preparedness Act/s:405/ss:b">Section 405(b) of the Pandemic and All-Hazards
			 Preparedness Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–6a/note">42 U.S.C. 247d–6a note</cato:entity-ref>)</cato:entity> is amended by striking
			 <quote>6-year</quote> and inserting <quote>12-year</quote>.</text>
					</paragraph>
          <paragraph id="id106b96a7-cc29-45eb-90d8-38913a84e56c">
            <enum>(2)</enum>
            <header>Effective
			 date</header>
            <text>This subsection shall take effect as if enacted on December
			 17, 2012.</text>
					</paragraph>
        </subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id2a4fb0b4-25e3-45c6-badb-531bad6a5ba8">
          <enum>(f)</enum>
          <header display-inline="yes-display-inline">Independent evaluation</header>
          <text display-inline="yes-display-inline">
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319L">Section 319L of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-7e">
                <cato:entity-ref entity-type="uscode" value="usc/42/247d–7e">42 U.S.C. 247d–7e</cato:entity-ref>
              </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idb9a104e9-d720-49d4-acf0-d2d03c036b2f" reported-display-style="italic" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="ideb13d5d5-2216-498b-bbd0-4746990ff5bc">
              <enum>(f)</enum>
              <header display-inline="yes-display-inline">Independent evaluation</header>
							<paragraph commented="no" display-inline="no-display-inline" id="id3f7de760-b952-49a6-82f9-3a1d7459df59">
                <enum>(1)</enum>
                <header display-inline="yes-display-inline">In general</header>
                <text display-inline="yes-display-inline">Not later than 180 days after the date of
				enactment of this subsection, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General of the United States</cato:entity-ref>
				shall conduct an independent evaluation of the activities carried out to
				facilitate flexible manufacturing capacity pursuant to this section.</text>
							</paragraph>
              <paragraph commented="no" display-inline="no-display-inline" id="idd08b240f-55fe-4d6d-a473-0bb36d8e05a5">
                <enum>(2)</enum>
                <header display-inline="yes-display-inline">Report</header>
                <text display-inline="yes-display-inline">Not later than 1 year after the date of
				enactment of this subsection, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General of the United States</cato:entity-ref>
				shall submit to the appropriate committees of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report concerning the
				results of the evaluation conducted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319L/ss:f/p:1" proposed="true">paragraph (1)</cato:entity-ref>. Such report shall
				review and assess—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="id462c4065-ed44-4a82-8be0-ec0c7e310035">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">the extent to which flexible manufacturing
				capacity under this section is dedicated to chemical, biological, radiological,
				and nuclear threats;</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="idba0395bb-0025-40a8-b6c5-ae165f0543c4">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">the activities supported by flexible
				manufacturing initiatives; and</text>
								</subparagraph>
                <subparagraph commented="no" display-inline="no-display-inline" id="ide108d05b-dbb7-4628-a95d-b10de6d5caf4">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">the ability of flexible manufacturing
				activities carried out under this section to—</text>
									<clause commented="no" display-inline="no-display-inline" id="idf503dbcf-43c2-4084-b2e8-0baf3fed0e8e">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">secure and leverage leading technical
				expertise with respect to countermeasure advanced research, development, and
				manufacturing processes; and</text>
									</clause>
                  <clause commented="no" display-inline="no-display-inline" id="ide0092641-6fd5-4e85-8f49-39616e1af783">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">meet the surge manufacturing capacity needs
				presented by novel and emerging threats, including chemical, biological,
				radiological, and nuclear
				agents.</text>
									</clause>
                </subparagraph>
              </paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</subsection>
        <subsection commented="no" display-inline="no-display-inline" id="id9f978055-a28c-4629-b078-7edd7fbb0f49">
          <enum>(g)</enum>
          <header display-inline="yes-display-inline">Definitions</header>
					<paragraph commented="no" display-inline="no-display-inline" id="idd702517b-750f-4357-9f0d-7595697075d3">
            <enum>(1)</enum>
            <header display-inline="yes-display-inline">Qualified countermeasure</header>
            <text display-inline="yes-display-inline">
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A">Section 319F–1(a)(2)(A) of the Public
			 Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–6a/a/2/A">42 U.S.C. 247d–6a(a)(2)(A)</cato:entity-ref>)</cato:entity> is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="idbc63e4f8-a48d-46a6-a229-619f9caf288b">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in the matter preceding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A/cl:i">clause (i)</cato:entity-ref>, by
			 striking <quote>to—</quote> and inserting <quote>—</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id8700c74d-c8aa-4299-86ca-2d7fd9a87531">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A/cl:i">clause (i)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id79671473-4fd8-4c28-a376-ce97181052ea">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <quote>diagnose</quote> and
			 inserting <quote>to diagnose</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id1d646c2b-4926-4dca-a944-abb98c6b9913">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking <quote>; or</quote> and
			 inserting a semicolon;</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id1aede926-73aa-49cb-ba95-8ba1e665ae68">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A/cl:ii">clause (ii)</cato:entity-ref>—</text>
							<clause commented="no" display-inline="no-display-inline" id="id68b16c94-3c05-4777-af12-6af07a3686cb">
                <enum>(i)</enum>
                <text display-inline="yes-display-inline">by striking <quote>diagnose</quote> and
			 inserting <quote>to diagnose</quote>; and</text>
							</clause>
              <clause commented="no" display-inline="no-display-inline" id="id9f4f1060-7196-44f1-bbb8-7e59788f944e">
                <enum>(ii)</enum>
                <text display-inline="yes-display-inline">by striking the period at the end and
			 inserting <quote>; or</quote>; and</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idd3c603a5-96a6-41df-8f61-5f87cba0df13">
              <enum>(D)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id503c41e4-3abc-4048-a0af-2edfafb5fa61" reported-display-style="italic" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="id4b21d40d-a788-45c8-8370-e97fd61f714c">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">is a product or technology intended to
				enhance the use or effect of a drug, biological product, or device described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A/cl:i">clause (i)</cato:entity-ref> or
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–1/ss:a/p:2/sp:A/cl:ii">(ii)</cato:entity-ref>.</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id16f0b693-cd43-410c-a930-25881ed4dbf3">
            <enum>(2)</enum>
            <header display-inline="yes-display-inline">Qualified pandemic or epidemic
			 product</header>
            <text display-inline="yes-display-inline">
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:A">Section
			 319F–3(i)(7)(A) of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–6d/i/7/A">42 U.S.C. 247d–6d(i)(7)(A)</cato:entity-ref>)</cato:entity>
			 is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="id081972d2-8403-4753-bd3f-5d2868b08a13">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:A/cl:i/scl:II">clause (i)(II)</cato:entity-ref>, by striking <quote>;
			 or</quote> and inserting <quote>;</quote>;</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idd47a699a-a6e5-4c6d-9878-d9d805f8ea33">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:A/cl:ii">clause (ii)</cato:entity-ref>, by striking <quote>;
			 and</quote> and inserting <quote>; or</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="idc494e09b-1a3d-4d6c-bef4-95c39748aed9">
              <enum>(C)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id1d3696f7-a054-44c8-bf64-343ec6c2942a" reported-display-style="italic" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="id57748aa1-7d9f-4216-b6d0-cf1fb74e644e">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">a product or technology intended to enhance
				the use or effect of a drug, biological product, or device described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:A/cl:i">clause
				(i)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:A/cl:ii">(ii)</cato:entity-ref>;
				and</text>
								</clause>
                <after-quoted-block>.</after-quoted-block>
              </quoted-block>
						</subparagraph>
          </paragraph>
          <paragraph commented="no" display-inline="no-display-inline" id="id3ee0023f-7739-49f3-a5d7-be61b1e025a1">
            <enum>(3)</enum>
            <header display-inline="yes-display-inline">Technical amendments</header>
            <text display-inline="yes-display-inline">
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–3/ss:i">Section 319F–3(i) of the Public Health
			 Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–6d/i">42 U.S.C. 247d–6d(i)</cato:entity-ref>)</cato:entity> is amended—</text>
						<subparagraph commented="no" display-inline="no-display-inline" id="idc5ee0829-610f-40e4-ba08-519c040f77a1">
              <enum>(A)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:1/sp:C">paragraph (1)(C)</cato:entity-ref>, by inserting <quote>,
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A" proposed="true">564A</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564B" proposed="true">564B</cato:entity-ref>
                </quote> after <quote>564</quote>; and</text>
						</subparagraph>
            <subparagraph commented="no" display-inline="no-display-inline" id="id86439c28-56f1-4380-b24f-88048c5301ad">
              <enum>(B)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–3/ss:i/p:7/sp:B/cl:iii">paragraph (7)(B)(iii)</cato:entity-ref>, by inserting
			 <quote>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564A" proposed="true">564A</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:564B" proposed="true">564B</cato:entity-ref>
                </quote> after <quote>564</quote>.</text>
						</subparagraph>
          </paragraph>
        </subsection>
      </section>
      <section commented="no" display-inline="no-display-inline" id="id16708ad4-9771-4e74-aedc-3456f4c7cea1" section-type="subsequent-section">
        <enum>403.</enum>
        <header display-inline="yes-display-inline">Strategic National Stockpile</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–2">Section 319F–2 of the Public Health Service
			 Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-6b">
              <cato:entity-ref entity-type="uscode" value="usc/42/247d–6b">42 U.S.C. 247d–6b</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="id968f1410-64f3-4150-8922-68bf2382646d">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:a">subsection (a)</cato:entity-ref>—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="id66bd091f-3e83-4331-ab07-7e0468f62c3a">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:a/p:1">paragraph (1)</cato:entity-ref>—</text>
						<clause commented="no" display-inline="no-display-inline" id="id4a072820-c084-4423-b64e-57759c2e1608">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">by inserting <quote>consistent with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2811">section
			 2811</cato:entity-ref>
                </quote> before <quote>by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> to be appropriate</quote>;
			 and</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="idd5d4935a-f794-4a55-87e3-4c0616eeb228">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">by inserting before the period at the end
			 of the second sentence the following: <quote>and shall submit such review
			 annually to the appropriate congressional committees of jurisdiction to the
			 extent that disclosure of such information does not compromise national
			 security</quote>; and</text>
						</clause>
          </subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="idc6d6c52e-240e-41e2-afc1-a02c6bce1dcb">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:a/p:2/sp:D">paragraph (2)(D)</cato:entity-ref>, by inserting before
			 the semicolon at the end the following: <quote>and that the potential depletion
			 of countermeasures currently in the stockpile is identified and appropriately
			 addressed, including through necessary replenishment</quote>; and</text>
					</subparagraph>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="id509b9373-1ef8-409c-a918-d74ae3d9afab">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319F–2/ss:f/p:1">subsection (f)(1)</cato:entity-ref>, by striking
			 <quote>$640,000,000 for fiscal year 2002, and such sums as may be necessary for
			 each of fiscal years 2003 through 2006. Such authorization is in addition to
			 amounts in the special reserve fund referred to in subsection
			 (c)(10)(A).</quote> and inserting <quote>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
                <cato:funds-and-year amount="533800000" year="2014, 2015, 2016, 2017, 2018">$533,800,000 for each of fiscal years
			 2014 through 2018</cato:funds-and-year>. Such authorization is in addition to amounts in the special
			 reserve fund referred to in <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319F–2/ss:h">subsection (h)</cato:entity-ref>.</cato:entity>
            </quote>.</text>
				</paragraph>
      </section>
      <section commented="no" display-inline="no-display-inline" id="ide59d9673-0287-44af-aa30-1aecf2e143f3" section-type="subsequent-section">
        <enum>404.</enum>
        <header display-inline="yes-display-inline">National Biodefense Science
			 Board</header>
        <text display-inline="no-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319M/ss:a">Section 319M(a) of the
			 Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/247d–f/a">42 U.S.C. 247d–f(a)</cato:entity-ref>)</cato:entity> is amended—</text>
				<paragraph commented="no" display-inline="no-display-inline" id="id3a342e9c-4461-4999-9d2a-8068fee7f8d6">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:2">paragraph (2)</cato:entity-ref>—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="id229a9291-5398-431b-a087-7ac037e6852d">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:2/sp:D">subparagraph (D)</cato:entity-ref>—</text>
						<clause commented="no" display-inline="no-display-inline" id="id3b4f9abe-3716-43cd-a1e0-ba83b1db2de9">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:2/sp:D/cl:i">clause (i)</cato:entity-ref>, by striking
			 <quote>and</quote> at the end;</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="id5f52b980-68fb-4813-b906-bdd09ed229e1">
              <enum>(ii)</enum>
              <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:2/sp:D/cl:ii">clause (ii)</cato:entity-ref>, by striking the period and
			 inserting a semicolon; and</text>
						</clause>
            <clause commented="no" display-inline="no-display-inline" id="id874840e1-cfb6-4ed9-bbfc-be3d1e64ebcf">
              <enum>(iii)</enum>
              <text display-inline="yes-display-inline">by adding at the end the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id0dc4b283-d64d-4ac1-ab77-93a3b7a177f6" reported-display-style="italic" style="OLC">
								<clause commented="no" display-inline="no-display-inline" id="id47b94596-202d-4533-b1ca-9b5632a39ddf">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">one such member shall be an individual with
				pediatric subject matter expertise; and</text>
								</clause>
                <clause commented="no" display-inline="no-display-inline" id="idb71fea95-dce6-402a-8c22-4c2356a15991">
                  <enum>(iv)</enum>
                  <text display-inline="yes-display-inline">one such member shall be a State, tribal,
				territorial, or local public health
				official.</text>
								</clause>
                <after-quoted-block>;
				and</after-quoted-block>
              </quoted-block>
						</clause>
          </subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="id34ee693e-824e-4824-b3d7-8337668a1262">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following flush
			 sentence:</text>
					</subparagraph>
          <continuation-text commented="no" continuation-text-level="paragraph">
            <quote>Nothing in this paragraph shall
			 preclude a member of the Board from satisfying two or more of the requirements
			 described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:2/sp:D">subparagraph (D)</cato:entity-ref>.</quote>; and</continuation-text>
        </paragraph>
        <paragraph commented="no" display-inline="no-display-inline" id="ida581d119-2b67-46a3-9ecc-3385f5723c26">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:5">paragraph (5)</cato:entity-ref>—</text>
					<subparagraph commented="no" display-inline="no-display-inline" id="id81b353fd-e924-43af-9064-c40be99abfa8">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:5/sp:B">subparagraph (B)</cato:entity-ref>, by striking
			 <quote>and</quote> at the end;</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="id43fca282-8823-4dec-9421-2b7a69941ff9">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319M/ss:a/p:5/sp:C">subparagraph (C)</cato:entity-ref>, by striking the period
			 and inserting <quote>; and</quote>; and</text>
					</subparagraph>
          <subparagraph commented="no" display-inline="no-display-inline" id="idc6256056-acd5-4a46-9ad1-e54ae8bd45d3">
            <enum>(C)</enum>
            <text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida7f49281-29a8-424e-8ab0-6a77c79ed131" reported-display-style="italic" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="idf3f49ee6-08ec-44f8-9b4a-109967e5d4d4">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">provide any recommendation, finding, or
				report provided to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> under this paragraph to the appropriate
				committees of
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>.</text>
							</subparagraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
					</subparagraph>
        </paragraph>
      </section>
    </title>
  </legis-body>
	<endorsement>
		<action-date>February 14, 2013</action-date>
		<action-desc>Reported with an amendment</action-desc>
	</endorsement>
</bill>
</doc>